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“The desire for cognitive enhancement is very strong, maybe 
stronger than for beauty, or athletic ability.” 
Benedict Carey1 
I. INTRODUCTION 
Brains + drugs = fried eggs, right?2  Not always.  Cognitive enhancers 
are drugs designed to boost mental powers and stamina without turning your 
brain into runny, white edibles.3  These enhancers affect the brain’s neural 
processes that trigger memory, attention, learning, and decision making by 
altering the balance of chemical neurotransmitters.4  While America’s 
favorite cognitive enhancer is caffeine,5 other study drugs are the “higher-
tech equivalents of NoDoz” or the two pots of coffee that students and 
professionals otherwise consume to pull all-nighters for presentations, term 
papers, or final exams.6  Such modern caffeine substitutes range from 
stimulants to narcolepsy pills and are enticingly attractive for an overworked 
twenty-four-seven society.7 
In 2008, as cognitive enhancement increasingly became a household 
name among scientists and academics, Henry Greely, Barbara Sahakian, and 
 
 1.  Benedict Carey, Smartening Up: Brain Enhancement is Wrong, Right?, N.Y. TIMES (Mar. 9, 
2008), http://www.nytimes.com/2008/03/09/weekinreview/09carey.html?_r=1&ref=todayspaper& 
pagewanted=2 (quoting Dr. Barbara Sahakian of Cambridge University); see also infra notes 8–9 
and accompanying text. 
 2.  See Partnership for a Drug-Free America, Your Brain on Drugs, YOUTUBE (Sept. 16, 2008), 
http://www.youtube.com/watch?v=3FtNm9CgA6U (depicting a well-known anti-drug commercial 
from the 1980s).  Drugs can be defined as any chemical agents that affect “living processes that may 
be ingested through the mouth, the rectum, by injection, or by inhalation.”  DAVID A. J. RICHARDS, 
SEX, DRUGS, DEATH, AND THE LAW: AN ESSAY ON HUMAN RIGHTS AND OVERCRIMINALIZATION 
158 (1982). 
 3.  See Cognitive Enhancement, All on the Mind: Prepare for Drugs That Will Improve 
Memory, Concentration and Learning, ECONOMIST, May 22, 2008, at 103 [hereinafter Cognitive 
Enhancement, All on the Mind]; see also Joanne Chen, Can a Pill Make You Smarter? A Series of 
New Drugs Promises to Increase Our Productivity and Focus, MARIE CLAIRE (Dec. 15, 2008), 
http://www.marieclaire.com/career-money/jobs/pill-for-productivity-focus (referring to cognitive 
enhancers as “[c]rack for nerds”). 
 4.  Cognitive Enhancement, All on the Mind, supra note 3, at 103. 
 5.  Karen J. Winkler, Pill-Popping Profs, CHRON. HIGHER EDUC., Jan. 11, 2008, at B4 
(describing the demand for and daily use of caffeine as staggering despite its side effects and 
addictive qualities). 
 6.  Henry T. Greely, Remarks on Human Biological Enhancement, 56 U. KAN. L. REV. 1139, 
1143–44 (2008) (discussing the future of cognitive enhancement). 
 7.  Chen, supra note 3, at 169; see, e.g., Jason Kirby, Going to Work on Smart Drugs: Will 
Employers Pressure Staff to Take Brain Boosters?, MACLEAN’S (Oct. 1, 2008), 
http://www.macleans.ca/science/health/article.jsp?content=20081001_98115_98115 (interviewing 
an aviation operations manager who takes narcolepsy medication as “part of a growing throng of 
otherwise healthy individuals popping high-powered pharmaceuticals to add some zing to their grey 
matter”). 
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several of their colleagues aroused mainstream media attention8 when they 
published a commentary in a prominent science journal that supported the 
use of cognitive-enhancing medications as a way for healthy adults to boost 
their mental capabilities.9  While they lobbied for general consumption by 
society, they warned that certain settings warranted closer ethical scrutiny.10  
Specifically, the authors mentioned the two most traditionally worrisome 
categories for medicinal brain boosting—military personnel11 and school 
children.12  Another area of concern, but one far less scrutinized, is the 
higher-education setting of medical and law schools, where graduate 
students intensely compete for grades in an environment designed to prepare 
them for their professional responsibilities.13 
 
 8.  See, e.g., Go Brain-Boosters, NEW SCIENTIST, Dec. 13, 2008, at 6; Ginger Rough, 
Popularity of Brain-Boost Pills Drives Debate, ARIZ. REPUBLIC (July 5, 2009), 
http://www.azcentral.com/arizonarepublic/news/articles/2009/07/05/20090705braindrugs0705.html; 
Judith Warner, Living the Off-Label Life, N.Y. TIMES (Dec. 27, 2008), http://www.nytimes.com/ 
2008/12/27/opinion/27warner.html.  George Annas, Chair of the Department of Health Law, 
Bioethics, and Human Rights at Boston University, contended that Greely and his co-authors had 
presented a rather idyllic view of cognitive enhancement that ignored the safety implications.  
Bernadette Tansey, Experts Urge Wider Use of Brain-Boosting Drugs, S.F. CHRON. (Dec. 8, 2008), 
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/12/07/MNHG14I85V.DTL.  Annas questioned, 
“[W]hat were they smoking when they wrote this article?”  Id. 
 9.  Henry Greely et al., Towards Responsible Use of Cognitive-Enhancing Drugs by the 
Healthy, 456 NATURE 702, 702 (2008); see also Brain Boosters: How Should We Deal with 
Cognitive-Enhancing Drugs?, STAN. MAG., Mar.–Apr. 2009, at 24, 25 [hereinafter Brain Boosters], 
available at http://www.stanfordalumni.org/news/magazine/2009/marapr/farm/news/greely.html (in 
a question-and-answer session, Professor Henry Greely argued that “[e]nhancement is not a dirty 
word”). 
 10.  Greely et al., supra note 9, at 703.  Their ethical concerns centered on safety, freedom, and 
fairness.  Id.  “[M]ore of this [is] coming down the road, and we’re just not prepared as a society yet 
for how we should deal with good, safe, cognitively enhancing drugs that will almost certainly be 
available in the next 10 to 20 years.”  Brain Boosters, supra note 9, at 24. 
 11.  See Greely et al., supra note 9, at 703; see also Catherine L. Annas & George J. Annas, 
Enhancing the Fighting Force: Medical Research on American Soldiers, 25 J. CONTEMP. HEALTH L. 
& POL’Y 283, 291 (2009). 
 12.  See Greely et al., supra note 9, at 703; see also Ann Chiumino, Class Action Suits Prompt 
Governmental Action to Examine Ritalin Use and Regulation, 13 LOY. CONSUMER L. REV. 380, 388 
(2001).  However, Greely also contended that scholastic cognitive-enhancement use that enhanced 
long-term learning is acceptable in non-zero-sum school environments.  Greely et al., supra note 9, 
at 704. 
 13.  See infra notes 16, 192–93 and accompanying text.  Medicinal brain boosting in higher 
education has barely generated any scrutiny or attention because medical and law school drug users 
are “driven, healthy A-plus students,” not the traditional cocaine or alcohol abusers.  See Nicholas 
W. Schieffelin, Maintaining Educational and Athletic Integrity: How Will Schools Combat 
Performance-Enhancing Drug Use?, 40 SUFFOLK U. L. REV. 959, 972 (2007).  More importantly, 
their drugs may be legal substances validly obtained through doctors’ prescriptions.  Maxwell J. 
Mehlman, Cognition-Enhancing Drugs, 82 MILBANK Q. 483, 492 (2004); see also infra notes 122–
24 and accompanying text. 
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In this higher-education context, students who consume cognitive 
enhancers may be like pupils who are allowed to use calculators on math 
tests, while others are forced to struggle with paper and pen.14  Notably, 
medical and law school students’ use of scholastic steroids generates more 
ethical implications than the rest of society because these students labor 
within unique ethical frameworks.15  Their prospective professions embrace 
values that set them apart from the general public.16  These students and their 
professional counterparts work under ethical codes and restrictions 
promulgated by their respective national associations—the American 
Medical Association (AMA) produces the Principles of Medical Ethics,17 
and the American Bar Association (ABA) publicizes the Model Rules of 
Professional Conduct.18  These codes govern students’ actions throughout 
the entire educational process.19  First, applicants must demonstrate integrity 
 
 14.  See Greely et al., supra note 9, at 703–04 (asking educators, academic admissions officers, 
and credentials evaluators to ensure validity and integrity of examinations by formulating policies 
addressing cognitive-enhancement drug use). 
 15.  See Linda A. McGuire & Julie Phye, The Hidden Curriculum in Medical and Law Schools: 
A Role for Student Affairs Professionals, 115 NEW DIRECTIONS STUDENT SERVICES 59, 63 (2006); 
see also infra notes 16–19 and accompanying text. 
 16.  McGuire & Phye, supra note 15, at 63 (explaining that doctors and lawyers are expected to 
be contributors to the community and role models of service); see also SHAUN D. PATTINSON, 
MEDICAL LAW AND ETHICS 2 (1st ed. 2006) (“Medical practice and the law regulating medical 
practice play out in an overtly moral arena.”).  In their education and employment, medical and law 
school students aim for professionalism, a term used to describe “adherence to a set of values 
beyond intellectual capacity that is common to the professions and gives practitioners the exclusive 
right to engage in the profession’s activities.”  McGuire & Phye, supra note 15, at 63.  
Professionalism encompasses honor, integrity, accountability, altruism, and respect for others.  Id. at 
63, 65 (noting that medical and legal clinics permit students to practice hands-on professionalism).  
The melding of professionalism and ethics into professional ethics forms guidelines on how to 
integrate actions, commitments, and traits of character typical of the professions so as to acquire a 
life well-lived.  DANIEL MARKOVITS, A MODERN LEGAL ETHICS: ADVERSARY ADVOCACY IN A 
DEMOCRATIC AGE 1 (2008). 
 17.  See CODE OF MEDICAL ETHICS OF THE AMERICAN MEDICAL ASSOCIATION (2010).  The 
Code of Medical Ethics has been the “authoritative ethics guide for practicing physicians” for more 
than 160 years.  History of AMA Ethics, AM. MED. ASS’N, http://www.ama-assn.org/ama/pub/about-
ama/our-history/history-ama-ethics.page (last visited Feb. 25, 2012) (providing a general history of 
the Code of Medical Ethics); see also Principles of Medical Ethics, AM. MED. ASS’N, 
http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/principles-
medical-ethics.page? (last visited Feb. 25, 2012) (tasking physicians to “uphold standards of 
professionalism,” “respect the law,” and “regard responsibility to the patient as paramount”). 
 18.  See MODEL RULES OF PROFESSIONAL CONDUCT (2010).  The Model Rules of Professional 
Conduct, which specifically requires lawyers to maintain the integrity of their profession, serves as a 
model for the ethical rules of forty-nine states and the District of Columbia.  See generally State 
Adoption of the ABA Model Rules of Professional Conduct, AM. BAR ASS’N, 
http://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professio
nal_conduct/alpha_list_state_adopting_model_rules.html (last visited Feb. 25, 2012) (conspicuously, 
California is absent from the list of states that have adopted the Model Rules). 
 19.  See Elizabeth Gepford McCulley, School of Sharks? Bar Fitness Requirements of Good 
Moral Character and the Role of Law Schools, 14 GEO. J. LEGAL ETHICS 839, 867 (2001) 
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and adherence to ethical conduct when they apply to medical20 or law 
schools.21  Second, once they officially become students, they must take 
mandatory ethics or professional responsibility courses within their 
medical22 or law school curriculum.23  After students graduate, entry into 
their professional practices mandates that they pass licensure exams, as well 
as moral fitness and character inquiries.24  Finally, after achieving 
 
(suggesting methods to enforce ethical standards); see also infra notes 20–25 and accompanying 
text. 
 20.  ROBERT H. MILLER & DANIEL M. BISSELL, MED SCHOOL CONFIDENTIAL 74 (2006) 
(discussing requirements for prospective medical students).  For medical school applications, good 
ethical conduct is usually assumed but, if an application reveals lapses in ethical conduct, the 
applicant must specifically address this in a letter of explanation.  Id. (“Any sort of criminal record, 
especially one involving substance abuse, will be a matter of serious concern to admissions 
committees.”).  When medical students transfer to other medical schools, applications for transfer 
should include a letter of evaluation from the current school’s Dean or Associate Dean of Student 
Affairs that specifically addresses any infractions of the school’s code of ethical conduct.  ASS’N OF 
AM. MED. COLLS., HANDBOOK FOR ADMISSIONS OFFICERS 88 (GSA Nat’l Comm. on Admissions 
Members eds., 2004). 
 21.  See, e.g., LAW. SCH. ADMISSION COUNCIL & AM. BAR ASS’N, ABA-LSAC OFFICIAL GUIDE 
TO ABA-APPROVED LAW SCHOOLS: 2012 EDITION 13–15 (2011).  Law school applicants must 
comply with the Law School Admission Council’s ethical standards—LSAC Rules Governing 
Misconduct and Irregularities in the Admission Process—or face serious sanctions and possible 
barring from the admission process.  Id. (explaining that a later finding of misconduct may lead to 
the closing of an admission file, the revocation of an offer of admission, dismissal from a law school, 
or disbarment).  Most law schools also inquire into applicants’ past criminal records on their 
admission applications.  Keith Swisher, The Troubling Rise of the Legal Profession’s Good Moral 
Character, 82 ST. JOHN’S L. REV. 1037, 1044 (2008). 
 22.  McGuire & Phye, supra note 15, at 64.  In medical school, students also learn the 
Hippocratic Oath, a declaration stating students and physicians’ intentions to practice medicine 
justly and ethically.  Raphael Hulkower, The History of the Hippocratic Oath: Outdated, 
Inauthentic, and Yet Still Relevant, 25/26 EINSTEIN J. BIOLOGY & MED. 41, 41 (2010).  Medical 
students may actually first recite this oath after their new student orientation and before beginning 
their formal education.  McGuire & Phye, supra note 15, at 65 (explaining that such a procedure 
alerts students to their professional responsibility for others’ well-being).  Most medical students 
also recite the oath during their graduation ceremonies.  Hulkower, supra, at 41. 
 23.  McCulley, supra note 19, at 862 (“The ABA requires accredited law schools to provide 
education in the responsibilities of the legal profession as well as education covering the Model 
Rules.”); see also PATTINSON, supra note 16, at 3 (noting that “morality is sometimes explicitly 
incorporated into legal doctrine”).  Law schools enforce ethical conduct with honor codes and ethics 
committees.  McCulley, supra note 19, at 858 (describing honor codes as promoting honesty, 
integrity, and fairness).  These honor codes are self-regulated and ask students to report suspected 
violations.  Id. at 858–60 (noting that some codes even allow sanctioning of witnesses who fail to 
disclose infractions). 
 24.  McGuire & Phye, supra note 15, at 63 (“[B]ecause lawyers and physicians take on the 
responsibility for their clients’ or patients’ health, lives, livelihoods, and liberty, entry into 
professional practice requires more than earning the terminal academic degree.”); see, e.g., Swisher, 
supra note 21, at 1043 (noting that every state requires applicants to prove “good moral character” 
before admission to the legal bar).  Bar committees screen applicants by inquiring into conduct such 
as illegal acts, academic misconduct, dishonesty, and drug abuse.  McGuire & Phye, supra note 15, 
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certification as physicians or lawyers, they “face lifelong regulation by 
governmental and professional entities and, in many areas, a requirement of 
annual continuing education.”25 
Because medical and law schools are such ethically-governed settings, 
the fundamental question then becomes whether scholastic use of cognitive-
enhancement medications is actually a form of cheating.26  If answered 
affirmatively, this question requires action from the AMA, ABA, and 
respective educational institutions for the formulation of ethical guidelines 
and policies that would address and limit such cheating.27  This Comment 
attempts to answer whether medicinal brain boosting within medical and law 
schools is cognitive cheating by addressing the issue through pertinent 
ethical concerns. 
Part II of this Comment provides a scientific overview of the four most 
common cognitive enhancers and their FDA-approved uses.28  Part II also 
discusses the off-label exploitation of these medications.29  Part III analyzes 
medicinal neurocognitive enhancement within medical and law schools 
through three ethical categories—safety concerns, social implications, and 
fairness issues—to determine if such use is cognitive cheating.30  Part IV 
presents possible steps that university administrators may implement to 
prevent or monitor consumption of cognitive enhancers.31  Part IV further 
suggests new AMA and ABA guidelines that would directly address this 
issue.32  Part V concludes.33 
II. POPPING SMART PILLS: USE AND ABUSE OF COGNITIVE ENHANCERS 
The question of whether medicinal cognitive enhancement is cheating in 
a higher-educational environment requires understanding both the science 
behind cognitive enhancers and their resulting uses.  This Comment will 
 
at 63.  For example, prospective lawyers must meet standards of fitness and demonstrate moral 
traits—including honesty, responsibility, and truthfulness.  McCulley, supra note 19, at 842, 850 
(explaining that one highly offensive act or pattern of minor offensive behavior can cause denial of 
admission to the state legal bar).  In most jurisdictions, they also must take and pass the Multistate 
Professional Responsibility Examination.  Bar Admissions Basic Overview, AM. BAR ASS’N, 
http://www.americanbar.org/groups/legal_education/resources/bar_admissions/basic_overview.html 
(last visited Feb. 25, 2012). 
 25.  McGuire & Phye, supra note 15, at 63. 
 26.  See infra notes 114–16 and accompanying text.  Cheating may be defined as an intentional 
violation of an explicit or implicit rule to gain an unfair advantage over others.  See M. Schermer, 
On the Argument that Enhancement Is “Cheating,” 34 J. MED. ETHICS 85, 85 (2008). 
 27.  See infra notes 291–92 and accompanying text. 
 28.  See infra notes 34–67 and accompanying text. 
 29.  See infra notes 70–111 and accompanying text. 
 30.  See infra notes 116–287 and accompanying text. 
 31.  See infra notes 290–364 and accompanying text. 
 32.  See infra notes 367–86 and accompanying text. 
 33.  See infra notes 387–92 and accompanying text. 
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begin with a technical overview of the four main cognitive enhancers.  It 
will then contrast their FDA-approved applications with their increasingly 
off-label, brain-boosting exploitation. 
A. Brain Therapy: The FDA-Approved Uses of Cognitive Enhancers 
Many medications prescribed to treat neurological conditions also boost 
the cognitive performances of healthy individuals because of these drugs’ 
distinctive effects on the human biological system.34  The most popular 
cognitive enhancers are Adderall, Ritalin, Provigil, and beta blockers35 
because of their individual chemical functions. 
1. Adderall and Ritalin 
Adderall and Ritalin are psychostimulant medications used in the 
treatment of AD/HD.36  Physicians prescribe both for children,37 but only 
Adderall is FDA-approved for the treatment of adult AD/HD.38  These 
medications work to lessen associated behavioral problems, such as 
 
 34.  Greely et al., supra note 9, at 702. 
 35.  See infra notes 73–74 and accompanying text. 
 36.  Nick Szuflita, Ritalin Abuse is Increasing, JOHNS HOPKINS NEWSL. (Nov. 22, 2002), 
http://www.jhunewsletter.com/sports/ritalin-abuse-is-increasing-1.1144049#.T0l1Y_HOW5I.  
AD/HD is the accepted acronym for two behavioral disorders—Attention Deficit Disorder (ADD) 
and Attention Deficit Hyperactivity Disorder (AD/HD).  Id.  These neurodevelopment disorders, or 
“processing deficit[s],” are lifelong and result from the underdevelopment of the area in the brain 
that stops inappropriate behavior and regulates attention.  Praveen Madhiraju, R.I.P. Ritalin in 
Proportion!  The Eighth Circuit’s Restriction on a Parent’s Right to Have Schools Accommodate the 
Needs of Their Disabled Children: Debord and Davis, 95 NW. U. L. REV. 1661, 1664–65 (2001) 
(explaining that children with AD/HD cannot control themselves and often disrupt class). 
 37.  What We Know: Managing Medication for Children and Teenagers with AD/HD, NAT’L 
RES. CTR. ON AD/HD, 2, http://www.help4adhd.org/documents/WWK3s.pdf [hereinafter Managing 
Medication].  While physicians usually first diagnose AD/HD during childhood, it commonly lasts 
into adulthood.  ADHD: Fact Sheet, CTRS. FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/ncbddd/actearly/pdf/parents_pdfs/ADHDFactSheet.pdf; see also Lawrence 
Scahill et al., Methylphenidate: Mechanism of Action and Clinical Update, 17 J. CHILD & 
ADOLESCENT PSYCHOL. NURSING 85, 85 (2004) (stating that in 60% to 80% of cases, AD/HD 
persists into adolescence, and in 30% to 40% of cases, it persists into adulthood). 
 38.  See Ritalin for Adults: An Overview, EMEDTV, http://adhd.emedtv.com/ritalin/ritalin-for-
adults.html (last visited Feb. 25, 2012).  Nonetheless, doctors still prescribe Ritalin to adults for off-
label purposes.  Id. (explaining that off-label use occurs when a medication is taken to treat a disease 
or age group the FDA has not approved to use that drug).  Actually, Ritalin is the most common 
medication used in the treatment of AD/HD.  Christina Pancheri & Mary Anne Prater, What 
Teachers and Parents Should Know About Ritalin, TEACHING EXCEPTIONAL CHILD., Mar.–Apr. 
1999, at 20; see also Szuflita, supra note 36 (“[O]ver 7 million children consume over eight tons of 
Ritalin every year in the United States . . . .”). 
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inattention, hyperactivity, and impulsivity.39  On a chemical level, they 
stimulate the frontal parts of the brain by increasing and balancing the levels 
of two neurotransmitters—dopamine40 and norepinephrine.41  While this 
brain stimulation helps individuals with AD/HD behave normally, it allows 
individuals without AD/HD to focus and concentrate better than normal.42 
Adderall is available in two commercial versions—standard Adderall43 
and Adderall XR.44  Both of these medications are mixtures of l-
amphetamine and d-amphetamine.45  Ritalin, or methylphenidate 
 
 39.  See ADHD: Fact Sheet, supra note 37 (listing the symptoms of AD/HD).  These medications 
lessen AD/HD symptoms in 70% to 80% of the children who take the stimulants.  Managing 
Medication, supra note 37, at 2 (“Medications are not used to control behavior.  Instead, they are 
used to make the symptoms of AD/HD better.”). 
 40.  See Managing Medication, supra note 37, at 4.  The brain contains at least five different 
types of dopamine receptors, but dopamine is linked primarily to the brain’s pleasure system that 
motivates individuals to proactively perform certain tasks.  See Karl Harrison, Dopamine, 
http://www.3dchem.com/molecules.asp?ID=289 (last visited Feb. 25, 2012); see also Scahill et al., 
supra note 37, at 86 (explaining that stimulants enhance dopamine function by promoting dopamine 
release and blocking reuptake).  Dopamine tends to promote mood elevations and “feelings of 
alertness, well-being and superiority.”  Szuflita, supra note 36. 
 41.  Karl Harrison, Norepinephrine, http://www.3dchem.com/molecules.asp?ID=288 (last visited 
Feb. 25, 2012).  Norepinephrine is a stress hormone that affects the part of the brain that controls 
attention and responding actions.  Id.  Although stimulants are the most common medications for 
AD/HD treatment, their “mechanism of action is not completely understood.”  Scahill et al., supra 
note 37, at 85.  Studies show that the hyperactivity and impulsivity of AD/HD is primarily associated 
with the reduced effectiveness of dopamine functions in the brain, while inattention is connected with 
the reduced effectiveness of norepinephrine, a neurotransmitter in the nervous system.  Terje Sagvolden 
& Tong Xu, L-Amphetamine Improves Poor Sustained Attention While D-Amphetamine Reduces 
Overactivity and Impulsiveness as Well as Attention-Deficit/Hyperactivity Disorder (ADHD), BEHAV. 
& BRAIN FUNCTIONS 10 (Jan. 23, 2008), available at http://www.behavioralandbrainfunctions.com/ 
content/pdf/1744-9081-4-3.pdf; see also Harrison, supra. 
 42.  See James Pavisian, The Case for Human Ingenuity: How Adderall Has Sullied the Game, 
48 WASHBURN L.J. 175, 179–80 (2008); see also Craig S. Lerner, “Accomodations” for the 
Learning Disabled: A Level Playing Field or Affirmative Action for Elites?, 57 VAND. L. REV. 1043, 
1069 (2004) (explaining that dopamine imbalances in the brain will increase an individual’s energy 
and concentration). 
 43.  Pavisian, supra note 42, at 177–78.  Standard Adderall is an immediate-acting tablet that 
lasts for four to six hours.  Managing Medication, supra note 37, at 5. 
 44.  Pavisian, supra note 42, at 177–78.  Half of every Adderall tablet consists of amphetamine.  
Ann P. Fenton & John M. Wunderlich, Mental Doping: The Untold Story of Modern Law School 
Exams, STUDENT LAW., Jan. 2010, at 17.  Adderall XR, as the longer-lasting version, is “chemically 
designed ‘to give a double-pulsed delivery of amphetamines, which prolongs the release of 
amphetamine . . . compared to the conventional (immediate-release) tablet formulation.’  By 
allowing you to stay high longer, a single dose of Adderall is almost like two for the price of one.”  
Id. at 17–18. 
 45.  Pavisian, supra note 42, at 178 n.17 (“When amphetamines are synthesized it creates two 
molecules known as d-amphetamine and l-amphetamine.”).  Because of this mixture, Adderall is 
called mixed-salts amphetamine or dl-amphetamine.  John E. Owen, Jr., The Influence of Dl-, D-, 
and L-Amphetamine and D-Methamphetamine on a Fixed-Ratio Schedule, 3 J. EXPERIMENTAL 
ANALYSIS BEHAV. 293, 294 (1960).  D-amphetamine is 1.5 to two times more potent than dl-
amphetamine and three to four times more potent than l-amphetamine.  Id.  D-amphetamine and l-
amphetamine also are different in how they affect the release of dopamine and norepinephrine.  See 
Sagvolden & Xu, supra note 41.  Studies show that d-amphetamine—which increases wakefulness, 
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hydrochloride, comes in three commercial versions—standard Ritalin, 
Ritalin LA, and Ritalin SR.46  Ritalin LA and Adderall XR are longer-lasting 
medications, available as extended release capsules.47 
The United States Food and Drug Administration (FDA)  has approved 
Adderall solely for use as an AD/HD medication and Ritalin both as an 
AD/HD medication and in the treatment of adult narcolepsy.48  These 
stimulant medications are federally controlled substances because they can 
engender abuse or lead to dependence.49  For example, Ritalin abuse creates 
almost the same adverse effects as those caused by cocaine use.50 
 
energy, and self-confidence, and decreases fatigue and appetite—is twice as potent as l-amphetamine 
in reducing hyperactivity and impulsivity.  Id. at 7; Karl Harrison, Dextroamphetamine, 
3DCHEM.COM, http://www.3dchem.com/molecules.asp?ID=401 (last visited Feb. 25, 2012).  
However, both amphetamines improve sustained attention.  Sagvolden & Xu, supra note 41. 
 46.  Managing Medication, supra note 37, at 4.  Standard Ritalin is an immediate release tablet 
that lasts three to four hours, while Ritalin SR is a sustained release tablet that works for six to eight 
hours.  Id. at 7–8. 
 47.  Id. at 4–5 (explaining that Ritalin LA works for eight to ten hours and Adderall XR lasts for 
eight to twelve hours). 
 48.  U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: ADDERALL XR (2011) [hereinafter 
MEDICATION GUIDE: ADDERALL XR], available at http://www.fda.gov/downloads/Drugs/ 
DrugSafety/ucm085819.pdf; U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: RITALIN (2010) 
[hereinafter MEDICATION GUIDE: RITALIN], available at http://www.fda.gov/downloads/Drugs/ 
DrugSafety/ucm089090.pdf; see also supra notes 37–38 and accompanying text (explaining that 
Adderall and Ritalin are both FDA-approved for adolescent AD/HD, but only Adderall is approved 
for adult AD/HD). 
 49.  MEDICATION GUIDE: ADDERALL XR, supra note 48, at 1; MEDICATION GUIDE: RITALIN, 
supra note 48, at 1; see also Prescription Drug Abuse: Hearing Before the Subcomm. on Crim. Just., 
Drug Pol’y, & Hum. Res. Comm. on Gov’t Reform, 109th Cong. (2006) [hereinafter Prescription 
Drug Abuse: Hearing], available at http://www.hhs.gov/asl/testify/t060726a.html (statement of Nora 
D. Volkow, Director, Nat’l Inst. on Drug Abuse) (“[T]hese classes of psychotherapeutic drugs have 
a real potential for leading to addiction, especially if abused repeatedly, at high doses, and/or by 
susceptible individuals.”).  Federal law classifies drugs that are popular for recreational or addictive 
use into “schedules” and “imposes special handling and paperwork requirements for their use.”  
Henry T. Greely, Disabilities, Enhancements, and the Meanings of Sports, 15 STAN. L. & POL’Y 
REV. 99, 115 (2004).  The U.S. Drug Enforcement Administration (DEA) has categorized Adderall 
and Ritalin as Schedule II drugs based on their potential for abuse.  U.S. DRUG ENFORCEMENT 
ADMIN., DRUGS OF ABUSE: 2011 EDITION: A DEA RESOURCE GUIDE 18–19 (2011) [hereinafter 
DRUGS OF ABUSE], available at http://www.justice.gov/dea/pubs/drugs_of_abuse.pdf (listing 
Schedules I–V, with I encompassing drugs with the highest addictive qualities).  Abuse of Schedule 
II drugs may cause severe psychological or physical dependence.  Id. at 9.  Other Schedule II drugs 
include morphine, methadone, and cocaine.  Id. 
 50.  Madhiraju, supra note 36, at 1667.  Ritalin abuse causes increased heart and respiratory 
rates, dilated pupils, elevated blood pressure, dry mouth, perspiration, and feelings of superiority.  
Chiumino, supra note 12, at 386; see also Szuflita, supra note 36 (noting that Ritalin and cocaine 
also generate aggression, hostility, and strange behavior in severe cases).  Ritalin and cocaine both 
block the reuptake of dopamine and actually compete for binding sites in the brain regions 
responsible for reward and pleasure-related behaviors.  Szuflita, supra note 36; see also supra note 
40 and accompanying text.  A person who injects either drug intravenously will experience a rush or 
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2. Provigil 
The second type of cognitive enhancer is Provigil, a psychostimulant 
medication that is FDA-approved to improve wakefulness in adults 
diagnosed with narcolepsy,51 obstructive sleep apnea,52 or shift-work sleep 
disorder.53,54  Provigil keeps individuals awake and alert regardless of the 
underlying causes for their sleepiness.55  On a chemical level, recent studies 
conclude that Provigil works in a similar fashion as Adderall and Ritalin by 
increasing dopamine and blocking dopamine transporters.56  Provigil also is 
 
high because the drugs will cause a rapid and large increase in dopamine.  Prescription Drug Abuse: 
Hearing, supra note 49; see also CYNTHIA KUHN ET AL., BUZZED: THE STRAIGHT FACTS ABOUT 
THE MOST USED AND ABUSED DRUGS FROM ALCOHOL TO ECSTASY 230 (3d ed. 2008) (warning that 
the injection of Ritalin is extremely dangerous because components of the pills can lodge in the tiny 
blood vessels of the lungs or eyes and create severe damage).  The oral administration of Ritalin 
does not produce this same rush since it elicits a gradual and sustained increase in dopamine.  
Prescription Drug Abuse: Hearing, supra note 49.  For this reason, abusers sometimes snort or inject 
Ritalin by crushing Ritalin tablets into a fine powder or dissolving the tablets into liquid.  Chiumino, 
supra note 12, at 388 (comparing such methods to cocaine and heroin administration). 
 51.  Narcolepsy is a sleep disorder characterized by a “sudden uncontrollable disposition to sleep 
occurring at irregular intervals . . . .”  STEDMAN’S MEDICAL DICTIONARY 923 (23d ed. 1976). 
 52.  Obstructive sleep apnea is a breathing disorder defined by recurring interruptions of 
breathing during sleep.  See id. at 99. 
 53.  Shift-work sleep disorder is a constant or recurrent pattern of sleep interruption commonly 
found in people who work nontraditional hours or frequently alternate shifts.  Michael J. Thorpy, 
Managing the Patient with Shift-Work Disorder, 59 SUPP. J. FAM. PRAC. 824, 826 (2010) (observing 
that the most common symptoms of shift-work disorder are insomnia and excessive sleepiness). 
 54.  See Media Fact Sheet: Provigil (Modafinil) Tablets, CEPHALON, 1–2, available at 
http://www.cephalon.com/fileadmin/media/downloads/PROVIGIL_Fact_Sheet.pdf [hereinafter 
Media Fact Sheet: Provigil]; Medication Guide: Provigil, U.S. FOOD & DRUG ADMIN., MEDICATION 
GUIDE: PROVIGIL 35–36 (2010), available at http://www.fda.gov/downloads/Drugs/DrugSafety/ 
UCM231722.pdf [hereinafter MEDICATION GUIDE: PROVIGIL] (noting that Provigil does not cure 
sleep disorders but works to prevent sleepiness caused by sleep disorders).  Provigil is available in 
100-milligram or 200-milligram doses with the general recommended dosage set at 200 milligrams 
consumed once per day.  Provigil, RXLIST: THE INTERNET DRUG INDEX, www.rxlist.com/provigil-
drug.htm (last visited Feb. 25, 2012) (advising that patients with narcolepsy take a single dose in the 
morning and patients with shift- work sleep disorder take a single dose one hour before their work 
shifts begin). 
 55.  John E. Osborn, Can I Tell You the Truth? A Comparative Perspective on Regulating Off-
Label Scientific and Medical Information, 10 YALE J. HEALTH POL’Y L. & ETHICS 299, 334 (2010).  
In 2004, the FDA specifically rejected manufacturers’ efforts to have Provigil approved for 
excessive sleepiness from any cause.  Anahad O’Connor, Wakefulness Finds a Powerful Ally, N.Y. 
TIMES (June 29, 2004), http://www.nytimes.com/2004/06/29/health/wakefulness-finds-a-powerful-
ally.html?pagewanted=all&src=pm.  However, physicians still prescribe it for off-label uses, such as 
aiding recovery from jet lag or staving off general fatigue.  Cognitive Enhancement, All on the Mind, 
supra note 3, at 103. 
 56.  See, e.g., Monica L. Andersen et al., Dopamine Transporter-Related Effects of Modafinil in 
Rhesus Monkeys, 210 PSYCHOPHARMACOLOGY 439, 440 (2010); Nora D. Volkow et al., Effects of 
Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain: Clinical 
Implications, 301 J. AM. MED. ASS’N 1148, 1152 (2009); see also supra notes 40–41 and 
accompanying text (discussing Adderall and Ritalin’s effects on dopamine).  Provigil may also 
elevate norepinephrine in select brain regions by preventing its reuptake.  Bertha K. Madras et al., 
Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the 
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a federally controlled substance because it can prompt abuse or lead to 
dependence.57 
3. Beta Blockers 
The final common cognitive enhancers are beta blockers, or beta-
adrenergic blocking agents, that are FDA-approved to manage a variety of 
conditions, such as cardiac arrhythmia, diabetes, and hypertension.58  
Chemically, they work by preventing two neurotransmitters—
norepinephrine (noradrenaline) and epinephrine (adrenaline)—from binding 
to beta receptors, which, in turn, blocks the effects of adrenaline.59  
 
Transporters and Trace Amine Activity in Vitro, 319 J. PHARMACOLOGY & EXPERIMENTAL 
THERAPEUTICS 561, 567 (2006); see also Dov Fox, Safety, Efficacy, and Authenticity: The Gap 
Between Ethics and Law in FDA Decisionmaking, 2005 MICH. ST. L. REV. 1135, 1142.  However, 
Provigil’s precise mechanism of action is not fully understood, although it is known to affect the part 
of the brain that regulates wakefulness.  Osborn, supra note 55, at 334. 
 57.  MEDICATION GUIDE: PROVIGIL, supra note 54, at 36; Media Fact Sheet: Provigil, supra note 
54.  The DEA has categorized Provigil as a Schedule IV drug.  DRUGS OF ABUSE, supra note 49, at 
9.  Relative to substances listed on Schedules I–III, Provigil has a low potential for abuse and may 
lead to limited physical or psychological dependence.  See id.; see also supra note 49 and 
accompanying text (explaining that Adderall and Ritalin are Schedule II drugs with higher potentials 
for addiction).  Other Schedule IV drugs include Xanax, Paxor, and Valium.  DRUGS OF ABUSE, 
supra note 49, at 23.  Although Provigil is listed as a low-abuse substance, its potential for abuse is 
still surrounded by debate.  See, e.g., Andersen et al., supra note 56, at 440; Volkow et al., supra 
note 56, at 1148.  Similar to Ritalin, Provigil binds to the same dopamine transporter sites as 
cocaine.  Volkow et al., supra note 56, at 1152; see also supra note 50 and accompanying text.  Still, 
reports of Provigil abuse are rare and significantly less frequent than those for Adderall and Ritalin.  
Volkow et al., supra note 56, at 1153 (suggesting, however, that the “risk for addiction in vulnerable 
persons merits heightened awareness”). 
 58.  Beta Blockers: Drug Information, RXLIST: THE INTERNET DRUG INDEX, www.rxlist.com/ 
script/main/art.asp?articlekey=90349 (last visited Feb. 25, 2012) (listing FDA-approved and off-
label uses).  Since the FDA-approved beta blockers in the 1960s, they have been the most commonly 
prescribed medication for heart failure and hypertension.  Vabren L. Watts, Beta-Blockers Used by 
Musicians, Athletes, Students to Enhance Performance, PHILA. INQUIRER (Aug. 16, 2010), 
http://articles.philly.com/2010-08-16/news/24973169_1_beta-blockers-graduatestudent-performance
-anxiety.  Traditionally, beta blockers were used in the treatment of heart problems because they 
“reduce blood pressure and improve the heart’s ability to relax and pump blood more effectively 
over time.”  Shayna M. Sigman, Are We All Dopes? A Behavioral Law & Economics Approach to 
Legal Regulation of Doping in Sports, 19 MARQ. SPORTS L. REV. 125, 156 (2008). 
 59.  Beta Blockers: Drug Information, supra note 58; see also Carl Elliott, In Defense of the Beta 
Blocker: Is This a Performance Drug That Could Actually Increase the Fairness of Olympic 
Contests?, ATLANTIC (Aug. 20, 2008), http://www.theatlantic.com/magazine/archive/2008/08/in-
defense-of-the-beta-blocker/6961 (explaining that beta blockers block particular nervous system 
receptors).  These nervous system or beta receptors are classified into two types—beta-1 receptors 
that control the heart and beta-2 receptors that control smooth muscle function in the body.  See E. 
Davis et al., The Rush to Adrenaline: Drugs in Sport Acting on the β-Adrenergic System, 154 BRIT. 
J. PHARMACOLOGY 584, 584–85 (2008).  “These receptors also happen to be the ones that get 
activated in times of fear or anxiety . . . .”  Elliott, supra.  However, beta blockers do not alleviate 
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Essentially, this medication prevents the body from triggering its “fight or 
flight” response.60 
More than fifteen different brands of beta blockers are available in the 
United States;61 some affect the heart, while others influence both the heart 
and blood vessels.62  Two of the most common beta blockers are propranolol 
(brand name Inderal)63 and metoprolol (brand names Lopressor and Toprol-
XL).64  Lopressor is the immediate release version of metoprolol,65 while 
Toprol-XL is the extended-release tablet.66  Unlike the other cognitive 
enhancers, beta blockers are generally not addictive.67 
Cognitive enhancers vary in their methods of administration and 
addiction potentials mainly because they differ in how they scientifically 
affect the human body.68  Nonetheless, the FDA has approved all of them for 
 
anxiety; instead, they block the outward signs of anxiety.  Id.  Unlike other cognitive enhancers, beta 
blockers do not affect dopamine levels.  See supra notes 40, 56 and accompanying text. 
 60.  Sigman, supra note 58, at 156 (describing beta blockers as inducing a calming effect).  Such 
an effect has generated off-label beta blocker use in the public performance setting.  Michael H. 
Shapiro, The Technology of Perfection: Performance Enhancement and the Control of Attributes, 65 
S. CAL. L. REV. 11, 42 (1991) (acknowledging beta blocker use by musicians, athletes, and other 
performers). 
 61.  Beta Blockers: Drug Information, supra note 58. 
 62.  Davis et al., supra note 59, at 584 (explaining that the effects of beta blockers depend on the 
type of beta receptor they block); see also supra note 59 and accompanying text. 
 63.  See Beta Blockers: Drug Information, supra note 58.  Inderal was the first beta blocker with 
widespread use and works on both the heart and blood vessels.  Adhi Sharma et al., Beta-Blocker 
Toxicity, MEDSCAPE REFERENCE, http://emedicine.medscape.com/article/813342-print (last updated 
Oct. 27, 2011).  It is a nonselective beta blocker because it blocks both types of beta receptors.  Id.; 
see also supra note 59 and accompanying text.  Inderal is available in tablets ranging from ten to 
eighty milligram doses with a recommended dosage generally beginning at forty milligrams twice 
daily.  Inderal, RXLIST: THE INTERNET DRUG INDEX, www.rxlist.com/inderal (last visited Feb. 25, 
2012); see also Mark A. Dotson, Restatement Third and Prescription Drug Liability: A Tough Pill to 
Swallow or Business as Usual?, 4 T.M. COOLEY J. PRAC. & CLINICAL L. 29, 36–37 (2000) (noting 
that Inderal is also available in “injectable form”).  Daily doses above 160 milligrams may cause 
fatigue, lethargy, and vivid dreams.  U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: INDERIDE 9 
(2008), available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/ 018031s035lbl.pdf. 
 64.  See Beta Blockers: Drug Information, supra note 58.  See generally Metoprolol, PUBMED 
HEALTH, http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000795 (last visited Feb. 25, 2012).  
Unlike Inderal, Toprol-XL is a selective beta blocker because it blocks only the beta-1 receptor.  
Beta Blockers: Drug Information, supra note 58; see also supra notes 59, 63 and accompanying text. 
 65.  See U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: LOPRESSOR HCT 1 (2008), available 
at http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018303s033lbl.pdf.  Lopressor’s 
initial dosage is usually 100 milligrams daily, but its most effective dose is between 100 to 450 
milligrams.  Id. at 9. 
 66.  See U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: TOPROL-XL 1 (2009), available at 
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019962s038lbl.pdf.  Toprol-XL is 
available in tablets ranging from 25 to 200 milligram doses.  Id. at 1, 15. 
 67.  Watts, supra note 58.  Unlike Adderall, Ritalin, and Provigil, the DEA has not categorized 
beta blockers as controlled substances.  See DRUGS OF ABUSE, supra note 49, at 15–25; see also 
supra notes 49, 57 and accompanying text. 
 68.  See, e.g., supra notes 41, 54, 59, 67 and accompanying text. 
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particular purposes while still explicitly declining to include cognitive-
enhancement use.69 
B. Brain Gain: The Off-Label Benefits of Cognitive Enhancers 
Medicinal off-label use is the utilization of a drug for purposes that are 
not FDA-approved.70  In the last decade, physicians have increasingly 
prescribed medications for off-label cognitive-enhancement reasons in a 
growing trend termed “cosmetic neurology”—where the focus is 
enhancement rather than treatment.71  As pharmaceutical laboratories race to 
develop the next blockbuster smart drug, commentators agree that the new 
frontier is mental doping.72  Although extensively prescribed for such an off-
label function,73 Adderall, Ritalin, Provigil, and beta blockers are just the 
 
 69.  See supra notes 48, 54, 58 and accompanying text (listing the FDA-approved uses for each 
cognitive enhancer). 
 70.  Letter from Jennifer C. Jaff, Exec. Director, Advocacy for Patients with Chronic Illness, 
Inc., to Internal Revenue Serv. (Sept. 15, 2010), available at 2010 WL 3829485 (“To give a simple 
example, if the approved use of aspirin were to address pain, the use of aspirin to prevent heart 
attacks would be considered off-label.”).  Similarly, off-label marketing occurs when drug 
manufacturers promote their products to users or in dosages not approved by the FDA.  Fox, supra 
note 56, at 1165–70 (listing arguments for and against FDA regulation of off-label use and 
prescription).  One doctor at Harvard University asserts that growing consumer demand for off-label 
use “reflects our bombardment with advertisements imploring us to ‘ask your doctor if this pill is 
right for you.’”  Richard Kadison, Getting an Edge—Use of Stimulants and Antidepressants in 
College, 353 NEW ENG. J. MED. 1089, 1089 (2005). 
 71.  V. Cakic, Smart Drugs for Cognitive Enhancement: Ethical and Pragmatic Considerations 
in the Era of Cosmetic Neurology, 35 J. MED. ETHICS 611, 611 (2009) (warning that the student 
demographic could be the largest non-therapeutic market for future smart drugs).  One influential 
approach to the ethics of enhancement has been to define the term “enhancement” as any 
intervention designed to improve human functioning beyond what is necessary to restore or sustain 
good health—in other words, it is always more than mere treatment.  Julian Savulescu, Justice, 
Fairness, and Enhancement, 1093 ANNALS N.Y. ACAD. SCI. 321, 322 (2006). 
 72.  See Cognitive Enhancement, All on the Mind, supra note 3, at 103 (arguing that mind 
expansion may soon become big business); Karen Kaplan & Denise Gellene, They’re Bulking Up 
Mentally, L.A. TIMES (Dec. 20, 2007), http://articles.latimes.com/2007/dec/20/science/sci-
braindoping20 (“Whatever company comes out with the first memory pill is going to put Viagra to 
shame.”).  One researcher at Cambridge University estimates that scientists are currently working on 
more than 600 new cognition enhancers.  Cognitive Enhancement, All on the Mind, supra note 3, at 
103. 
 73.  Kaplan & Gellene, supra note 72 (noting that some students, academics, musicians, 
corporate executives, and professional poker players currently take these drugs to clarify minds, 
control emotions, and improve concentration); see also Cognitive Enhancement, All on the Mind, 
supra note 3, at 103 (describing off-label use as a means to increase energy and boost exam 
performance). 
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precursors to this anticipated smart drug, which could make mind 
enhancement “as ordinary as a cup of coffee.”74 
Adderall and Ritalin75 work chemically by increasing two 
neurotransmitters—dopamine and norepinephrine—within the brain.76  In a 
healthy person, this brain stimulation enhances energy and concentration.77  
Recent tests have affirmed these positive cognitive effects.78  Such a perk 
understandably has popularized stimulant medications on United States 
college campuses.79  For example, one study, which surveyed 10,904 
students at 119 four-year universities, found that 6.9% of these students had 
taken prescription stimulants for non-medical uses.80  Other surveys have 
yielded higher numbers ranging from 16% to 60%.81  While some of these 
 
 74.  Melissa Healy, Sharper Minds, L.A. TIMES (Dec. 20, 2004), http://articles.latimes.com/ 
2004/dec/20/health/he-smartdrugs20.  “In the coming years science is likely to create more novel 
drugs that boost memory, concentration and planning.  These may well be less harmful than 
coffee—and will almost certainly be more useful.”  Smart Drugs: Drugs to Make You Cleverer Are 
in the Test-Tube, ECONOMIST (May 24, 2008), http://www.economist.com/ node/11412603. 
 75.  See supra note 36 and accompanying text. 
 76.  See supra notes 40–41 and accompanying text. 
 77.  See supra note 42 and accompanying text.  For example, one California writer confessed to a 
journalist that he managed to speed write several lucrative soft porn novels while on Ritalin.  
Minette Marrin, It’s a No-Brainer: Bring on the Pills That Will Make Us Smarter, SUNDAY TIMES, 
Jan. 3, 2010, at 14. 
 78.  See, e.g., C. Thomas Gualtieri & Lynda G. Johnson, Medications Do Not Necessarily 
Normalize Cognition in ADHD Patients, 11 J. ATTENTION DISORDERS 459, 460, 464 (2008) (noting 
that stimulant use improved school performance); Maia Szalavitz, Popping Smart Pills: The Case for 
Cognitive Enhancement, TIME (Jan. 6, 2009), http://www.time.com/time/health/article/ 
0,8599,1869435,00.html (“Research shows that in normal people, stimulants consistently and 
significantly improve learning of material that must be recalled days later—exactly what you want 
from a drug when you are prepping for exams.”). 
 79.  Alan D. DeSantis & Audrey Curtis Hane, “Adderall Is Definitely Not a Drug:” 
Justifications for the Illegal Use of ADHD Stimulants, 45 SUBSTANCE USE & MISUSE 31, 31 (2010) 
(listing seven scientific surveys conducted at different college campuses).  “[S]ome of the most 
competitive college campuses are rife with illicit use of ADD medication.”  Chris Good, Give 
Scientists Performance-Enhancing Drugs, ATLANTIC (June 30, 2010), http://www.theatlantic.com/ 
special-report/ideas/archive/2010/06/give-scientists-performance-enhancing-drugs/58941. 
 80.  Sean Esteban McCabe et al., Non-Medical Use of Prescription Stimulants Among U.S. 
College Students: Prevalence and Correlates from a National Survey, 99 ADDICTION 96, 102–03 
(2005) (finding that cognitive-enhancement drug use is highest among students from colleges with 
more competitive admission standards). 
 81.  See, e.g., Alan D. DeSantis et al., Illicit Use of Prescription ADHD Medications on a 
College Campus: A Multimethodological Approach, 57 J. AM. C. HEALTH 315, 316 (2008) 
(reporting that 34% of the surveyed students claimed to have used AD/HD drugs illegally); Christian 
J. Teter et al., Illicit Use of Specific Prescription Stimulants Among College Students: Prevalence, 
Motives, and Routes of Administration, 26 PHARMACOTHERAPY 1501, 1507 (2006) (explaining that 
the most common motives for illegal stimulant use among the surveyed students were improved 
concentration and aid in studying).  One study at the University of Wisconsin found that a staggering 
one in five students had taken either Ritalin or Adderall illegally.  Szuflita, supra note 36.  Another 
survey estimated that 7% to 25% of all college students had used Adderall “not to get high, but to 
get higher grades.”  Fenton & Wunderlich, supra note 44, at 18 (emphasis added); see also Rob 
Goodman, Cognitive Enhancement, Cheating, and Accomplishment, 20 KENNEDY INST. ETHICS J. 
145, 148 (2010) (noting that the U.S. Department of Education identifies Ritalin as the most 
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students buy the drugs illegally on the black market, others simply use their 
legal prescriptions in non-FDA-approved ways.82  Academically, some 
students who take these stimulants significantly improve their focus and 
concentration to the point where they morph into study machines.83  Now 
this coveted power has placed bottles of Adderall and Ritalin in the medicine 
cabinets of higher education—where medical84 and law85 school students 
face steep grading curves and declining job prospects. 
 
commonly abused study drug on college campuses).  More recently, 60 Minutes reported that 50% to 
60% of all college students had used AD/HD medications.  60 Minutes: Popping Pills a Popular 
Way to Boost Brain Power (CBS television broadcast Apr. 25, 2010) [hereinafter 60 Minutes], 
available at http://www.cbsnews.com/2100-18560_162-6422159.html. 
 82.  See Fenton & Wunderlich, supra note 44, at 17; see also 60 Minutes, supra note 81 (noting 
that black market stimulant pills cost between three and five dollars on college campuses).  
Interestingly, prescriptions for stimulant medications have doubled in the last eight years from four 
million to eight million; during that same time span, calls to poison-control centers reporting 
overdoses of legal stimulants by young adults shot up seventy-six percent.  Walter Kirn, A 
Pharmacological Education, N.Y. TIMES (Sept. 2, 2009), http://www.nytimes.com/2009/09/06/ 
magazine/06FOB-wwln-t.html. 
 83.  Pavisian, supra note 42, at 181, 184 (emphasizing that stimulants clear minds and improve 
concentration for the tasks at hand); see, e.g., Margaret Talbot, Brain Gain: The Underground World 
of “Neuroenhancing” Drugs, NEW YORKER (Apr. 27, 2009), http://www.newyorker.com/reporting/ 
2009/04/27/090427fa_fact_talbot (featuring a Harvard student who experimented with Adderall 
dosage to make his impossible schedule of work, school, and recreation “possible”).  One consumer 
described Adderall as a career transformer: “I’m talking about being able to take on twice the 
responsibility, work twice as fast, write more effectively, manage better, be more attentive, devise 
better and more creative strategies.”  Carey, supra note 1. 
 84.  Jadon R. Webb et al., Contemplating Cognitive Enhancement in Medical Students and 
Residents, 53 PERSP. BIOLOGY & MED. 200, 200 (2010) (exploring stimulant use among medical 
students for increased study, higher grades, and better care of patients).  In recent years, the growing 
number of medical students who take Adderall and Ritalin has created a “significant controversy” 
that the health community has just begun to acknowledge.  Alison Hayward et al., Stimulant Use 
Among Professional Students, STUDENT DOCTOR NETWORK (June 28, 2008), 
http://studentdoctor.net/2008/06/stimulant-use-among-professional-students; see also Katharine 
Hibbert, Ways to Make You Think Better, GUARDIAN (Nov. 8, 2007), http://www.guardian.co.uk/ 
society/2007/nov/08/health.lifeandhealth (describing Ritalin use by medical students as 
“unexceptional”).  One medical student said it was impossible to juggle both academics and a social 
life without stimulant use—“The only people who get through the (med school) program I’m in 
either use stimulants or have no social life whatsoever.  There is no other way.”  An Ethical Look at 
Cognitive Stimulants, Part 1, TECHNOLOGICAL CITIZEN, http://thetechnologicalcitizen.com/?p=2444 
(last visited Feb. 27, 2012).  However, another student from the same medical school chat forum 
countered, “People use these medications because they’re lazy, and because they have no study 
habits.  They’re a crutch for people who need a last minute way to get work done, fast.”  Id. 
 85.  See Fenton & Wunderlich, supra note 44, at 17 (commenting on the extensive use of 
stimulant medications by law school students).  One commentator explained this prevalence aptly: 
They’re well aware of the dire economic news—big law firms instituting hiring freezes; 
whole industries . . . imploding—and it’s natural that they would welcome any advantage 
in their quests to get the grades that will get them the jobs that will get them the insurance 
that will get them the medications to do the jobs. 
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Another medication increasingly booking its appearances during final 
exams is Provigil,86 a pill that boosts dopamine levels and blocks dopamine 
transporters within the brain—keeping individuals awake and alert.87  
Provigil, short for “promotes vigilance,”88 is a “nap in the form of a pill”89 
that leaves its users refreshed and alert despite hours or even days of 
wakefulness.90  Individuals take this drug for off-label uses like jet-lag 
recovery and exam-performance enhancement.91  In fact, more than eighty 
 
Kirn, supra note 82.  In 2008, the Volokh Conspiracy group blog, composed mostly of law 
professors, posted a poll that asked law school students: “[H]ow common is use of Adderall and/or 
Ritalin among law students who do not have a prescription to . . . boost law school performance?”  
Law Student Use of Adderall and/or Ritalin, VOLOKH CONSPIRACY (Mar. 26, 2008, 2:10 PM), 
http://volokh.com/posts/1206555052.shtml.  Of 1063 responses, only 157 stated that such stimulant 
use was rare or never happened; 350 voted that fifty percent or more of all law school students had 
used Adderall or Ritalin to improve grades.  Id.  In 2010, The Onion chipped in with its own satirical 
commentary in an article that reported Harvard University’s conferment of an honorary doctorate 
degree on a bottle of Adderall for its cognitive “inspiration to [them] all.”  Adderall Receives 
Honorary Degree from Harvard, ONION (May 31, 2010), http://www.theonion.com/articles/adderall-
receives-honorary-degree-from-harvard,17527. 
 86.  See supra note 54 and accompanying text. 
 87.  See supra notes 55–56 and accompanying text; see also Miriam Hill, Concerns Raised on 
Cephalon’s Stay-Awake Drug Provigil, PHILA. INQUIRER, Mar. 17, 2009, at C01 (noting the 
increasing evidence that shows Provigil use by students and professors as a brain-boosting drug).  
One psychologist, who works at Cambridge University and writes about the ethics of cognitive 
enhancement, stated that her first Provigil session allowed her to intensely “work at her computer for 
hours straight.”  Kaplan & Gellene, supra note 72.  One study demonstrated that test subjects who 
took Provigil were able to concentrate on a specific task “for as long as fifty-four consecutive 
hours.”  Greely, supra note 49, at 127. 
 88.  Andrew Pollack, A Biotech Outcast Awakens, N.Y. TIMES (Oct. 20, 2002), 
http://www.nytimes.com/2002/10/20/business/a-biotech-outcast-awakens.html?pagewanted=all&src
=pm.  
 89.  O’Connor, supra note 55.  Provigil has “rapidly become a tempting pick-me-up to a nation 
that battles sleep with more than 100 million cups of coffee a day.”  Id. 
 90.  Sanneke A.M. van Vliet et al., Efficacy of Caffeine and Modafinil in Counteracting Sleep 
Deprivation in the Marmoset Monkey, 197 PSYCHOPHARMACOLOGY 59, 60 (2007) (listing studies 
that demonstrate Provigil’s beneficial effects during sleep deprivation).  See generally Joseph V. 
Baranski et al., Effects of Modafinil on Cognitive Performance During 40 Hr of Sleep Deprivation in 
a Warm Environment, 14 MIL. PSYCHOL. 23, 23 (2002); Joseph V. Baranski et al., Modafinil During 
64 Hr of Sleep Deprivation: Dose-Related Effects on Fatigue, Alertness, and Cognitive 
Performance, 10 MIL. PSYCHOL. 173, 173 (1998).  Physicians prescribe Provigil to pilots, truck 
drivers, college students, and any others who “simply were sleepy or tired during the day without 
any associated medical condition.”  Osborn, supra note 55, at 335 (“FDA’s Dr. Robert Temple 
suggested that he was not necessarily troubled by off-label use of Provigil in the case of truck drivers 
or others who might be driving while sleepy, noting that ‘[i]f they’re driving next to me, I think I’d 
prefer they be on it.’”). 
 91.  See supra note 55 and accompanying text.  Provigil enhances cognitive abilities in healthy 
individuals; for example, it enables people to remember an extra digit when the average person can 
hold only seven random digits in his or her memory.  Cognitive Enhancement, All on the Mind, 
supra note 3, at 103.  Besides increasing digit span, it also improves spatial planning, visual pattern-
recognition memory, and response inhibition.  Danielle C. Turner et al., Modafinil Improves 
Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia, 29 
NEUROPSYCHOPHARMACOLOGY 1363, 1364 (2004). 
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percent of all prescriptions for this medication are for off-label purposes.92  
Commentators have described this energy drug “as a more effective, non-
addictive substitute to caffeine and amphetamines.”93  Doctors declare it the 
new “lifestyle drug for a sleep-deprived 24/7 society.”94  Johann Hari, an 
award-winning journalist who writes for the New York Times, Los Angeles 
Times, and New Republic, described his experiments with Provigil—as he 
took 200 milligrams every day for five days: 
 I picked up a book about quantum physics and super-string 
theory I have been meaning to read for ages . . . .  It had been 
hanging over me, daring me to read it.  Five hours later, I realised 
[sic] I had hit the last page . . . .  I hadn’t noticed anything, except 
the words I was reading, and they came in cool, clear passages; I 
didn’t stop or stumble once. 
 Perplexed, I got up, made a sandwich—and I was overcome with 
the urge to write an article that had been kicking around my 
subconscious for months.  It rushed out of me in a few hours, and it 
was better than usual . . . . 
 . . . . 
 
 92.  See O’Connor, supra note 55; see also Osborn, supra note 55, at 305 (explaining that current 
law prohibits drug manufacturers from promoting off-label uses for their products).  Interestingly, 
Cephalon, the U.S. manufacturer of Provigil, actually facilitated off-label campaigns until 2008.  
Evelyn Pringle, The Rise and Fall of Provigil—Part II, EVELYN PRINGLE’S CATALOG OF ARTICLES 
(Sept. 21, 2010, 4:49 AM), http://evelynpringle.blogspot.com/2010/09/rise-and-fall-of-provigil-part-
ii.html (noting that Provigil sales continued to increase and topped the billion dollar mark in 2009). 
 93.  Fox, supra note 56, at 1142; see also O’Connor, supra note 55 (describing Provigil as a 
small, white pill that “revs up the central nervous system without the jitteriness of caffeine or the 
addiction and euphoria of amphetamines”).  However, some contend that Provigil is not significantly 
more effective at promoting wakefulness than a large dose of caffeine.  Mehlman, supra note 13, at 
484. 
 94.  Pollack, supra note 88, at 31 (“[O]ne analyst at a brokerage firm . . . [said], ‘I used to drink 
twelve cups of coffee a day and now I don’t do that anymore.’”).  Not all doctors consider Provigil 
beneficial; for example, Dr. Martha J. Farah, director of the Center for Cognitive Neuroscience at the 
University of Pennsylvania, explained, “‘This drug enables us to be that much more workaholic and 
that much more obsessed with accomplishments and productivity, and I think our society is already 
extreme along those lines . . . .  [N]atural checks on that tendency, like needing to go to bed, are 
being rolled back by [Provigil].’”  O’Connor, supra note 55.  Others contend that the off-label 
cognitive use of Provigil represents a high-risk behavior that calls for further monitoring and 
intervention efforts.  See Andersen et al., supra note 56, at 446. 
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 The next morning I woke up and felt immediately alert.  
Normally it takes a coffee and an hour to kick-start my brain; today 
I’m ready to go from the second I rise.  And so it continues like this, 
for five days: I inhale books and exhale articles effortlessly . . . .  I 
keep waiting for an exhausted crash, and it doesn’t seem to come.95 
Because Provigil costs almost twenty-seven dollars per pill,96 it is 
primarily popular with the higher education and income crowd.97  For 
example, one recent survey of 1400 academics from sixty countries reported 
that one in five had taken medications for non-medical cognitive-enhancing 
purposes;98 of that one in five, 40% used Provigil.99  Students see it as the 
difference between an A and a B,100 where enhanced concentration, 
 
 95.  Johann Hari, My Experiment with Smart Drugs, JOHANNHARI.COM (May 5, 2008), 
www.johannhari.com/2008/05/06/my-experiment-with-smart-drugs (describing how he bought 
Provigil online from a foreign pharmacy and without a prescription).  For a similar account detailing 
a writer’s personal experiences with Provigil, see Chen, supra note 3, at 170. 
 96.  In March 2012, one hundred 200-milligram tablets of Provigil cost $2661.20—or $26.61 per 
pill—at drugstore.com.  Provigil, DRUGSTORE.COM, http://www.drugstore.com/provigil/200mg-
tablets/qxn63459020101 (last visited Mar. 1, 2012).  Dr. Eric Heiligenstein, a psychiatrist at the 
University of Wisconsin, noted that while Provigil is a “very clean drug,” the “main barrier to more 
widespread use is that it’s expensive, which will change as more insurance companies start to cover 
it.”  O’Connor, supra note 55. 
 97.  See Kirby, supra note 7, at 94 (calling Provigil an “entrepreneur’s drug of choice”); see, e.g., 
O’Connor, supra note 55 (describing Provigil use as a “fixture” among college students, computer 
programmers, and “others determined to burn the midnight oil”); 60 Minutes, supra note 81 
(depicting an interview with a Harvard professor who uses Provigil and calls such cognitive 
enhancement “extremely common” in his profession). 
 98.  Brendan Maher, Poll Results: Look Who’s Doping, 452 NATURE 674, 674 (2008).  
“Apparently, while the chattering classes tsk-tsked the doping habits of pro athletes, those within 
their own circles—writers, designers, scientists, scholars—have been juicing up themselves, or 
secretly wishing they could.”  Chen, supra note 3, at 170. 
 99.  Maher, supra note 98, at 674 (noting that half of the respondents reported adverse side 
effects).  One-third of the respondents purchased the drug over the Internet, while the remaining 
two-thirds obtained Provigil from pharmacies or with prescriptions.  Id. at 675.  “‘We aren’t the teen 
clubbers popping uppers to get through a hard day running a cash register after binge drinking,’ 
wrote a Ph.D. research scientist . . . .  ‘We are responsible humans.’”  Alexis Madrigal, Wired.com 
Readers’ Brain-Enhancing Drug Regimens, WIRED (Apr. 24, 2008), http://www.wired.com/ 
medtech/drugs/news/2008/04/smart_drugs.  Other individuals who used Provigil in their cognitive-
enhancement drug regimens included neuroscience graduate students, lawyers, and an elementary 
school teacher.  Id.; see also Hill, supra note 87, at C01 (detailing the nonmedical use of Provigil 
among students and professionals). 
 100.  Studies report Provigil’s presence on both sides of the Atlantic—in the hands of U.S. and 
English university students.  See, e.g., Katy Lee, Wired Awake, VARSITY (Nov. 16, 2007), 
http://www.varsity.co.uk/news/807; Margaret Talbot, Can a Daily Pill Really Boost Your Brain 
Power?, OBSERVER (Sept. 20, 2009), http://www.guardian.co.uk/science/2009/sep/20/ 
neuroenhancers-us-brain-power-drugs (describing students’ personal experiences with the 
medication); see also Madrigal, supra note 99 (coining this new era of scholastic drug 
experimentation as “personalized research”). 
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alertness, and short-term memory are useful qualities for complex term 
papers and all-night study sessions.101 
The final commonly utilized cognitive enhancer is the beta blocker,102 
which primarily enables off-label use in the public-performance setting.103  
Because beta blockers block the effects of adrenaline, they leave individuals 
calm in typically anxious situations.104  Most likely, the first performers to 
exploit this off-label result were musicians, whose hands tend to become 
clammy and tremble during concert performances.105  Now, beta blockers 
are found in a variety of other settings—golf tournaments,106 pistol shooting 
contests,107 and college campuses.108  In a 1991 study investigating beta 
 
 101.  Being Provigilant About Enhancing the Brain, BIOETHICS.NET BLOG (June 27, 2006, 12:59 
AM), http://www.bioethics.net/2006/06/being-provigilant-about-enhancing-the-brain (describing 
Provigil as a new smart pill and even a possible ticket to Harvard Law).  But cf. Gary Stix, 
Turbocharging the Brain, SCI. AM., Oct. 2009, at 46, 53 (“Users with lower IQs appear to derive a 
large performance boost from [Provigil], whereas those with more innate ability show little or no 
benefit.”).  Specifically, medical students and residents admit to using Ritalin and Provigil to face 
24-hour or longer work shifts, but the medical community largely polices itself, leaving many 
students with the belief that cognitive enhancement will continue to spread if not checked.  Greely, 
supra note 6, at 1143; Mark Meier, The End of Impairment? Generation Rx Goes to Medical School, 
SCI. PROGRESS (Sept. 30, 2008), http://scienceprogress.org/2008/09/the-end-of-impairment. 
 102.  See supra note 58 and accompanying text. 
 103.  See supra note 60 and accompanying text. 
 104.  See supra notes 59–60 and accompanying text; see also Elliott, supra note 59 (noting that 
the drug can keep the voice from quavering, hands from trembling, heart from pounding, and 
forehead from sweating). 
 105.  Elliott, supra note 59 (describing a 1970s British study that tested the effects of beta 
blockers on musicians and found a significant improvement with usually nervous players); see also 
Watts, supra note 58 (reporting beta blocker use among musicians and music students).  Musicians 
primarily rely on beta blockers to control fine motor tremors.  Claudio M. Tamburrini & Torbjorn 
Tannsjo, Transcending Human Limitations, 1 SPORT, ETHICS & PHIL. 113, 113 (2007).  One 
musician estimates that three-quarters of her peers use the drugs at least occasionally.  Kaplan & 
Gellene, supra note 72.  While professional musicians have taken this medication for years to 
combat stage fright, students in music schools are increasing their prescriptions too.  David Stabler, 
Better Music Through Chemistry?  Music Students Turn to Medications to Calm Stage Fright, 
PORTLAND OREGONIAN (Mar. 3, 2010), http://www.oregonlive.com/performance/index.ssf/ 
2010/03/better_music_through_chemistry.html. 
 106.  Sigman, supra note 58, at 156–57.  Several top golfers have admitted to taking beta blockers 
or accused others of such use.  See Christopher Clarey, Clean as a Whistle That’s Never Blown, 
INT’L HERALD TRIB., July 17, 2004, at 18; Dave Feschuk, PGA Drug Tests Looming, TORONTO 
STAR, Sept. 7, 2006, at B01. 
 107.  Davis et al., supra note 59, at 586 (noting beta blocker use among athletes to reduce motor 
tremors, particularly in motor racing and pistol shooting).  In 2008, an Olympic pistol shooter lost 
his medals after testing positive for beta blockers, and at the 2010 Paralympics, a Swedish 
wheelchair curler garnered suspension after taking a beta blocker.  Watts, supra note 58.  In general, 
beta blockers are used by individuals whose activities require “precision.”  Shapiro, supra note 60, at 
42.  “Some may prefer to view such enhancement as more athletic than intellectual, but there is no 
sharp line here.”  Id. 
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blocker effectiveness on test performance, thirty-two high school students, 
who had already taken the SAT and exhibited general exam anxiety, 
received a beta blocker one hour before retaking the test.  The results?  On 
average, they scored 130 points higher than their previous exams.109  
Professionally, both lawyers and doctors use beta blockers to combat the 
fear of public speaking.110 
All four of these cognitive enhancers have already claimed a place next 
to textbook supplements and commercial outlines as modern educational 
study aids,111 but with this rise in academic brain boosting, proponents and 
critics have called for a strict ethical scrutiny in certain situations, such as 
lower education classrooms.112  Medical and law schools, which are ethically 
governed settings, also merit the same stringent analysis.113  As medical and 
law school students continue to jump on the bandwagon of cosmetic 
neurology,114 the question becomes whether their medicinal brain boosting is 
actually cheating.115 
 
 108.  Watts, supra note 58 (reporting that beta blockers significantly improve exam performance 
for students who suffer from test anxiety).  One scientific study noted that “beta-blockers may be 
particularly useful for students who do not do themselves justice because of examination nerves.”  
Desmond Kelly, Beta-Blockers in Anxiety, 1 STRESS MED. 143, 148 (1985).  While beta blockers 
still allow energizing adrenaline to flow through people’s bodies, they prevent test takers from 
feeling that adrenaline, so they are not distracted by their own nervousness.  Kaplan & Gellene, 
supra note 72. 
 109.  Harris C. Faigel, The Effect of Beta Blockade on Stress-Induced Cognitive Dysfunction in 
Adolescents, 30 CLINICAL PEDIATRICS 441, 441 (1991) (noting that a normal score increase would 
have been thirty points).  Other studies have duplicated similar results with other testing situations.  
See, e.g., D.Q. Beversdorf et al., Central Beta-Adrenergic Modulation of Cognitive Flexibility, 13 
NEUROREPORT 2505, 2505 (2002) (using anagram problems); D.Q. Beversdorf et al., Noradrenergic 
Modulation of Cognitive Flexibility in Problem Solving, 10 NEUROREPORT 2763, 2764–66 (1999) 
(using three problem solving tasks—number series, shape manipulation, and anagrams); J.A. Silver 
et al., Effect of Anxiolytics on Cognitive Flexibility in Problem Solving, 17 COGNITIVE & BEHAV. 
NEUROLOGY 93, 93 (2004) (using three test sessions).  Of course, beta blockers work best for 
nervous test takers, while non-anxious students show minimal improvement.  See Elliott, supra note 
59 (“[T]hey seem to level the playing field for anxious and non-anxious performers, helping nervous 
performers much more than they help performers who are naturally relaxed.”). 
 110.  See Zev Chafets, Drugs that Give You an Edge Just Part of the Game, J. GAZETTE (Fort 
Wayne) (Feb. 15, 2009), http://www.journalgazette.net/article/20090215/EDIT05/302159938/-
1/EDIT01 (“Trial lawyers and Broadway actors pop beta blockers to ward off stage fright.”).  
Kaplan & Gellene, supra note 72 (“[S]ome doctors had . . . used the drugs themselves to calm their 
own nerves before making presentations at medical meetings.”).  In the 2008 Nature survey, 15% of 
its academic respondents who reported use of cognitive-enhancement medications picked beta 
blockers as their drug of choice before giving presentations.  Maher, supra note 98, at 674; see also 
Kelly, supra note 108, at 147–48 (“[T]here is no doubt that beta-blocking drugs can alleviate the 
unpleasant subjective symptoms associated with public speaking, especially in susceptible people.  
The major advantage is that the speaker is not sedated in any way, and so is not robbed of mental 
agility.”). 
 111.  See supra notes 79, 100, 108 and accompanying text. 
 112.  See supra notes 10–12 and accompanying text. 
 113.  See supra notes 15–25 and accompanying text. 
 114.  See supra notes 71, 101, 108 and accompanying text. 
 115.  See supra note 26 and accompanying text. 
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III. NO BRAINER: IS COGNITIVE ENHANCEMENT CHEATING? 
Taking medications—such as Adderall, Ritalin, or Provigil—without a 
physician’s prescription is illegal and, as such, is “a per se ethics 
violation.”116  While federal and state statutes govern the sale, distribution, 
and use of prescription drugs,117 the Controlled Substances Act compiles 
national regulations that individual states apply as their legal floor.118  This 
Act prohibits a person from “knowingly or intentionally” distributing, 
dispensing, or possessing a controlled substance not lawfully obtained from 
a doctor.119  As federally classified drugs, Adderall, Ritalin, and Provigil are 
such substances.120  Federal and state laws stipulate that individuals who (1) 
take these cognitive-enhancement medications without prescriptions, (2) buy 
these medications from others, or (3) sell and share these medications with 
others are subject to criminal penalties—including arrest, fines, and 
imprisonment.121  Both the AMA and ABA recognize illegal acts like these 
 
 116.  Fenton & Wunderlich, supra note 44, at 17; see also infra note 122 and accompanying text.  
Medical prescriptions are licenses that permit a drug’s sale or use in certain circumstances.  
RICHARDS, supra note 2, at 190.  States license doctors as “competent medical professional[s]” so 
that they can then license the sale or use of medications.  Id. 
 117.  See Leamor Kahanov et al., Adherence to Drug-Dispensation and Drug-Administration 
Laws and Guidelines in Collegiate Athletic Training Rooms: A 5-Year Review, 45 J. ATHLETIC 
TRAINING 299, 299 (2010) (explaining that federal and state laws direct prescription and over-the-
counter drug dispensation and administration); see also John Goetz & Donald Lund, What the Law 
Allows, PHARMACEUTICAL EXECUTIVE, Aug. 2000, at 76, 78, 82 (addressing the state and federal 
statutes that govern online pharmaceutical sales). 
 118.  See 21 U.S.C. § 801 (2006). 
 119.  Id. § 841.  Controlled substances are the drugs listed in Schedules I through V of the 
Controlled Substances Act.  Id. §§ 811–812.  Illegal drug use is the use of a controlled substance not 
in accordance with a valid prescription.  See 10 C.F.R. § 707.4 (2012). 
 120.  See supra notes 51, 57 and accompanying text (explaining that Adderall and Ritalin are 
Schedule II drugs and Provigil is a Schedule IV drug).  The Controlled Substances Act does not 
apply to beta blockers.  See supra note 67 and accompanying text.  As Schedule II drugs, Adderall 
and Ritalin prescriptions are limited to thirty days worth of doses with no automatic refills.  DeSantis 
et al., supra note 81, at 320 (noting that these medications are also subject to DEA production 
quotas).  As a Schedule IV drug, Provigil is not restricted in its production; instead, the DEA places 
restraints on its manufacture and distribution.  RICHARDS, supra note 2, at 164. 
 121.  See 21 U.S.C. § 841 (2006); see also supra note 117 and accompanying text.  While 
penalties vary depending on the amount of medication and its schedule classification, imprisonment 
ranges from one year to life and fines from $100,000 to $50,000,000, with penalties doubling for 
second offenses.  See 21 U.S.C. § 841.  Federal law also prohibits buying controlled substances 
online without a valid prescription and recognizes the importation of drugs into the United States as 
a felony.  Goetz & Lund, supra note 117, at 78; see also Consumer Alert, Prescription Drugs: 
Buying On-Line Could Mean Doing Time, DEA OFFICE OF DIVERSION CONTROL, 
www.deadiversion.usdoj.gov/consumer_alert.htm (last visited Mar. 1, 2012) (warning that most 
rogue pharmaceutical websites are usually based in foreign countries).  A 2008 study found that 85% 
of all websites that sold medications required no physician’s prescription, making the illicit nature of 
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as per se ethics violations.122  But ethical lines begin to blur when brain-
boosting users obtain legal prescriptions for off-label purposes, and the real 
question becomes whether “legal” use is unethical when students pop 
cognitive enhancers for medical and law school examinations.123 
When debating the ethical implications of cognitive enhancement by 
society at large, proponents and critics commonly focus on three concerns: 
safety concerns, social implications, and fairness issues.124  These categories 
provide an apt framework for the analysis of brain boosting within a 
narrower segment of society—the classrooms of medical and law school 
universities.125 
A. Look Who’s Doping: Safety Concerns with Scholastic Steroids 
The Federal Food, Drug, and Cosmetic Act requires that drug 
manufacturers establish that medications are safe for their intended 
purposes.126  However, the law permits physicians to prescribe drugs for off-
 
online drug sales apparent.  Bryan A. Liang & Tim Mackey, Searching for Safety: Addressing 
Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales, 35 AM. J.L. & 
MED. 125, 126 (2009).  For example, one recent survey of 1811 students at a large public university 
discovered that 34% of the students who reported taking stimulants for cognitive enhancement 
claimed to use such prescription medications illegally.  DeSantis & Hane, supra note 79, at 32. 
 122.  See generally CODE OF MEDICAL ETHICS OP. 8.15 (1986) (addressing substance abuse 
among doctors); MODEL CODE OF PROF’L CONDUCT R. 8.4(b) (2010) (discussing professional 
misconduct among lawyers).  The AMA also discourages doctors or student doctors from self-
prescribing or prescribing for their peers.  See CODE OF MEDICAL ETHICS OP. 8.19 (1993); CODE OF 
MEDICAL ETHICS OP. 8.191 (2008). 
 123.  See Fenton & Wunderlich, supra note 44, at 17.  This ethical analysis should focus on the 
subjective intent of the drug takers, or the medical and law school students “who ‘game’ the system 
to get legally—yet ethically questionable”—prescription medications.  Id.  As one journalist 
summarized, “In the real world, there are no rules to prevent overachievers from using legally 
prescribed drugs to operate at peak mental performance.”  Kaplan & Gellene, supra note 72 (asking 
what patient would not want his or her surgeon to be at such a level for life-or-death procedures). 
 124.  See, e.g., Fox, supra note 56, at 1146–49; Greely, supra note 6, at 1148.  For instance, a 
commentator explained, “While [cognitive-enhancement drug] use is not inherently unethical, steps 
must be taken to ensure that they are safe, that they are widely available to promote equality of 
opportunity, and that individuals are free to decide whether or not to use them.”  Mehlman, supra 
note 13, at 483. 
 125.  See supra text accompanying notes 113–15. 
 126.  21 U.S.C. § 355(b)(1) (2006).  Congress passed the Food, Drug, and Cosmetic Act in 1938 
to ensure that the FDA had the authority to conduct pre-market safety reviews for all “new drugs.”  
Victor E. Schwartz et al., Marketing Pharmaceutical Products in the Twenty-First Century: An 
Analysis of the Continued Viability of Traditional Principles of Law in the Age of Direct-to-
Consumer Advertising, 32 HARV. J.L. & PUB. POL’Y 333, 339 (2009) (providing a detailed history 
behind the Act); see also Michelle Meadows, A Century of Ensuring Safe Foods and Cosmetics, 
FDA CONSUMER, Jan.–Feb. 2006, at 6, 8–9 (explaining the Act’s impact on drug and food 
regulation).  Although the Act represents federal law, more than half of the states have adopted a 
Uniform State Food, Drug, and Cosmetic Bill, closely patterned after the federal act.  Developments 
in the Law—The Federal Food, Drug, and Cosmetic Act, 67 HARV. L. REV. 632, 636 (1954); see 
also JOHN E.H. SHERRY, THE LAWS OF INNKEEPERS—FOR HOTELS, MOTELS, RESTAURANTS, AND 
DO NOT DELETE 4/20/2012  1:33 PM 
[Vol. 39: 989, 2012] Scholastic Steroids 
PEPPERDINE LAW REVIEW 
1011 
label reasons, although manufacturers have not submitted any “safety or 
efficacy data to the FDA substantiating the so-called off-label use.”127  This 
means cognitive enhancement—an unapproved, unsubstantiated, non-
therapeutic purpose128—may pose unknown safety risks, including adverse 
side effects, addictive propensities, other long-term dangers, and 
personalized research hazards.129  For example, the World Anti-Doping 
Agency (WADA) already prohibits all four types of cognitive enhancers in a 
variety of sports, primarily relying on their actual or potential risks to an 
athlete’s health, rather than their ability to create unfair advantages.130 
 
CLUBS 633 (3d ed. 1993) (explaining that the federal law does not completely preempt state law as 
long as the states do not contravene the federal act). 
 127.  Mehlman, supra note 13, at 486 (“Organized medicine has staunchly defended this 
prerogative as an exercise of professional autonomy within the practice of medicine, a realm that the 
FDA has long acknowledged lies outside the scope of its authority.”).  Although the law does restrict 
manufacturers’ abilities to promote off-label medicinal use, the practice still persists.  Marc A. 
Rodwin, Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical 
Review and Reform Proposal, 38 J.L. MED. & ETHICS 807, 809 (2010); see, e.g., Stix, supra note 
101, at 55 (explaining that Cephalon already paid nearly $444 million to two states and the federal 
government for its illegal promotion of Provigil for unapproved uses); supra note 92 and 
accompanying text (noting Cephalon’s off-label marketing of Provigil); see also Michael Jon 
Andersen, Bound Guidance: FDA Rulemaking for Off-Label Pharmaceutical Drug Marketing, 60 
CASE W. RES. L. REV. 531, 532 (2010) (“[D]espite the marketing restrictions, manufacturers utilize a 
number of methods to promote off-label uses of pharmaceuticals, including paying for professional 
education sessions, hiring speakers, engaging in direct mail campaigns, and reprinting favorable 
journal articles.”). 
 128.  See supra text accompanying note 69 (noting that FDA-approved uses do not include 
cognitive enhancement). 
 129.  See Greely, supra note 49, at 129–30 (stating that safety concerns are the strongest 
arguments against medicinal cognitive enhancement).  “‘It would be wonderful if one could take a 
drug and be smarter, faster, or have more energy,’ said Nora Volkow, director of the National 
Institute on Drug Abuse . . . .  ‘But that is like fairy tales.  We currently have nothing that has those 
benefits without side effects.’”  Carla K. Johnson, The Downside of ‘Smart Drug’: Study Finds It 
May Be Addictive, STAR-LEDGER, Mar. 18, 2009, at 9, available at 2009 WLNR 5142091. 
 130.  Cakic, supra note 71, at 613 (“Caffeine, for example, reliably increases performance in a 
range of sports including swimming, cycling and running at doses allowed by WADA.  Yet despite 
being a form of ‘cheating’ in the same vein as anabolic steroids, caffeine’s use in sport is permitted 
because it is relatively harmless.”).  See generally The World Anti-Doping Code: The 2011 
Prohibited List—International Standard, WORLD ANTI-DOPING AGENCY (Sept. 18, 2010), available 
at http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_ 
be_effective/WADA_Prohibited_List_2011_EN.pdf (noting that this list took effect January 1, 
2011).  WADA prohibits Adderall, Ritalin, and Provigil for all in-competition situations but it bans 
beta blockers only for sixteen in-competition sports and two out-of-competition and in-competition 
categories—archery and shooting.  Id. at 7–9. 
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1. Adverse Side Effects 
Possible side effects of cognitive enhancers vary depending on the 
medication.  Adderall and Ritalin commonly cause dizziness, irritability, 
headache, appetite suppression, and insomnia.131  Their more serious side 
reactions include stroke, seizure, heart attack, blurred vision, psychiatric 
disturbance, and death.132 
While Provigil chemically works in a similar manner as Adderall and 
Ritalin,133 its common side effects are less severe: back pain, stuffy nose, 
and upset stomach.134  Provigil’s more serious potential side effects include 
psychiatric experiences, heart difficulties, and rashes that require 
 
 131.  MEDICATION GUIDE: ADDERALL XR, supra note 48, at 3; MEDICATION GUIDE: RITALIN, 
supra note 48, at 2; see also Johnny Graham & David Coghill, Adverse Effects of 
Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: Epidemiology, Prevention and 
Management, 22 CNS DRUGS 213, 216 (2008) (analyzing numerous studies that largely agree on the 
common adverse effects of stimulant medications).  But see Madhiraju, supra note 36, at 1666 
(noting that Ritalin’s common side effects of headache, insomnia, and loss of appetite usually 
dissipate quickly).  Ritalin’s other possible adverse reactions include a decreased ability to learn, 
social withdrawal, abdominal pain, extensive bruising, and abnormally low white and red blood cell 
counts.  Szuflita, supra note 36; see also Chiumino, supra note 12, at 383 (warning that children also 
may develop Tourette’s Syndrome). 
 132.  Schieffelin, supra note 13, at 973.  See also Gardiner Harris, Warning Urged on Stimulants 
Like Ritalin, N.Y. TIMES (Feb. 10, 2006), http://www.nytimes.com/2006/02/10/health/policy/ 
10drug.html?pagewanted=all (explaining that reports of sudden death have never exceeded one in a 
million for any stimulant drug).  In 2004, more than 3000 people visited hospital emergency rooms 
because of adverse reactions from AD/HD medications.  Miranda Hitti, ADHD Drugs Tied to ER 
Visits, WEBMD HEALTH NEWS (May 25, 2006), http://www.webmd.com/add-adhd/news/20060525/ 
adhd-drugs-tied-to-er-visits (noting that most of the cases requiring hospitalization were linked to 
inappropriate use of the stimulant drugs).  In 2006, a federal advisory panel recommended that drug 
manufacturers place prominent warnings describing their possible dangerous cardiac effects on 
AD/HD medication labels.  Harris, supra (“[The committee] voted 8 to 7 to suggest that stimulant 
labels carry the most serious of the agency’s drug-risk warnings—a ‘black box.’”).  Both the 
Adderall and Ritalin medication guides already caution that people who are very agitated, anxious, 
or tense should not take these stimulants, thereby warning against consumption by most medical and 
law school students.  See MEDICATION GUIDE: ADDERALL XR, supra note 48, at 1; MEDICATION 
GUIDE: RITALIN, supra note 48, at 2. 
 133.  See supra note 56 and accompanying text. 
 134.  MEDICATION GUIDE: PROVIGIL, supra note 54, at 39; see also Yaron Dagan & Julia T. 
Doljansky, Cognitive Performance During Sustained Wakefulness: A Low Dose of Caffeine Is 
Equally Effective as Modafinil in Alleviating the Nocturnal Decline, 23 CHRONOBIOLOGY INT’L 973, 
974 (2006) (observing that Provigil’s mild side effects are only expressed at high doses—usually 
requiring more than 600 milligrams). 
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hospitalization.135  In actuality, Provigil’s adverse side effects “are rarely 
worse than a mild headache or slight nausea.”136 
Lastly, beta blockers commonly engender dizziness, fatigue, and cold 
hands.137  Their less recognized reactions include loss of sex drive, breathing 
difficulties, insomnia, abdominal cramping, hallucination, and short-term 
memory loss.138  Although Provigil and beta blocker consumption rarely 
pose serious safety concerns—unlike Adderall and Ritalin139—all four 
cognitive enhancers can create severe complications, including heart 
problems, psychiatric experiences, and death.140 
2. Abuse Potentials 
These cognitive enhancers also differ in their potential for abuse or 
addiction.141  Adderall, Ritalin, and Provigil are federally-specified schedule 
drugs, or federally controlled substances, because they can encourage abuse 
or dependence.142  As Schedule II medications, Adderall and Ritalin exhibit 
a high potential for prompting severe physical and psychological 
 
 135.  MEDICATION GUIDE: PROVIGIL, supra note 54, at 39; Cephalon Response to the March 18, 
2009, JAMA Article, “The Effects of Modafinil on Dopamine and Dopamine Transporters in the 
Male Human Brain,” CEPHALON (Mar. 2009), http://www.cephalon.com/media/on-the-
record/cephalon-response-to-march-18-2009-jama-article-the-effects-of--modafinil-on-dopamine-
and-dopamine-transporters-in-the-male-human-brain.html (additionally listing chest pain, breathing 
difficulty, hallucination, aggression, and suicidal thoughts). 
 136.  O’Connor, supra note 55 (noting that in clinical trials, only about one percent of patients 
complained of any side effects).  Most Provigil users do not even experience the jitteriness 
associated with amphetamines.  Osborn, supra note 55, at 334.  At an advisory panel meeting in 
2003, FDA officials even suggested “they were not overly concerned” with Provigil use by healthy 
adults because it was “generally safe.”  Andrew Pollack & Alicia Ault, Advisory Panel Endorses 
More Uses for Stimulant, N.Y. TIMES (Sept. 26, 2003), http://www.nytimes.com/2003/09/26/ 
business/advisory-panel-endorses-more-uses-for-stimulant.html. 
 137.  MEDICATION GUIDE: LOPRESSOR HCT, supra note 65, at 7–8 (noting that adverse effects are 
“mild and transient”); MEDICATION GUIDE: TOPROL-XL, supra note 66, at 13; see also Sigman, 
supra note 58, at 157.  Beta blockers can make users tired or dizzy by slowing or weakening their 
heartbeat.  Catherine Nelson, The Taboo Tablet: Drugs and Performance, STRAD, Aug. 2010, at 24, 
26.  These medications can also cause cold hands and feet by constricting small blood vessels and, 
consequently, reducing the blood’s circulation to these limbs.  Id.  Generally, any unwanted effects 
are uncommon.  Kelly, supra note 108, at 149. 
 138.  Sigman, supra note 58, at 157; see also Inderal, supra note 63. 
 139.  See supra notes 131, 134, 137 and accompanying text. 
 140.  See supra notes 132, 135, 138 and accompanying text. 
 141.  See supra notes 49, 57, 67 and accompanying text. 
 142.  See supra note 120 and accompanying text.  Schedules are federally-imposed classifications 
of drugs that are popular for addictive or recreational use.  Greely, supra note 49, at 115 (noting that 
federal law requires special handling and paperwork requirements for scheduled medications). 
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dependence.143  Provigil, a Schedule IV medication, is said to have a lesser 
potential for abuse and may lead to dependence in only some users.144  
However, recent scientific studies have found that Provigil chemically binds 
to the same dopamine transporter sites as cocaine and Ritalin—leaving its 
abuse potential in question.145  In contrast, beta blockers are not federally 
controlled substances because they present zero addiction potential.146  They 
also tend to be fairly safe147 and relatively inexpensive.148 
3. Long-Term Dangers 
Regardless of their differing potentials for dependence,149 cognitive-
enhancement medications can create undesirable risks if non-addicted 
 
 143.  See supra note 49.  Dependence leads to extended stimulant use or abuse, which can create 
numerous adverse reactions.  See infra notes 156–57 and accompanying text.  Besides a high abuse 
potential, stimulant medications also induce unpleasant withdrawal effects.  Vliet et al., supra note 
90, at 60.  Physical dependence generates withdrawal symptoms when drug use is stopped.  
RICHARDS, supra note 2, at 174. 
 144.  See supra note 57 and accompanying text.  For instance, after Hari experimented with 
Provigil for five days and decided to take a three-day break, he reported he “painlessly sagged back 
to [his] former somewhat-depleted state, as though the Provigil had never happened.”  Hari, supra 
note 95; see also supra note 95 and accompanying text (recounting Hari’s short experience with 
Provigil).  Nonetheless, he also wrote that he “stared sadly at the pack of Provigil, and every time 
[he] hit a mental stumbling block, [he] had to discipline [himself] not to crack out a Provigil.”  Hari, 
supra note 95. 
 145.  See supra notes 56–57; see also Raminder Kumar, Approved and Investigational Uses of 
Modafinil: An Evidence-Based Review, 68 DRUGS 1803, 1828–29 (2008) (describing a recent study 
where Provigil had a similar profile as Ritalin).  But see Volkow et al., supra note 56, at 1152–53 
(noting that reports of Provigil abuse are rare and less frequent than those for Adderall and Ritalin).  
However, one psychiatrist said he has treated three cases of Provigil addiction—“I had two doctors 
back-to-back who were addicted . . . [to Provigil], so I became alarmed . . . .”  Rita Rubin, A 
Warning on Off-Label Use of Sleep-Disorder Drug, USA TODAY (Mar. 17, 2009), 
http://www.usatoday.com/news/health/2009-03-17-awake-modafinil_N.htm (explaining that drugs 
that increase dopamine levels have potential for abuse).  In July 2010, the European Medicines 
Agency recommended that Europeans only use Provigil to treat sleepiness associated with 
narcolepsy; the Agency presented this advisement to the European Commission after concluding that 
Provigil’s medicinal risks outweighed any other beneficial purpose.  See Press Release, European 
Meds. Agency, European Meds. Agency Recommends Restricting the Use of Modafinil (July 22, 
2010), available at http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/ 
07/WC500094976.pdf (noting safety concerns that related to psychiatric disorders, skin reactions, 
potential for abuse, and significant off-label use). 
 146.  See supra note 67 and accompanying text.  Nevertheless, extended beta blocker use may still 
cause adverse side effects.  See infra notes 161–62 and accompanying text. 
 147.  SYNCOPE: MECHANISMS AND MANAGEMENT 60 (Blair P. Grubb & Brian Olshansky eds., 2d 
ed. 2005).  Contra infra notes 174–77 and accompanying text (describing the effects of beta blocker 
poisonings). 
 148.  Beta blockers usually are the cheapest cognitive-enhancement medications; for example, 
drugstore.com sells 100 twenty-milligram tablets of propranolol hcl for $13.99—about 14¢ per pill.  
Propranolol Hcl, DRUGSTORE.COM, http://www.drugstore.com/propranolol-hcl/inderal/ 
20mg-tablets/qxn23155011110 (last visited Mar. 1, 2012); see also supra note 96 (noting, in 
contrast, that drugstore.com sells Provigil for $26.61 per pill). 
 149.  See supra text accompanying note 141. 
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students voluntarily take them over a protracted time.150  While students 
usually complete medical and law school educations within three or four 
years,151 they may not stop taking brain boosters upon graduating if their 
high-pressured professions seem to demand the enhanced capabilities the 
drugs can provide.152  Both brain-boosting critics and proponents 
acknowledge a lack of concrete information about the long-term use of 
cognitive enhancers by healthy adults—leaving medicinal mental doping in 
a state of dangerous uncertainty.153  Questions remain as to whether 
extended use actually diminishes vital aspects of intellectual activity—such 
as verbal fluency, creativity, and abstract thinking—through cognitive 
constriction.154  “[I]t remains to be seen whether [cognitive enhancers] 
 
 150.  See Mehlman, supra note 13, at 485 (arguing that deleterious side effects may be 
exacerbated by long-term use). 
 151.  See U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-10-412, FOREIGN MEDICAL SCHOOLS: 
EDUCATION SHOULD IMPROVE MONITORING OF SCHOOLS THAT PARTICIPATE IN THE FEDERAL 
STUDENT LOAN PROGRAM 20 (2010), available at http://www.gao.gov/assets/310/306021.pdf 
(noting that most U.S. medical school programs last four years and some foreign programs last 
three); William D. Henderson, The LSAT, Law School Exams, and Meritocracy: The Surprising and 
Undertheorized Role of Test-Taking Speed, 82 TEX. L. REV. 975, 998, 1023 (2004) (observing that 
law school programs usually last three years). 
 152.  See Mehlman, supra note 13, at 485.  “Even if the use of cognitive enhancements is not 
explicitly mandated, people may feel that they must do so in order to succeed or just to stay where 
they are in competitive endeavors.”  Id. at 488.  Another commentator warned against the future of 
employment discrimination, where students must either continue to enhance their brains for 
employers who expect the same output they demonstrated in school or endure discrimination 
because of their lessened cognitive abilities.  See J.M. Appel, When the Boss Turns Pusher: A 
Proposal for Employee Protections in the Age of Cosmetic Neurology, 34 J. MED. ETHICS 616, 617 
(2008); see also Megan Ogilvie, Stronger, Faster, Smarter?, TORONTO STAR (Feb. 2, 2008), 
http://www.thestar.com/News/article/299706 (explaining that employees may use cognitive 
enhancers to work better, faster, and longer, and to keep up with other colleagues who also consume 
brain boosters). 
 153.  Daniel J. DeNoon, Brain-Boosting Drugs FAQ: What You Must Know, WEBMD HEALTH 
NEWS (Dec. 11, 2008), http://www.webmd.com/brain/news/20081211/brain-boosting-faq-what-you-
must-know (observing that scientists recommend “[a]ccelerated research into the risks and benefits 
of cognitive enhancement”); see, e.g., Watts, supra note 58 (asserting that research has yet to 
determine the consequences of long-term beta blocker use by the healthy).  A shortage of focused 
research hampers not only the understanding of long-term effects of these drugs but also the 
development of more effective cognitive enhancers.  Nick Jackson, Against the Grain: ‘The Benefits 
of Brain-Boosting Drugs Are Huge,’ INDEP. EDUC. (May 29, 2008), http://www.independent.co.uk/ 
news/education/higher/against-the-grain-the-benefits-of-brainboosting-drugs-are-huge-835576.html.  
One neuroscientist at Brown University Medical School explained, “There are lots of quick and dirty 
studies of cognitive enhancement that make the news, but the number of rigorous, well-designed 
studies that will stand the test of time is much smaller . . . .  We’re sort of in the Wild West.”  Sharon 
Begley, Can You Build a Better Brain?, NEWSWEEK, Jan. 2011, at 40. 
 154.  Jacquelyn H. Flaskerud, American Culture and Neuro-Cognitive Enhancing Drugs, 31 
ISSUES MENTAL HEALTH NURSING 62, 63 (2010); see also Goodman, supra note 81, at 148 
(discussing the concerns with hampered lateral thinking).  Cognitive constriction is the “narrowing 
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represent a pharmacological ‘free lunch’ or if the enhancement of some 
cognitive functions can only be realized at the expense of others.”155 
For Adderall and Ritalin, the nationwide McCabe survey found long-
term, non-medical prescription stimulant consumers were “more likely to 
report use of alcohol, cigarettes, marijuana, ecstasy, cocaine, and other risky 
behaviors.”156  Moreover, extensive abuse of stimulant medications can 
encourage nervous system anomalies, extreme depression, seizures, 
schizophrenia, and toxic psychosis.157  Although doctors consider Provigil 
less harmful than stimulants,158 some scientists declare that its long-term 
manipulation of the sleep system can have dire consequences.159  Chronic 
sleep deprivation weakens the immune system, damages health, increases 
the likelihood of disease, and is linked to a shorter life span.160  Finally, for 
beta blocker consumption, studies demonstrate that extended use causes 
such adverse effects as depression, nightmares, wheezing, sexual 
 
of attentional focus, such that stimuli which are ‘peripheral’ in space, time, or meaning to the subject 
are relatively ignored.”  Mary V. Solanto, Dosage Effects of Ritalin on Cognition, in RITALIN: 
THEORY AND PATIENT MANAGEMENT 233, 240 (Laurence L. Greenhill & Betty B. Osman eds., 
1991).  For example, a lawyer who took Provigil daily for several months said all his daydreaming, 
extraneous thoughts, and distractions disappeared—leaving only complete concentration for the task 
at hand.  Madrigal, supra note 99.  But one college student claimed stimulant medications made her 
feel more creative, focused, and energetic.  Id. (explaining how Adderall helped her write a thirty-
five-page thesis in less than twelve hours).  Many critics of cognitive enhancement suggest that 
unknown future harms outweigh any short-term intellectual benefits.  Appel, supra note 152, at 617. 
 155.  Cakic, supra note 71, at 613.  The executive director of the Neurotechnology Industry 
Organization warned that poor research on healthy adult consumption means consumers may not 
notice serious side effects of cognitive enhancers until at least twenty years down the road.  Kirby, 
supra note 7, at 94. 
 156.  McCabe et al., supra note 80, at 96; see also supra note 80 and accompanying text 
(describing the survey’s general results). 
 157.  See Madhiraju, supra note 36, at 1667; Pavisian, supra note 42, at 179.  Toxic psychosis is a 
“severe mental illness in which the patient loses contact with reality.”  BANTAM MEDICAL 
DICTIONARY 358 (rev. ed. 1990). 
 158.  See supra note 94 and accompanying text. 
 159.  O’Connor, supra note 55; see also Szuflita, supra note 36 (“[A]buse of such drugs can lead 
to serious sleep deprivation in a demographic group that is already very sleep deprived.”).  Dr. David 
Slamowitz, a sleep disorder specialist, cautioned, “‘People think they can now burn the candle at 
both ends and not have to pay for it if they take this drug’ . . . .  But even if a person doesn’t feel the 
need for sleep . . . doing without it can be harmful.”  Pollack, supra note 88, at 31. 
 160.  O’Connor, supra note 55.  But see Vliet et al., supra note 90, at 59 (recommending wake-
promoting drugs to combat the detrimental consequences of sleepiness).  Skimping on sleep affects a 
person’s judgment; for example, many blame the lack of sleep for such disasters as the Exxon 
Valdez oil spill, Chernobyl nuclear meltdown, and the space shuttle Challenger incident.  O’Connor, 
supra note 55.  In terms of mental impairment, eighteen hours of no sleep is equivalent to a 0.05 
blood alcohol level; twenty-one hours of no sleep is equivalent to a 0.08 blood alcohol level—which 
is illegal when driving in most states.  Id. (quoting the director of the University of Michigan’s sleep 
disorders center). 
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dysfunction, and light-headedness.161  Rarer reactions include weight gain, 
hypotension, and increased risk of new-onset diabetes.162 
4. Personalized Research Risks 
The final safety concern for medicinal cognitive enhancement is the risk 
inherent in personalized research, or self-experimentation,163 where 
individuals try different dosages and methods of administration “in a wild, 
crowdsourced, ad hoc brain-enhancement experiment.”164  Because cognitive 
enhancement is an off-label purpose, the FDA does not require drug 
manufacturers to set dosages and methods for this type of use—leaving 
consumers to discover their own personal drug regimens.165  Even in the face 
of hazardous uncertainty, these consumers still readily embark on such a 
precarious path: 
It’s hard to know exactly how many healthy adults are doping their 
brains.  Anecdotal evidence on the Internet suggests an 
underground enhancement culture is taking shape not unlike what 
occurred in the early days of steroid use in bodybuilding.  In online 
forums devoted to cognition enhancement, participants rhyme off 
their pharmaceutical regimens the same way other people swap 
 
 161.  F.H. Messerli et al., Cardioprotection with Beta-Blockers: Myths, Facts and Pascal’s 
Wager, 266 J. INTERNAL MED. 232, 239 (2009); see, e.g., Watts, supra note 58 (describing an 
incident where a doctor passed out during his presentation after taking a beta blocker for stage 
fright).  A 1998 research study confirmed that some beta blockers can decrease sexual libido and 
even cause impotence with long-term use.  R. Fogari et al., Libido Decreases with Long-Term Beta-
Blocker Use, 11 AM. J. HYPERTENSION 1244, 1244 (1998); see also Paul C. Ajamian, Beta-Blockers: 
Treat with Care, REV. OPTOMETRY, Feb. 2001, at 89, 89 (recommending that physicians advise male 
patients that beta blocker consumption may affect their sexual performances). 
 162.  Messerli et al., supra note 161, at 239. 
 163.  See THE OXFORD ILLUSTRATED COMPANION TO MEDICINE 744–45 (Stephen Lock et al. 
eds., 3d ed. 2001) (“Observing and measuring the effects on oneself of ingested or injected drugs 
have long been mainstays of experimental pharmacology.”). 
 164.  Madrigal, supra note 99 (listing more than fifteen different drug regimens from students, 
scientists, and executives).  For example, a scientist at the MIT-affiliated Whitehead Institute for 
Biomedical Research explained how he experimented with Provigil dosages over several weeks: 
“200 mg in the morning, 100 mg, 50 mg, 10 mg, and then split doses of more in the morning and a 
reduced dose at lunch.”  Id.  A wireless ISP owner said his drug regimen was half a Provigil tablet 
and three gingko capsules in the mornings—to activate his triple espresso.  Id.  Lastly, a Florida 
college student claimed that taking thirty-milligram Adderall XR improved his focus, attention to 
detail, and test scores.  Id. 
 165.  See supra notes 69, 127–28 and accompanying text.  This lack of FDA oversight may 
explain why a recent survey among doctors found that “they’re more comfortable prescribing sex 
drugs than smart drugs.”  Begley, supra note 153, at 41. 
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cocktail recipes.  Except in this case, the ingredients are some of the 
most powerful compounds on the market, approved to treat not just 
narcolepsy and attention deficit disorder, but also Parkinson’s 
disease, Alzheimer’s and depression.166 
The two most notable dangers of self-experimentation are drug 
overdose167 and unforeseeable medicinal interactions.168  Overdosing can be 
accidental or premeditated.169  For stimulant users, most overdosing is 
probably premeditated because unintentional overdosing on the 
recommended amount is a rare occurrence.170  When acute Adderall 
overdose does occur, it can result in hypertension, seizure, hyperthermia, 
hallucination, stroke, or death.171  Similarly, Ritalin overdose can cause 
irregular heartbeat, seizure, and cardiac failure.172  Provigil overdose has less 
severe consequences—such as nausea, diarrhea, confusion, and 
hallucination.173  Lastly, beta blockers vary in their acute overdose potential 
 
 166.  Kirby, supra note 7, at 94. 
 167.  DeNoon, supra note 153.  Overdosing is “a result of ‘super dosage’ in the use of one or 
more substances that trigger physiological alterations which can seriously compromise the user’s 
health and require immediate medical attention to avoid death.”  Eroy Aparecida da Silva et al., 
Death by Drug Overdose: Impact on Families, 39 J. PSYCHOACTIVE DRUGS 301, 302 (2007). 
 168.  Barbara Sahakian & Sharon Morein-Zamir, Professor’s Little Helper, 450 NATURE 1157, 
1158 (2007) (explicitly not advocating self-medication because of potential drug interactions). 
 169.  Silva et al., supra note 167, at 303 (noting that unintentional “super dosage” occurs (1) when 
compulsive drug use leads consumers to lose awareness of their past ingestion or (2) when drugs 
contain unexpectedly high lethal potentials). 
 170.  See Robert M. Diener, Toxicology of Ritalin, in RITALIN: THEORY AND PATIENT 
MANAGEMENT 35, 42 (Laurence L. Greenhill & Betty B. Osman eds., 1991); Pavisian, supra note 
42, at 179.  For example, while a single recommended Adderall dosage is ten to thirty milligrams, a 
person may need to consume 400 to 500 milligrams before a dose turns fatal.  Pavisian, supra note 
42, at 178–79.  Overdosing on Adderall more easily occurs when users do not swallow extended-
release Adderall XR tablets whole, but instead crush or chew them, because too much of the drug 
enters a body’s biological system at one time.  See MEDICATION GUIDE: ADDERALL XR, supra note 
48, at 2.  If consumers cannot swallow Adderall XR capsules, the medication guide recommends 
they open the capsules, sprinkle the medicine on a spoonful of applesauce, and swallow all the 
applesauce without chewing.  Id.  Although overdose potential is low for recommended doses, 
prolonged stimulant use can create dependence and tolerance that may necessitate higher doses to 
achieve desired effects.  See Pritesh J. Gandhi et al., Myocardial Infarction in an Adolescent Taking 
Adderall, 62 AM. J. HEALTH-SYS. PHARMACY 1494, 1494 (2005). 
 171.  Gandhi et al., supra note 170, at 1494.  However, statistical reports suggest most Adderall-
related deaths result from chronic or extended consumption, not acute toxicity.  Steven Karch, The 
Problem of Methamphetamine Toxicity, 170 W. J. MED. 232, 232 (1999). 
 172.  Diener, supra note 170, at 42.  Mild Ritalin overdoses potentially foster insomnia, 
nervousness, hypersensitivity, anorexia, palpitations, drowsiness, headache, blood pressure changes, 
and abdominal pain.  Id. 
 173.  Provigil, supra note 54; see also MEDICATION GUIDE: PROVIGIL, supra note 54, at 39.  
Contra Kumar, supra note 145, at 1804 (asserting that Provigil has “serious dermatological 
toxicity”).  Provigil overdose is infrequent and rarely life threatening.  Henry A. Spiller et al., 
Toxicity from Modafinil Ingestion, 47 CLINICAL TOXICOLOGY 153, 155 (2009).  While 137 Provigil 
overdoses were reported at fifteen poison centers from eleven states during an eight-year period, 
intentional abuse occurred in only seven of those cases.  Id. 
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with Inderal predominantly provoking the most beta blocker poisonings.174  
However, overdosing on Inderal, Lopressor, or Toprol-XL can all lead to 
seizure, bronchospasm,175 hypotension,176 and cardiac failure.177 
Besides the possibility of an overdose, self-experimenting with 
cognitive enhancers can result in unanticipated interactions with other drugs 
or substances.178  For instance, the medication guides for Adderall, Ritalin, 
and Provigil warn that interactions with other prescriptions may engender 
serious side effects.179  FDA-approved medication guides also advise 
Provigil and beta blocker patients to avoid alcohol.180  Lastly, the beta 
blocker medication guides specifically list other drugs that inhibit or 
exacerbate medicinal effects with concurrent use.181 
While risks are inherent with all medications, the fact that healthy 
individuals consume cognitive enhancers for mental enhancement rather 
 
 174.  Sharma et al., supra note 63; see also Jeffrey N. Love et al., Acute Beta Blocker Overdose: 
Factors Associated with the Development of Cardiovascular Morbidity, 38 CLINICAL TOXICOLOGY 
275, 277 (2000) (finding that Propanalol was implicated in 121 of 280 beta blocker overdoses).  
Possible overdose is more common with beta blockers than with other cognitive enhancers; for 
example, in 1997, consumers reported 8553 beta blocker exposures to the American Association of 
Poison Control Centers (AAPCC).  Love et al., supra, at 278–79; see also supra notes 170, 173 and 
accompanying text (describing smaller overdose rates for the other cognitive enhancers). 
 175.  Bronchospasm is the spasmodic narrowing of the windpipe.  STEDMAN’S MEDICAL 
DICTIONARY, supra note 51, at 197. 
 176.  Hypotension is low blood pressure.  Id. at 682. 
 177.  See MEDICATION GUIDE: INDERIDE, supra note 63, at 10; see also David M. Reith & 
Andrew H. Dawson, Relative Toxicity of Beta Blockers in Overdose, 34 J. TOXICOLOGY 273, 273 
(1996).  In 2003, consumers reported 15,350 beta blocker exposures—including 2163 severe 
overdose cases—to the AAPCC; of these, thirty-three resulted in death.  Joel S. Holger et al., A 
Comparison of Vasopressin and Glucagon in Beta-Blocker Induced Toxicity, 44 CLINICAL 
TOXICOLOGY 45, 45 (2006). 
 178.  DeNoon, supra note 153; see also Syed F. Ali & S.C. Bondy, Red Wine But Not Ethanol at 
Low Doses Can Protect Against the Toxicity of Methamphetamine, BRAIN RES., July 30, 2010, at 
247, 248 (explaining that drug abusers often consume several substances in conjunction). 
 179.  See MEDICATION GUIDE: ADDERALL XR, supra note 48, at 1; MEDICATION GUIDE: 
PROVIGIL, supra note 54, at 37; MEDICATION GUIDE: RITALIN, supra note 48, at 1.  These guides 
caution consumers to tell their doctors about all medicinal use—including prescriptions, vitamins, 
herbal supplements, and nonprescription medications.  See MEDICATION GUIDE: ADDERALL XR, 
supra note 48, at 1–2; MEDICATION GUIDE: PROVIGIL, supra note 54, at 37; MEDICATION GUIDE: 
RITALIN, supra note 48, at 1–2. 
 180.  See MEDICATION GUIDE: INDERIDE, supra note 63, at 7; MEDICATION GUIDE: PROVIGIL, 
supra note 54, at 39 (“It is not known how drinking alcohol will affect you when taking 
PROVIGIL.”). 
 181.  See MEDICATION GUIDE: INDERIDE, supra note 63, at 6–7 (listing such medications as 
catecholamine-depleting drugs, calcium-channel blocking drugs, nonsteroidal anti-inflammatory 
drugs, and aluminum hydroxide gel); MEDICATION GUIDE: LOPRESSOR HCT, supra note 65, at 5 
(also including clonidine and general anesthetics); MEDICATION GUIDE: TOPROL-XL, supra note 66, 
at 11 (further listing digitalis glycosides and CYP2D6 inhibitors). 
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than medical treatment may indicate that any type of risk is unacceptable.182  
However, the true exercise of personal autonomy requires individuals who 
are aware of the possible safety concerns to make their own free-will 
decisions.183  For example, in the recent Nature survey, questioning 1400 
academics from sixty countries, half of the respondents who took cognitive 
enhancers for non-medical purposes reported unpleasant side effects, but 
only some chose to discontinue use.184  Sixty-nine percent of all surveyed 
stated they would risk mild side effects for the cognitive-enhancement trade-
off, and 80% thought healthy adults should have the choice to participate in 
brain-boosting use.185  Generally, some ethicists argue that civil liberties 
should outweigh theoretical safety hazards, especially those created when 
 
 182.  Cakic, supra note 71, at 613; see also Sahakian & Morein-Zamir, supra note 168, at 1157 
(“For all medications, the chief concern cautioning against their use is adverse side effects that affect 
the individual’s health and well being [sic].”).  Acceptable safety risks depend on the potential 
benefits, which understandably are slim for already healthy individuals.  See Greely et al., supra note 
9, at 703; see also Michael K. Ahlijanian, Eschew Enhancement: Memory-Boosting Drugs Should 
Not Be Made Available to the General Public, TECH. REV. (May 1, 2009), 
http://www.technologyreview.com/biomedicine/22476 (contending that the risks of harm 
substantially outweigh any cognitive benefits). 
 183.  Cakic, supra note 71, at 613; see also Enhancing, Not Cheating, 450 NATURE 320, 320 
(2007) (describing the opponents of cognitive enhancement as “whistling in the wind” against the 
opposing ethical argument of the “pursuit of personal liberty”).  It would appear these two extremes 
exist in an untenable compromise—where consumers have the right to decide if risks are acceptable, 
but their “civil liberties must also be balanced by the need to safeguard the public good.”  Cakic, 
supra note 71, at 613.  For illustration, one survey of 1811 students at an American public university 
found that none of the interviewed respondents had “sought out information from health 
professionals, medical or pharmaceutical reference guides, or even Internet sites” before taking their 
first cognitive enhancer.  DeSantis et al., supra note 81, at 317 (reporting that most first-time 
cognitive-enhancement use occurred at times of high academic stress and anxiety).  Further, the 
researchers discovered that a majority of the student users possessed limited knowledge about the 
cognitive enhancers they voluntarily consumed, with no understanding of their appropriate doses, 
psychological or physiological side effects, or the legal ramifications of their illicit use.  Id. at 320–
21 (finding that 96% of the student consumers had obtained their cognitive enhancers without 
prescriptions).  Such survey results may dictate a shift away from personal autonomy and towards 
mandatory safeguards for the well-being of society.  See Cakic, supra note 71, at 613. 
 184.  Maher, supra note 98, at 674 (listing the reported side effects as headaches, anxiety, 
jitteriness, and sleeplessness); see also supra note 98 and accompanying text (describing the 
survey’s general results). 
 185.  Maher, supra note 98, at 674.  Academics that would employ cognitive enhancers, 
notwithstanding their risks, follow an already established practice in athletics—where sports 
competitors continue to take anabolic steroids, despite their serious adverse effects.  Mehlman, supra 
note 13, at 487.  For example, one biannual study repeatedly reveals that more than half of the 200 
world-class athletes interviewed “would take a drug that guaranteed them a gold medal but would 
also kill them within five years.”  Gretchen Reynolds, Phys Ed: Will Olympic Athletes Dope If They 
Know It Might Kill Them?, N.Y. TIMES WELL BLOG (Jan. 26, 2010, 12:01 AM), 
http://well.blogs.nytimes.com/2010/01/20/phys-ed-will-olympic-athletes-dope-if-they-know-it-
might-kill-them (discussing the Goldman Dilemma survey).  Surprisingly, a similar question asked 
of nonathletes in a 2009 study reported that only two of the 250 respondents would take a 
medication that would ensure both success and an early death.  J.M. Connor & J. Mazanov, Would 
You Dope? A General Population Test of the Goldman Dilemma, 43 BRIT. J. SPORTS MED. 871, 871 
(2009) (only surveying Australians). 
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healthy adults consume legally prescribed medications.186  But when these 
adults are medical or law school students in an arena governed by ethical 
codes, perhaps the scales tip toward mandatory safeguards.187  To fully 
determine whether administrators and professional associations should be 
tasked to monitor this medicinal practice, an ethical analysis must also 
consider social implications and fairness concerns.188 
B. All on Everyone’s Mind: Social Concerns with Prevalent Use 
Cognitive enhancement in the medical and legal academic setting 
creates a unique social ramification that is less prevalent or nonexistent in 
other specialties—namely, social coercion.189  In many medical and law 
schools, the educational stakes are high.190  Students work to outperform 
their peers so they can earn high GPAs on tightly graded curves, to secure 
the clinical or journal positions that will better position them to obtain the 
limited career positions available in this increasingly competitive job 
market.191  And if they do secure that coveted position at a “big name” 
hospital or firm, the pressure to outperform may remain just as, or more, 
intense.192  Individuals in these academic and professional settings often 
 
 186.  RICHARDS, supra note 2, at 170, 184.  Richards contends that personal autonomy means 
healthy adults may consciously choose medicinal use to obtain a more fulfilling life: 
It is, of course, a banality of the literature of perceptive observers on drug experience that 
the quality of such experience varies according to the expectations, aims, and identity that 
the person brings to the experience.  This should confirm that drug experience is neither 
satanic damnation nor divine redemption of the self, but merely one means by which the 
already existing interests of the person may be explored or realized. 
Id. at 170.  If the interests of free will allow for unchecked medicinal cognitive enhancement, 
physicians and consumers themselves can still act as the gatekeepers that prevent unsafe drug use.  
See Mehlman, supra note 13, at 486.  This presupposes that physicians and the general public are 
making informed choices because they know the risk–benefit profiles of the cognitive enhancers 
they either are prescribing or consuming.  Id.  But see supra note 183 and accompanying text 
(discussing the possible ramifications from uninformed cognitive-enhancement use). 
 187.  See supra notes 26–27 and accompanying text.  For a setup of the ethical restrictions on both 
medical and law school students and their respective professions, see supra notes 15–25 and 
accompanying text. 
 188.  See supra notes 124–25 and accompanying text. 
 189.  See Cynthia Forlini & Eric Racine, Autonomy and Coercion in Academic “Cognitive 
Enhancement” Using Methylphenidate: Perspectives of Key Stakeholders, 2 NEUROETHICS 163, 164 
(2009) (explaining that the key concern is the degree of freedom that students have to abstain from 
or engage in cognitive enhancement). 
 190.  Id. at 167 (“In terms of grad studies, we’re getting into a highly competitive level where you 
can be replaced at the snap of a finger purely based on grades.”). 
 191.  See, e.g., id.; Webb et al., supra note 84, at 200 (describing medical school pressures). 
 192.  See supra note 152 and accompanying text; see also Peter J. Whitehouse & Eric Juengst, 
Enhancing Cognition in the Intellectually Intact, HASTINGS CENTER REP., May–June 1997, at 14, 21. 
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experience social coercion—they think they must take brain boosters to 
succeed or even stay on equal footing with their cognitively-enhanced 
peers.193  This implicit coercion interferes with the exercise of free choice, 
meaning that those who are opposed to using cognitive enhancers 
themselves may either acquiesce to peer pressure or give up hopes of 
academic and professional success.194  Those who ignore social coercion 
may begin to resent their medicinal-using peers—creating more competitive 
and stressful learning and working environments.195  Besides implicit 
coercion, the prevalence of cognitive enhancement also may generate direct 
coercion—leading parents196 and employers197 to strongly encourage 
continued use for the sake of acquiring a consumer’s peak performance.198  
 
 193.  See Greely, supra note 6, at 1150 (equating implicit coercion with competition); Mehlman, 
supra note 13, at 488 (discussing the pressures and inducements of performance-enhancing drug 
use).  “So long as resources remain scarce and continue to be apportioned to such a large extent 
competitively, this type of inducement will persist.”  Mehlman, supra note 13, at 500.  For example, 
if most students use stimulants to vastly improve their grades, then the remaining nonusers may feel 
pressure to follow suit if they wish to remain competitive.  Cakic, supra note 71, at 612 (comparing 
performance pressure in sports to cognitive pressure in schools). 
 194.  Fox, supra note 56, at 1148.  “Environments, like academia, can constitute ‘winner take all’ 
situations meaning that slight gains in cognitive performance can translate into substantial benefits.”  
Forlini & Racine, supra note 189, at 164. 
 195.  See Kaplan & Gellene, supra note 72 (quoting a professor who noticed resentment growing 
among her students who refrained from cognitive enhancers).  Abstaining students may resent their 
peers because of the idea that their peers’ artificial study habits undermine the value of their natural 
hard work.  See id. 
 196.  See Sarah Harris, Fears for ‘Smart Pill’ Generation, DAILY MAIL (London), Aug. 19, 2008, 
at 60.  Parental coercion has a long history with various levels of outrageousness.  Greely, supra note 
6, at 1151.  Presently, evidence points to ambitious parents tackling the cognitive arena by buying 
smart pills from the Internet for their studious children.  See Marrin, supra note 77, at 65 (discussing 
correlating safety concerns); see also Forlini & Racine, supra note 189, at 167 (interviewing parents 
who felt the pressure to perform and succeed supported cognitive-enhancement practices).  “These 
pressures were often described as a demand for the individual to be the best in contrast to simply 
being average.”  Forlini & Racine, supra note 189, at 167. 
 197.  See supra note 152 and accompanying text.  In considering employer coercion, it is 
important to note that “[e]ventually, without preventive legislative action, employers [may] begin to 
demand that their employees accept neurological enhancement as a condition for employment or 
promotion—and the working stiffs of the world will not have the financial power to resist.”  Appel, 
supra note 152, at 618.  Two commentators have speculated on the possibilities of such a future: 
It is not difficult to imagine that a worker’s willingness to use a drug that increased 
productivity would soon become a factor in hiring and promotion.  A company deciding 
which law firm to engage might want to know which of them requires their attorneys to 
use cognitive enhancers: the presumably higher efficiency would translate into fewer 
hours billed and lower cost.  Attorneys willing to use cognitive enhancers might earn 
better fees and find more firms ready to hire them. 
Whitehouse & Juengst, supra note 192, at 20.  Employers already insist on some types of 
enhancement; for instance, they may force their employees to take mandatory training programs or 
risk losing their jobs.  Greely, supra note 6, at 1150.  However, this pressure does not consider other 
ethical concerns involved with drug use—such as safety and fairness.  See supra note 124 and 
accompanying text. 
 198.  Greely et al., supra note 9, at 703 (asking whether schools and employers “[s]hould be 
allowed to require pharmaceutical enhancement”); see also Sahakian & Morein-Zamir, supra note 
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These different social scenarios increasingly can emerge as medicinal brain-
boosting use becomes more widespread.199  Coercion—indirect or direct—
proscribes personal autonomy and lacks legitimate justification in the 
educational setting.200  Instead of promoting a cognitive arms race among 
students,201 educational policies may need to prohibit social pressures if the 
ethical scales tilt towards these mandatory safeguards for the students’ 
greater good.202  To determine this ethical balance requires the analysis of 
one final consideration—fairness.203 
 
168, at 1159 (stressing the concern of direct and indirect coercion).  For an in-depth study on school 
administration coercion, see Marc Bousquet, Take Your Ritalin and Shut Up, 108 S. ATLANTA Q. 
623, 625 (2009). 
 199.  Fox, supra note 56, at 1148; see also Cakic, supra note 71, at 612 (explaining that a 
sufficiently high portion of students must use cognitive enhancers before nonusers feel peer 
pressured with the perception that “everybody else is taking them”).  Studies already reveal that 
brain-boosting drugs are prevalent on school campuses.  See supra note 111 and accompanying text.  
But, as one doping researcher explained, if drugs actually made people smarter, their use would turn 
epidemic.  Kaplan & Gellene, supra note 72.  “‘Just think what it would do to anybody’s career in 
about any area.  There are not too many occupations where it’s really good to be dumb.’”  Id. 
 200.  See Greely et al., supra note 9, at 703 (“Employers, schools or governments should not 
generally require the use of cognitive enhancements.”).  Contra Cakic, supra note 71, at 613 
(contending that restraining others’ actions to protect nonusers from feelings of coercion is equally 
an attack on personal freedom).  However, giving free reign to every cognitive-enhancer user 
actually may allow individuals to identify their use as voluntary self-improvement, rather than 
coerced consumption.  Forlini & Racine, supra note 189, at 164; see also RICHARDS, supra note 2, at 
172 (noting that treating everyone as equals means respecting the individual’s ability to choose).  
Arguably, cognitive coercion may be appropriate when considering the safety of individuals that 
others depend on in dangerous situations; for example, soldiers sometimes take stimulants to 
increase alertness, but perhaps surgeons also should use safe brain boosters if the drugs would enable 
them to save more lives.  See Greely et al., supra note 9, at 703; see also Carol Lewis, Chemical 
Allies to Boost Performance, TIMES (London), Oct. 14, 2004, at 10 (considering smart drugs for 
doctors and pilots to facilitate sharper minds and faster reactions). 
 201.  See Nick Bostrom & Rebecca Roache, Ethical Issues in Human Enhancement, in NEW 
WAVES IN APPLIED ETHICS 120, 137 (Jesper Ryberg et al. eds., 2007). 
 202.  See supra note 183 and accompanying text.  However, one commentator warns, “[T]here is 
something morally perverse in condemning drug use as intrinsic moral slavery when the very 
prohibition of it seems to be an arbitrary abridgement of personal freedom.”  RICHARDS, supra note 
2, at 177. 
 203.  See supra notes 124–25 and accompanying text.  As one editorial stressed, “If you take away 
the risk of personal harm, it becomes largely an argument of fairness.”  Daniel Malherbe, Blogs Are 
Abuzz About Brain Boosters, CAPE TIMES (S. Afr.), Mar. 11, 2008, at E1 (asking whether cognitive-
enhancement medicinal use is cheating).  Other ethicists suggest fairness is the predominant 
consideration to determine the existence of cheating because the definition of “cheating” is mainly a 
matter of fairness.  Schermer, supra note 26, at 85; see also supra note 26. 
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C. Mind Hacks: Fairness Concerns with Cognitive Advantages 
Fairness encompasses a spectrum of ethical concerns from both 
individual and societal perspectives.204  On the individual level, fairness 
considerations largely focus on personal achievements and competition,205 
while on the societal level, they primarily involve equal access and the 
possibilities of increased discrimination.206 
1. Personal Achievement 
Critics of cognitive enhancement traditionally object to drug use as an 
unnatural means to improve one’s mental abilities.207  This overlooks the 
fact that while stimulants, narcolepsy medications, and beta blockers may 
not be natural substances,208 other cognitive enhancers do occur in nature—
including caffeine, gingko, and nicotine.209  However, even naturally 
occurring compounds may be used in an unnatural manner to artificially 
boost cognition.210  In the classroom setting, this method of obtaining 
scholastic achievement is a false self-improvement that differs from innate 
talent or diligent study,211 partially because (1) it is more transitory in nature 
 
 204.  Greely, supra note 6, at 1151–52. 
 205.  See infra notes 207–48 and accompanying text. 
 206.  See infra notes 249–80 and accompanying text. 
 207.  See Mehlman, supra note 13, at 491 (noting that cognitive enhancers are singled out for 
rebuke because they are not customary, traditional, or natural).  In actuality, unnatural cognitive 
enhancers may be traditional because of their long-lived existence: 
Since Adam and Eve’s apple, however, the most controversial means of cognitive 
enhancement have always been the enhancers we take rather than the ones we invent or 
earn: the supernatural gifts, magic potions, or medical drugs that promise to expand our 
abilities without requiring us to exert ourselves unduly in the process. 
Whitehouse & Juengst, supra note 192, at 14; see, e.g., infra note 209 (noting the traditional use of 
caffeine).  In fact, proponents of cognitive enhancement call the “preferability of the natural” a status 
quo bias that has long affected ethical analyses.  Nick Bostrom & Toby Ord, The Reversal Test: 
Eliminating Status Quo Bias in Applied Ethics, 116 ETHICS 656, 679 (2006). 
 208.  See, e.g., supra note 92 (explaining that Provigil is a manufactured drug). 
 209.  Mehlman, supra note 13, at 492 (specifically mentioning that caffeine has been used as a 
natural brain booster for centuries); see also supra note 5 and accompanying text. 
 210.  Greely, supra note 6, at 129.  Some critics contend that this unnatural method of obtaining 
academic accomplishments makes them both unearned and unworthy of reward.  Mehlman, supra 
note 13, at 492 (noting, however, that medicinal consumers are still likely to expend some effort to 
produce praiseworthy results). 
 211.  Katrina A. Bramstedt, Caffeine Use by Children: The Quest for Enhancement, 42 
SUBSTANCE USE & MISUSE 1237, 1247 (2007).  In finding the distinction between natural and 
unnatural self-improvement, Bramstedt relies on the reasons behind the medicinal use: 
The test for whether or not cognitive enhancement is cheating is the concurrent presence 
or absence of a clinically diagnosed cognitive deficit.  In the presence of such a deficit, 
drug-mediated cognitive enhancement is not cheating but rather correction of a medical 
problem.  In the absence of such a deficit, drug-mediated cognitive enhancement is a 
form of cheating because it circumvents the honest way of attaining excellence—that is, 
diligent study. 
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than the cognitive permanence gained by other natural means,212 and (2) it 
diminishes the accomplishments of those who only use those other means.213  
It also belies the consumer’s achievements by “confounding the 
identity . . . acquired through natural gift cultivated by genuinely lived 
experiences.”214  Studies demonstrate that mental characteristics like 
intelligence are more fundamental to self-identity than physical attributes.215  
Because people generally desire to express and preserve their own self-
identities,216 an unnatural enhancement of such a personal trait for the sake 
of achieving better grades may engender personal antipathy rather than any 
sense of actual accomplishment.217  In a correlating manner, enhancements 
 
Id. at 1247–48.  Bramstedt further points out that even if some students have more natural abilities 
than others, unethical behavior is not the ethically appropriate means to fill gaps in natural talent.  Id. 
at 1248.  This reasoning especially holds true for the unique ethically bound environments of 
medical and law schools.  See supra note 15 and accompanying text. 
 212.  Whitehouse & Juengst, supra note 192, at 21.  To actually increase the mind’s potential 
requires the repeated use of the brain’s neural circuits; therefore, when a person focuses on or learns 
a particular skill or subject, the mind’s capacity to process and retain data also improves as more 
“neuronal real estate” is used.  Begley, supra note 153, at 44. 
 213.  Schieffelin, supra note 13, at 976–77. 
 214.  Jason Riis et al., Preferences for Enhancement Pharmaceuticals: The Reluctance to Enhance 
Fundamental Traits, 35 J. CONSUMER RES. 485, 497 (2008); see also Fox, supra note 56, at 1150 
(“This objection has to do with the shift away from achievements humans undertake through self-
initiated striving, and toward those they experience by biochemical interventions, which act on us as 
passive subjects.”).  Life experiences, which take time and effort, have the potential to develop many 
individual attributes—including emotions, strength, beauty, and intellectual endeavors.  Torbjorn 
Tannsj, Ought We to Enhance Our Cognitive Capacities?, 23 BIOETHICS 421, 428 (2009).  For 
example, while medicinal cognitive enhancement may enable a user to more easily learn a second 
language, it also deprives such a consumer from the accomplishment of immersing oneself into a 
foreign culture.  Id. at 428–29 (“Generally speaking, making life easier is not tantamount to making 
life better.”).  Therefore, cognitive enhancers actually may violate the integrity of a person’s efforts 
or endeavors.  See Greely, supra note 6, at 1152. 
 215.  Riis et al., supra note 214, at 497, 503; see also Whitehouse & Juengst, supra note 192, at 
17 (noting that the human race’s “self defining feature and point of pride is that the form of sensation 
we prize most is that which constitutes the life of the mind: cognitive experience”). 
 216.  Riis et al., supra note 214, at 497.  Nevertheless, some proponents of cognitive enhancement 
contend that it is humanity’s “biologically grounded nature” to be open to artificial tools and 
medications that literally become part of the consumer and create a new identity as the “soft self.”  
Andy Clark, Re-Inventing Ourselves: The Plasticity of Embodiment, Sensing, and Mind, 32 J. MED. 
& PHIL. 263, 278 (2007). 
 217.  See Riis et al., supra note 214, at 497; see also Fox, supra note 56, at 1150 (explaining that 
cognitive enhancers undermine the authenticity of self).  This scenario may be more common with 
cognitive enhancers that offer only a slight mental boost at the cost of reducing other human 
capacities—such as creative thought, emotional depth, and perceptiveness.  See Whitehouse & 
Juengst, supra note 192, at 22; see also supra notes 154–55 and accompanying text.  However, “[i]t 
is possible that people who perceive themselves as worse than they ‘should be’ on some trait 
dimension are more likely to enhance that trait in an effort to become ‘who they really are.’”  Riis et 
al., supra note 214, at 506.  Other cognitive proponents additionally note that even if cognitive 
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that require effort, such as meditation and brain games,218 are deemed more 
socially and morally acceptable because they enable rather than artificially 
enhance the self.219  Ultimately, the concern becomes whether obtaining 
cognitive achievements through brain-boosting use “make[s] individuals less 
themselves—less human and less them—in a way that deprives them of a 
life lived genuinely and fully.”220 
While considerations of personal achievement predominantly focus on 
the subjective self,221 a fairness assessment also requires understanding how 
potentially cheating the self can affect the accomplishments of others.222  A 
consumer’s use of cognitive enhancers can be viewed in this larger 
framework by questioning the effects of brain boosting in competitive 
environments.223 
 
enhancers negatively affect character, it would only be certain aspects of character.  Maartje 
Schermer, Enhancements, Easy Shortcuts, and the Richness of Human Activities, 22 BIOETHICS 355, 
357 (2008) (“Virtues like justice, wisdom, humanity or transcendence appear to be less vulnerable to 
the use of enhancers.”). 
 218.  Begley, supra note 153, at 45. 
 219.  See Riis et al., supra note 214, at 506; see also Whitehouse & Juengst, supra note 192, at 21 
(“The traditional methods of expanding our capabilities, the pharmaceutical Calvinists argue, are 
‘natural’ and therefore praiseworthy, while drug-induced abilities are ‘artificial’ and thereby 
suspect.”).  Contra Enhancing, Not Cheating, supra note 183, at 320.  In opposition, the editorial 
board of Nature contends that if medicinal enhancement can enable scientists or artists to achieve 
new heights of performance, they are not suspect mechanisms.  Id.  Instead, “[f]ar from cheating on 
themselves or others, they would be delivering a higher return on their investment of effort, and 
indeed on society’s investment in them.”  Id. 
 220.  Fox, supra note 56, at 1151; see also supra notes 216–19 and accompanying text.  Not all 
ethicists view the utilization of brain boosters as a form of self-deprivation; instead, they argue the 
opposite—that the banning of cognitive enhancers is an attack on personal autonomy that deprives 
consumers of their human fulfillment: 
Many other courses may reasonably and responsibly accommodate the diverse 
individuality of human competences, aspirations, and ends.  What for one is a reasonable, 
self-imposed ideal of self-control and social service may be for another a self-defeating 
impoverishment of human experience and imagination, a rigid and inflexible willfulness 
without intelligent freedom or reasonable spontaneity, a masochistic denial of self and 
subjectivity in the service of uncritical and dubiously manipulative moral aims. 
RICHARDS, supra note 2, at 172 (arguing that moral conceptions are not valid justifications for 
sanctioning or restricting drug use).  But see supra notes 183, 202 and accompanying text. 
 221.  See supra notes 211, 214 and accompanying text. 
 222.  See, e.g., supra note 213 and accompanying text. 
 223.  See supra note 205 and accompanying text.  Competition, which can be defined as the 
pursuit of victory or excellence, necessarily involves weighing or judging the accomplishments of all 
competitors to determine the winners.  See Sarah J. Wild, On Equal Footing: Does Accommodating 
Athletes with Disabilities Destroy the Competitive Playing Field or Level It?, 37 PEPP. L. REV. 1347, 
1353 (2010); see also supra note 222 and accompanying text (noting the need to consider others’ 
achievements in a fairness analysis). 
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2. Competitive Endeavor 
Any analysis that considers the fairness implications of medicinal 
enhancement in competitive situations should begin with a look at the 
clearest example of competitive activity—sports.224  In the athletic arena, 
drug use is not only viewed as taboo, it also is seen as fundamentally 
incompatible with sports225 because society values winners for their 
natural226 rather than artificial efforts.227  Illegal drug use also violates the 
actual rules of sport.228  Most notably, WADA already prohibits all four 
types of cognitive enhancers in different athletic competitions.229  When 
deciding whether to ban a substance from international athletics, WADA 
 
 224.  See Savulescu, supra note 71, at 326.  Athletics offers a fitting starting point for most 
fairness evaluations because the “paradigmatic example of cheating as gaining an unfair advantage 
over others by breaking the rules comes from competitive sports.”  Schermer, supra note 26, at 85. 
 225.  Mehlman, supra note 13, at 490; see, e.g., supra notes 106–07 and accompanying text.  For 
instance, Kelli White, an American sprinter who won two gold medals at the 2003 World Track 
Championships, lost her medals and received a two-year suspension after testing positive for 
Provigil.  Greely, supra note 49, at 126–27.  Although her family exhibited a history of narcolepsy 
and she had a valid prescription, White admitted to taking the drug for competitive rather than health 
reasons.  Wild, supra note 223, at 1379 n.142.  Even before her confession, the International 
Association for Athletics Federations was contemplating punishment merely because her case 
involved drug use during competition.  See Greely, supra note 49, at 127. 
 226.  Natural efforts encompass determination, talent, and luck.  Mehlman, supra note 13, at 490.  
Some proponents of performance enhancement point out that victory in competition is significantly 
dependent on the “genetic lottery.”  W. Miller Brown, The Case for Perfection, 36 J. PHIL. SPORT 
127, 128 (2009).  They contend, “No matter the extent of our effort and courage in the pursuit of 
athletic excellence, most of us do not have the genetic endowments to succeed at world-class 
competition.”  Id.  While this genetic discrepancy probably is unfair, more importantly from an 
ethical view, natural efforts are morally neutral—neither just nor unjust.  Id. 
 227.  Mehlman, supra note 13, at 490; see also supra notes 210–11 and accompanying text.  
Society upholds natural efforts as the means to make victories both deserved and authentic; 
conversely, the general public views drug use as the tool that creates undeserved and inauthentic 
accomplishments.  See Mehlman, supra note 13, at 490, 493.  Therefore, true competition is the 
“quest for excellence through challenge,” and the question becomes whether medicinal performance-
enhancement use essentially destroys such a challenge.  Wild, supra note 223, at 1354–55, 1362 
(mentioning that some view drug use as an easy way to win).  For a more in-depth analysis of the 
“easy win” or shortcut contention, see Schermer, supra note 217, at 360–63. 
 228.  Mehlman, supra note 13, at 490; see also Savulescu, supra note 71, at 327 (noting that 
“[c]onsiderations of fairness play a prominent part in the regulation of drugs in sport”).  For an 
examination on the standardized rules governing athletic competitions, see Wild, supra note 223, at 
1356–58 (describing how these regulations attempt to create fair results that reflect the competitors’ 
pursuits of excellence). 
 229.  See supra note 130 and accompanying text; see also Wild, supra note 223, at 1359–60 
(explaining that the regulation of performance enhancers primarily focuses on substances rather than 
other artificial tools).  To enforce these prohibitions, the International Olympic Committee drug tests 
or “dope checks” athletes at all major games and contests.  Schermer, supra note 26, at 85; see, e.g., 
supra note 225. 
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considers whether the drug would (1) potentially enhance sport performance, 
or (2) violate the spirit of sport.230  Therefore, WADA prohibits cognitive 
enhancers because it recognizes that they can give athletes an unfair 
advantage or violate the fundamental spirit of competition, or both.231  If 
athletes break these explicit rules to gain an enhancing edge, they 
unequivocally cheat the game.232  Essentially, performance-enhancing drugs 
jeopardize the integrity of sports and transform their athletic users into 
“cheaters” when they “eliminate athletic talent as a prerequisite for 
competition.”233 
Similar to athletics, medical and law schools are also competitive 
environments234 where students continuously compete for the handful of top 
positions in their class ranks so they can earn academic gold medals—such 
as Dean’s recognitions, clinical and journal positions, graduation honors, 
and employment opportunities.235  In this competitive setting, students “are 
often driven by the rewards and permitted by the low penalties to seek unfair 
advantage[s]”236—specifically through brain-boosting medications.237  
However, unlike the sports world, medical and legal academia does not have 
 
 230.  Savulescu, supra note 71, at 327.  WADA actually defines the “spirit of sport” as ethics, fair 
play, honesty, respect for rules and laws, and respect for the self and other participants.  Id. 
 231.  Id.  But see supra note 130 and accompanying text.  For instance, Greely explained that 
significant fairness concerns arise when some athletic competitors use enhancing drugs, while others 
do not.  Greely, supra note 6, at 1151. 
 232.  See Schermer, supra note 26, at 85.  For the definition of cheating, see supra note 26. 
 233.  Wild, supra note 223, at 1359. 
 234.  McGuire & Phye, supra note 15, at 63.  It is important to establish medical and law school 
educations as uniquely competitive activities to differentiate these settings from other graduate or 
lower education programs.  See supra note 13 and accompanying text.  Of course, although this 
outlook is realistic and accurate, it undercuts the ideological view of higher education: 
Education and studying have internal goods next to their more instrumental goals.  Such 
internal goods may be the attained appreciation of the internal goods of the practices one 
is educated in, knowledge and truth, the activity of studying with its character-building 
side effects, or the general (moral) self-development it effectuates. . . .  [T]hese are the 
ends of education, but these are increasingly substituted by a rat-race in which only 
exams and test-results count. 
Schermer, supra note 26, at 88 (contending that cognitive enhancers cannot add to the ultimate ends 
of education).  For instance, while brain boosters may temporarily improve memory or attention, 
they still undermine active learning, disciplined study, and creative insight.  Id.; see also supra notes 
154–55 and accompanying text. 
 235.  See supra notes 190–91 and accompanying text.  Because this type of competition involves 
limited prizes, it engenders an “inherently selfish venture” that essentially transforms medical and 
law schools into zero-sum settings.  See Wild, supra note 223, at 1353; see also supra note 12 
(noting that Greely argued for the acceptance of medicinal cognitive enhancement in non-zero sum 
school environments). 
 236.  See Savulescu, supra note 71, at 328; see also supra note 194. 
 237.  See, e.g., supra notes 71, 80, 111 and accompanying text.  Brain boosters are inherently 
unfair and facilitate deceptive behavior in an examination setting because an exam performance is 
supposed to represent the “accumulation of a semester’s worth of work” and the student’s own 
efforts, not the student’s “chemically induced performance.”  Fenton & Wunderlich, supra note 44, 
at 18. 
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an oversight body like WADA that explicitly forbids legally prescribed 
medications in a classroom setting.238  Instead, these schools establish honor 
codes that implicitly govern different forms of scholastic conduct.239  When 
applicants become students and take up the mantels of the medical or legal 
profession, they are tacitly accepting these rules and their professional 
associations’ corresponding ethical guidelines as valid restrictions on their 
actions.240  When they break these rules to create unfair advantages against 
their studious peers, they become academic cheaters against themselves241 
and others.242  This holds especially true in a competition analysis because 
medical and law school examinations243 are the epitome of zero-sum 
activities.244 
 
 238.  See supra note 219 and accompanying text; see also Schermer, supra note 26, at 87 (noting 
that the rules of the educational game are not as clear or explicit as sports regulations). 
 239.  See supra notes 22–23 and accompanying text.  Nevertheless, honor codes or exam 
regulations are not overt rules against medicinal cognitive enhancement because they do not 
expressly forbid such drug use before exams or during study.  Schermer, supra note 26, at 87. 
 240.  See Schermer, supra note 26, at 85; see also supra notes 17–24 and accompanying text. 
 241.  See supra notes 211–14 and accompanying text.  If exams are meant to test a student’s 
personal performance and signify his or her individual achievement, the use of a cognitive enhancer 
to acquire a certain grade would be akin to allowing the use of a calculator on a math test or roller 
skates in a marathon.  Schermer, supra note 26, at 87 (asking whether the brain booster would 
undercut the rationale behind an exam); see also supra note 14 and accompanying text. 
 242.  See Schermer, supra note 26, at 85; see also supra note 231 and accompanying text.  For 
example, if a student takes Adderall to obtain better grades than his or her academic peers and such a 
“study tool” is against school rules, the student is cheating.  Savulescu, supra note 71, at 327.  Here, 
cheating essentially means earning prized grades through artificial tools, rather than on actual merit.  
See Schermer, supra note 26, at 86.  GPA rankings are only fair if schools distribute them to students 
because they are earned or deserved through natural abilities or studious training.  See id.  In the 
most basic sense, justice and fairness dictate that the top ten to fifteen percent of each class actually 
merit their rankings.  See id. at 87. 
 243.  Respective universities usually require professors to grade medical and law school exams on 
predefined tight curves, where sometimes less than fifteen percent of the class even has a chance at 
earning an A-level grade.  See, e.g., George Kulick & Ronald Wright, The Impact of Grading on a 
Curve: A Simulation Analysis, INT’L J. SCHOLARSHIP TEACHING & LEARNING, July 2008, at 1, 3–4, 
available at http://academics.georgiasouthern.edu/ijsotl/v2n2/articles/PDFs/Article_Kulick_Wright.pdf 
(discussing grade curves in pre-med and medical programs); Law School Grading Curves, 
Memorandum by Andy Mroch, from Ass’n of Am. Law Schs., (Mar. 30, 2005), available at 
http://www.aals.org/deansmemos/Attachment05-14.pdf (analyzing grade curves from a swath of 
legal universities).  This type of grading creates the zero-sum setting.  See supra note 235 and 
accompanying text.  When medicinal cognitive enhancement enters this grading calculation, 
professors must try to compare “apples and oranges”—students with the added medicinal edge, and 
those taking examinations under normal conditions.  Fenton & Wunderlich, supra note 44, at 20. 
 244.  See Fox, supra note 56, at 1147 (“[E]nhancements generate unfairness when individuals use 
them to gain relative advantage over others in zero-sum competitions such as athletic events and 
academic testing.”); Goodman, supra note 81, at 149; see also supra notes 234, 242 and 
accompanying text.  Zero-sum activities or environments always require the existence of a winner 
and a loser.  Goodman, supra note 81, at 149.  This zero-sum delineation may explain why 
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Although medicinal cognitive enhancement clearly creates unfair 
scholastic advantages in medical and law schools,245 it may not be a form of 
academic cheating if no specific regulatory framework actually forbids such 
enhancement.246  After all, cheating fundamentally requires the violation of a 
rule to obtain that unfair edge.247  If the unfair advantages themselves 
disappear because all students acquire equal access to the enhancement, then 
the fairness equation changes even more dramatically—perhaps even 
necessitating a new calculation.248 
3. Equal Access 
Cognitive enhancers are positional goods249 because they give users 
advantages over others when competing for academic grades and honors.250  
Unfairness thus arises when only a select few have the ability to purchase or 
consume these goods.251  This necessarily raises social-equity concerns252 
 
numerous commentators analogize athletic performance-enhancement drug use with academic 
cognitive-enhancement drug use.  See, e.g., Bostrom & Roache, supra note 201, at 137 (“Just as 
using drugs to enhance one’s strength is seen as cheating in professional sport, using drugs to 
improve one’s memory in order to perform better in an examination could be seen as cheating.”); 
Schermer, supra note 26, at 87 (noting that the parallel with sports offers insights into educational 
cheating arguments). 
 245.  See supra notes 241–42 and accompanying text. 
 246.  See supra note 239 and accompanying text.  “So, as long as schools or universities, or other 
supervising authorities do not issue rules against the use of modafinil, Ritalin or any other cognitive 
enhancer, students can use whatever they want without it being cheating.”  Schermer, supra note 26, 
at 87 (noting, however, that “[t]here may be some inarticulate rule broken by the use of cognitive 
enhancers, which would make their use a form of cheating”). 
 247.  See supra note 26 and accompanying text; see also Greely, supra note 6, at 1152 (explaining 
that cheating unequivocally happens when a person does not follow a rule that actually is enforced).  
Merely obtaining an unfair advantage without breaking the rules is not necessarily cheating.  
R. MERKEL ET AL., INTERVENING IN THE BRAIN: CHANGING PSYCHE AND SOCIETY 353 (Carl 
Friedrich Gethmann ed., 2007).  For example, genetic disposition and innate natural intelligence 
foster discrepant advantages that society admires and encourages.  See id. (“What then exactly 
explains the difference if we substitute ‘artificial medical enhancement’ for ‘genetic giftedness’?”); 
see also supra note 226 and accompanying text. 
 248.  See Schermer, supra note 26, at 86. 
 249.  Positional goods are tangibles or intangibles that “confer substantial advantages on their 
possessors relative to others within the context of social competition for scarce and valued positions 
and other desired goods.”  MERKEL ET AL., supra note 247, at 359. 
 250.  Bostrom & Roache, supra note 201, at 137; see also supra text accompanying note 245. 
 251.  Mehlman, supra note 13, at 488; see also Fox, supra note 56, at 1147 (“[L]imited access to 
enhancement biotechnologies exacerbates inequalities of wealth and status between the haves and 
the have-nots.”). 
 252.  Purchasable positional goods generate social-equity concerns because their limited 
availability can create a spiraling effect that interferes with the idea of equitable distribution: 
If (1) means of mental enhancements are available only to the wealthy and (2) making 
use of such means confers substantial competitive advantages for the acquisition of 
additional advantages, including wealth, and (3) a grossly unequal distribution of wealth 
is a matter of concern for distributive justice, then the exacerbating effect of artificial 
mental enhancements on problematic patterns of social distribution is obvious. 
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that stem from the public’s desire to establish equality “between individuals 
and across society.”253  However, such concerns may be alleviated if 
everyone has equal access to these positional goods.254  Presently, the use of 
cognitive enhancers is limited by income,255 chance, and geography.256  In 
light of such limitations, proponents of medicinal enhancement suggest that 
health insurance companies, the government, or even private philanthropies 
could provide cognitive enhancers to those without sufficient means.257  The 
President’s Committee on Bioethics also added (perhaps sarcastically) that 
free cognitive enhancers could be supplied “at the door as students file into 
the testing room, so that all who wished to take [them] could do so, and we 
 
MERKEL ET AL., supra note 247, at 359. 
 253.  Greely, supra note 6, at 1151–52 (noting, for example, that society already provides 
equitable access to education for all children across class and racial lines).  However, society does 
tolerate certain sources of inequality, including the advantages obtained by wealth, natural talent, 
good luck, and powerful social connections.  Mehlman, supra note 13, at 490.  Nevertheless, society 
may decline to accept the inequalities fostered by medicinal cognitive enhancement because 
“cognitive enhancement could be so powerful a determinant of social success that it would 
undermine the foundations of our liberal, democratic society.”  Id.; see also supra note 251 and 
accompanying text. 
 254.  Savulescu, supra note 71, at 332–33.  This “would make everyone more equal, creating a 
society in which there was greater equality of opportunity.”  Mehlman, supra note 13, at 498. 
 255.  See, e.g., supra note 148 and accompanying text (explaining the significant difference in the 
prices for beta blockers and Provigil).  Because cognitive enhancers are relatively expensive, they 
can potentially create a “modern caste system” that will favor the wealthy.  MERKEL ET AL., supra 
note 247, at 43. 
 256.  See Greely, supra note 49, at 129.  Furthermore, the DEA places manufacturing restrictions 
on Adderall, Ritalin, and Provigil because they are controlled substances.  See Mehlman, supra note 
13, at 488; see also supra note 120 and accompanying text.  This limits their overall supply and 
national availability.  Mehlman, supra note 13, at 488.  However, even if they existed in an 
unlimited supply, the FDA still requires valid physician prescriptions for all four types of cognitive 
enhancers.  See id.; see also supra note 118 and accompanying text.  A prescription requirement 
mandates access to a personal physician—creating yet another cost-prohibitive hurdle.  See 
Mehlman, supra note 13, at 488, 490 (noting, for instance, that more than 40 million Americans lack 
health-insurance coverage).  But see supra note 121 (describing online purchasing without needing a 
prescription). 
 257.  See MERKEL ET AL., supra note 247, at 358 (discussing the possibility of health-care 
coverage); Mehlman, supra note 13, at 489, 498–500 (promoting subsidy programs).  However, if 
these entities provide medications that consumers will use for mere enhancement purposes, they 
potentially could be wasting the available supply of medical resources.  See MERKEL ET AL., supra 
note 247, at 362–63 (explaining the “resource-squandering” effect).  This essentially means: 
[T]hat medical means, including expert manpower, used up for one particular purpose are 
necessarily unavailable for any other potential application.  If they are used for 
enhancement purposes, the resources thus deployed are not available for use in the much 
more important area of treatment, where they function as potentially life-saving or health-
restoring means. 
Id. at 363.  Besides the waste of medicinal resources, some may argue that these public and private 
entities are misusing their own funds that could be utilized to help the truly unhealthy.  See id. 
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would know it was being properly administered.”258  Securing equitable 
access may “potentially increase equality in society by enabling those with 
lower cognitive ability to function at a level that is closer to those with 
naturally high cognitive ability.”259  However, if cognitive enhancers do 
become available to everyone, questions of social coercion260 would again 
emerge—would individuals who deliberately refuse to take these drugs be 
disadvantaged given that others’ cognitive levels were artificially raised as 
standard procedure?261  Moreover, equal access may not be the end-all 
solution when considering the entire ethical status of enhancement.262  In 
fact, it actually may facilitate the final societal concern by increasing 
discrimination.263 
4. Increased Discrimination 
While equal access to cognitive enhancers initially appears to “make 
everyone more equal [by] creating a society in which there [is] greater 
equality of opportunity,” this oversimplifies the approach.264  Instead, 
consider the ramifications of equal access on a standard population 
characterized by intellectual differences: 
 
 258.  Lerner, supra note 42, at 1071 (noting that this suggestion has its own drawbacks). 
 259.  Bostrom & Roache, supra note 201, at 138.  Equal access levels the mental playing field.  
See MICHAEL S. GAZZANIGA, THE ETHICAL BRAIN: THE SCIENCE OF OUR MORAL DILEMMAS 70 
(2005).  But see infra notes 265–69 and accompanying text.  Two proponents recently suggested that 
such mental equality also will level economic disparities: “[I]t has been estimated that a 3 per cent 
population-wide increase in IQ could reduce poverty rates by up to 25 per cent and increase GDP by 
up to 1.5 per cent.”  Barbara J. Sahakian & Ahmed D. Mohamed, Going Mental, PROSPECT, June 
2010, at 68, 68.  Basically, they propose that equal access to cognitive enhancers will eventually 
mitigate societal poverty.  Id. 
 260.  See supra notes 193–98 and accompanying text. 
 261.  See MERKEL ET AL., supra note 247, at 43; see also supra notes 194–95 and accompanying 
text.  If cognitive-enhancement drug use became a “social practice undertaken by large numbers of 
people,” the “aggregate will of others” will exert pressure on the drug free.  MERKEL ET AL., supra 
note 247, at 364. 
 262.  Michael J. Sandel, The Case Against Perfection: What’s Wrong with Designer Children, 
Bionic Athletes, and Genetic Engineering, ATLANTIC MONTHLY, Apr. 2004, at 50, 52 (“[T]he 
fundamental question is not how to ensure equal access to enhancement but whether we should 
aspire to it in the first place.”). 
 263.  Whitehouse & Juengst, supra note 192, at 19; see also supra note 206 and accompanying 
text.  For example, equal access potentially fosters discrimination against the naturally fortunate by 
equalizing the mental playing field.  Whitehouse & Juengst, supra note 192, at 19.  Contra 
Savulescu, supra note 71, at 335.  In this sense, discrimination means a person is guilty or unethical 
when his actions penalize another simply because that other person is a member of a certain group.  
See Lerner, supra note 42, at 1049. 
 264.  Mehlman, supra note 13, at 498.  In actuality, equal access can potentially “reshape the 
[mental] playing field in unanticipated ways—just as the use of calculators works to the relative 
disadvantage of students who are quickest at doing long division with pencil and paper.”  Goodman, 
supra note 81, at 150. 
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[S]uppose cognitive enhancements gave people a certain boost in 
their cognitive ability—say made them 20 percent smarter.  
Suppose further that cognitive enhancements were given to all those 
in the lower half of the “normal” range.  These individuals, along 
with those with below-normal cognitive ability who received the 
interventions therapeutically, would move up 20 percentage points.  
But people in the upper half of the population range who obtained 
enhancements on their own would move up as well.  The entire 
population would move upward in terms of cognitive ability, but the 
disparities created by natural talent and luck would remain.265 
Nonetheless, cognitive enhancers do not affect everyone equally;266 they do 
not raise everyone’s cognitive ability to the same mental ceiling.267  While 
some drug users may achieve a fifty percent mental improvement, others 
may only see a five percent increase.268  Similarly, consumers who attain 
small intellectual gains can still accomplish significant scholastic outcomes 
through other abilities.269  Therefore, cognitive enhancers may only add to 
the list of undeserved factors270 that generate individual success and increase 
societal differences.271 
Furthermore, cognitive-enhancement drug use by the healthy “usurps 
the accommodation provided to those with real disability, thus denying them 
 
 265.  Mehlman, supra note 13, at 498–99.  This hypothetical demonstrates how equal access fails 
to remove natural discrepancies in intellectual abilities, especially if naturally smart people also take 
brain boosters—meaning people who function at lower levels will never have the opportunity to 
catch up.  See id.; see also supra note 253.  But both the equal access and personal autonomy 
concerns suggest that medicinal cognitive enhancement cannot and should not be limited to those 
below a certain intellectual level.  See supra notes 183, 251 and accompanying text.  However, this 
scenario also assumes that cognitive enhancers boost everyone’s mental capacity in the same 
incremental amount.  See Mehlman, supra note 13, at 498.  Contra infra notes 266–67 and 
accompanying text. 
 266.  Begley, supra note 153, at 43.  For example, because Adderall and Ritalin work by raising 
dopamine levels in the brain, they provide less benefit to individuals with naturally high dopamine 
activity.  Id.  In fact, some people can achieve the same dopamine-boosting benefits by simply 
believing in their own success—which also increases dopamine.  Id. 
 267.  Mehlman, supra note 13, at 499. 
 268.  See id. 
 269.  See Sahakian & Mohamed, supra note 259, at 68 (“[A] 10 per cent improvement in memory 
score could [still] lead to a higher A-level grade or degree classification.”). 
 270.  See supra notes 227, 253 and accompanying text.  In a university setting, good school 
performances are partly determined by unearned factors, such as inborn ability and luck, but they 
also require effort and determination.  Schermer, supra note 26, at 87 (explaining that praise is given 
for the effort and endurance that is put into the performance, and not just for the final outcome). 
 271.  Mehlman, supra note 13, at 499. 
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their equal playing field.”272  All four types of cognitive enhancers are 
medications that doctors prescribe for FDA-approved treatments.273  
Students who take cognitive enhancers for learning disabilities like 
AD/HD274 are disadvantaged when the healthy consume the same 
medications for purely enhancement purposes.275  However, some of these 
students may have actively pursued a learning disability diagnosis merely to 
obtain their own prescription enhancers.276 
To understand the ethical difficulties arising from these different 
scenarios, imagine that intelligence is ranked on a scale from 1 to 10.277  A 
performs at Level 8, B performs at Level 5, and C performs at Level 2.  At 
Level 2, C obtains a prescription for Adderall based on a validly diagnosed 
learning disability, but this drug enables C to perform at Level 7.  Is this fair 
to B, especially in a zero-sum scholastic setting?278  Perhaps B should now 
take cognitive enhancers because he is mentally below both A and C.  
Assume B does “game the system” and with the help of Ritalin now 
performs at Level 9.  A discovers the cognitive use and secures her own 
brain boosters, which may or may not increase her cognitive abilities.  Either 
way, C—who had the valid disability—is still denied equal footing on the 
intelligence scale.  Such a hypothetical illustrates the inherent unfairness of 
improper cognitive-enhancer use279 and has led numerous critics to contend 
 
 272.  Fenton & Wunderlich, supra note 44, at 18.  “Proper use [of cognitive enhancers] is like a 
person with poor vision wearing glasses so they can see the ball as clearly as those who naturally 
have 20/20 vision.  Improper use is more akin to a nonhandicapped person parking in handicapped 
spaces.”  Id.  Proper use occurs when an intellectually disabled individual takes cognitive enhancers 
for the chance to lead a good life.  Savulescu, supra note 71, at 334.  Low intelligence is a disease 
when the IQ is less than 70, and doctors already use pharmacological means to treat this disease.  Id. 
 273.  See supra notes 128, 256 and accompanying text. 
 274.  A learning disability is an “unexplained learning discrepancy—academic underachievement 
that cannot be explained by an observable physical or mental handicap.”  Lerner, supra note 42, at 
1059–60, 1065; see, e.g., supra note 272. 
 275.  See Greely, supra note 6, at 1153 (noting that in a society of enhanced individuals, 
discrimination may increase against those—such as the disabled or sick—who cannot achieve this 
same mental enhancement); see, e.g., supra note 42 and accompanying text; see also MERKEL ET 
AL., supra note 247, at 388 (explaining the difference between enhancement and valid treatment).  
Essentially, if everyone is “focused on becoming Supermen and Superwomen, the people who are 
left behind will be left even further behind.”  Greely, supra note 6, at 1153. 
 276.  See Lerner, supra note 42, at 1075 (additionally discussing how “an LD diagnosis can mean 
shortened homework assignments, additional and personalized assistance, exemptions from 
otherwise required classes, and accommodations on exams”); see also Freedley Hunsicker, Learning 
Disabilities, Law Schools and the Lowering of the Bar, 42 S. TEX. L. REV. 1, 4–5, 13–17 (2000) 
(analyzing the fairness of learning-disability accommodations in law schools).  Of course, if other 
students suspect that their peers are “gaming the system,” they may (1) socially stigmatize the 
cognitive-enhancer users, (2) report them to administration, or (3) follow their examples.  See 
Lerner, supra note 42, at 1075; see also supra notes 23, 194 and accompanying text. 
 277.  The author created the following hypothetical to illustrate the fairness implications involved 
infra at notes 278–80 and accompanying text. 
 278.  See supra notes 243–44 and accompanying text. 
 279.  Fenton & Wunderlich, supra note 44, at 18. 
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that natural efforts free of drug use are the more acceptable means of 
securing academic achievements because they are morally neutral.280 
While safety concerns, social implications, and fairness issues are the 
three main concerns that proponents and critics repeatedly address when 
debating the morality of cognitive-enhancement use by society at large,281 
these categories take on new meaning and generate even more ethical 
dilemmas when analyzed within the narrower setting of medical and law 
schools.282  For example, the zero-sum characteristic of most medical and 
law school examinations dictates that most artificially-obtained unfair 
advantages are forms of scholastic cheating.283  Fundamental to this ethical 
analysis is the reality that medical and law school students must study and 
work within ethics-based guidelines and rules.284  Therefore, after fully 
weighing all three ethical concerns,285 it becomes clear that the scales tip 
away from personal autonomy and towards mandatory safeguards in these 
higher education settings.286  This means that university administrators and 
professional associations should both recognize and monitor medical and 
law school students’ medicinal cognitive-enhancement use if they wish to 
prevent cognitive cheating and uphold the values embraced by their 
respective professions.287 
IV. SMART POLICY: SUGGESTIONS TO PREVENT COGNITIVE CHEATING 
Greely and Sahakian—well-known proponents of medicinal 
enhancement288—have both cautioned that in a scholastic environment, 
educators and professional organizations should implement regulations when 
cognitive-enhancement drug use imparts unfair advantages.289  Such 
 
 280.  See supra note 226 and accompanying text.  Specifically, one commentator suggests that 
cognitive enhancers disrupt the ideal of fairly earned praise in academia: “[T]o what extent can you 
take credit for accomplishments if they are not achieved through the socially valued practices, like 
study and effort that have traditionally produced them?”  Schermer, supra note 26, at 87. 
 281.  See supra note 124 and accompanying text. 
 282.  See, e.g., supra notes 189–92, 216–17, 235–37 and accompanying text. 
 283.  See supra notes 241–44 and accompanying text. 
 284.  See supra notes 239–42 and accompanying text. 
 285.  See supra notes 126–280 and accompanying text. 
 286.  See supra notes 186–87 and accompanying text. 
 287.  See supra notes 15–16, 188 and accompanying text. 
 288.  See supra notes 8–9 and accompanying text. 
 289.  See Greely et al., supra note 9, at 704–05; Sahakian & Morein-Zamir, supra note 168, at 
1159.  For well-written analyses explaining why the government and Congress cannot create and 
enforce these laws or regulations that prohibit cognition-improving products, see RICHARDS, supra 
note 2, at 185–88, and Mehlman, supra note 13, at 495–97. 
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regulations are particularly needed in medical and law schools where 
students’ medicinal brain boosting gives them an academic edge against 
their studious, but drug-free, peers.290 
A. The Drug War: Recruitment of University Administrators 
Because cheating involves obtaining an unfair advantage,291 ethicists 
suggest that universities could implement two different procedures to 
eliminate medicinal cognitive advantages: 
Academic institutions could follow the model of sports leagues and 
explicitly ban enhancers for students enrolled in competitive 
courses or taking competitive exams; they could even institute 
random drug testing.  At the other extreme, they could follow the 
lead of ethicists like Allen Buchanan, who compare the use of 
CEDs [cognitive enhancement drugs] to the use of calculators on 
math exams.  On that reasoning, professors might make cognitive 
enhancement an explicit course expectation and even distribute 
CEDs before exams, or professors might permit CEDs without 
distributing them.292 
Both these approaches focus on obtaining fairness through consistent, clear, 
and enforceable rules.293  However, the ethical concerns stemming from 
cognitive-enhancement drug use encompass more than fairness inquiries.294  
When safety and societal implications enter the cheating equation,295 the 
equal access approach is no longer a valid consideration.296  Instead, 
suggestions for university monitoring must focus on methods that ban or 
discourage medicinal brain boosting as an ethical violation.297 
Traditionally, educational institutions have dealt with impermissible 
drug use in three ways—drug testing, transcript asterisking, and early 
preventative action.298  While these methods also may work to prevent 
medicinal cognitive enhancement, universities must first establish rules that 
 
 290.  See supra notes 241–44 and accompanying text. 
 291.  See supra note 26 and accompanying text. 
 292.  Goodman, supra note 81, at 150 (citations omitted); see also supra notes 238, 258 and 
accompanying text. 
 293.  Goodman, supra note 81, at 150. 
 294.  See supra note 124 and accompanying text. 
 295.  See supra notes 124–25 and accompanying text. 
 296.  See supra notes 260–63, 292 and accompanying text. 
 297.  See supra notes 287, 292 and accompanying text; see also Fenton & Wunderlich, supra note 
44, at 18 (noting that medicinal cognitive enhancement is an unethical and deceptive practice that 
undermines the integrity of education). 
 298.  See Fenton & Wunderlich, supra note 44, at 20–21. 
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clearly prohibit this type of drug consumption.299  The government already 
recognizes that cognitive-enhancer use is illegal without a physician’s 
prescription.300  In upholding these laws, both medical and law school 
student handbooks include rules that forbid illicit drug use.301  Some 
universities also penalize and discourage the abuse of legally obtained 
drugs.302  However, medical and law schools still need to establish policies303 
that explicitly ban illegally304 and legally obtained prescription medications 
when used purely for cognitive-enhancement purposes before medicinal 
brain boosting officially becomes a recognized form of scholastic 
cheating.305  Clear, consistent rules allow university administrators to 
 
 299.  See Goodman, supra note 81, at 150. 
 300.  See supra notes 119–21 and accompanying text. 
 301.  See, e.g., EMORY UNIV. SCH. OF MED., MEDICAL STUDENT HANDBOOK 65–66 (2010), 
available at http://www.med.emory.edu/education/omesa/SOM_Handbook_2010_2011.pdf; HARVARD 
LAW SCH., HANDBOOK OF ACADEMIC POLICIES 99–100 (2011), available at 
http://www.law.harvard.edu/academics/handbook/2011-12handbookofacademicpolicies.pdf; MERCER 
UNIV. SCH. OF MED., MEDICAL STUDENT HANDBOOK 74 (2011), available at 
http://medapps.mercer.edu/index.php?header=off&file_path=/mednet/handbooks/&file_name=stude
nthandbook.pdf; SUFFOLK UNIV., GRADUATE STUDENT HANDBOOK 95–101 (2010), available at 
http://www.suffolk.edu/files/Student_Services_PDF/Grad_Student_Handbook_2010_092910.pdf; 
WASH. & LEE UNIV., STUDENT HANDBOOK 33 (2011), available at http://law.wlu.edu/ 
deptimages/student%20services/StudentHandbook.pdf. 
 302.  See, e.g., BIRMINGHAM SCH. OF LAW, STUDENT HANDBOOK 35–36 (2009), available at 
http://www.bsol.com/BSL_Handbook09.pdf (warning that “[a]ny student who presents themselves 
for class in an impaired state (including over medicating with prescription drugs) is subject to being 
dismissed from class by their professor and subject to possible dismissal from BSL” and that any 
“student suspected of substance abuse or dependency (prescription or non-prescription drugs) may 
be required to undergo testing and/or treatment as a condition of . . . continued attendance”); DUKE 
SCH. OF NURSING, STUDENT HANDBOOK 38 (2010), available at http://nursing.duke.edu/sites/ 
default/files/current_students/phd_student_handbook_2011-20121.pdf (cautioning that “misuse of 
legal drugs” that can result in “health difficulties impairing performance” may warrant withdrawal 
from the nursing program if it poses a danger to patients or other students); GEORGE WASHINGTON 
SCH. OF MED., STUDENT HANDBOOK FOR HEALTH SCIENCES PROGRAMS 16 (2011), available at 
http://www.gwumc.edu/healthsci/academics/Health_Sciences_Student_Handbook.pdf (explaining 
that inappropriate student behavior includes “using illegal drugs or abusing controlled substances”). 
 303.  I emphasize “still” because higher educational institutions typically are reluctant to address 
medicinal cognitive enhancement.  See Appel, supra note 152, at 616.  For example, “[f]or all 
particular purposes—except within the limited realm of state-run schools—neurocognitive 
enhancement remains no more regulated today than any other basic medical or pharmacological 
interventions.”  Id. 
 304.  Although university drug policies already ban illicit drug use, prohibitions must explicitly 
focus on medicinal cognitive enhancement as a separate form of academic cheating.  See supra note 
301 and accompanying text. 
 305.  See supra notes 246–47 and accompanying text.  One commentator aptly explained the need 
for unambiguous rules: 
When new enhancement technologies are introduced . . . the question of cheating cannot 
be answered with a simple appeal to existing rules.  The question is whether the old rules 
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enforce the prohibition on such cheating through the common methods 
employed against any other forbidden drug use.306 
1. Drug Testing 
Drug testing is the most common traditional tool employed to deter 
prohibited drug abuse in many sectors of society.307  For example, the United 
States Department of Defense began drug testing military personnel as early 
as the 1960s.308  Drug testing has since expanded to the athletic,309 
employment,310 and educational arenas.311  When applying drug-testing 
 
still suffice to deal with the new technological possibilities.  If the new technology offers 
some unfair advantage, it may have to be banned by new rules. 
Schermer, supra note 26, at 85–86; see also infra note 306 and accompanying text.  In the law 
school setting, if administrators unequivocally recognize medicinal cognitive enhancement as a form 
of cheating, then law schools and individual professors can report this questionable behavior to state 
bar authorities when they consider certifying applicants who incurred this academic violation.  
McCulley, supra note 19, at 856. 
 306.  See supra notes 298–99 and accompanying text. 
 307.  See Stephen O. Griffin et al., Developing a Drug Testing Policy at a Public University: 
Participant Perspectives, 30 PUB. PERSONNEL MGMT. 467, 468 (2001); see also infra notes 308–11 
and accompanying text. 
 308.  Griffin et al., supra note 307, at 468. 
 309.  Pavisian, supra note 42, at 194–96.  Both WADA and the National Collegiate Athletic 
Association (NCAA) administer random drug tests on qualifying athletes.  Id.; see also supra note 
229 and accompanying text.  The NCAA is a private entity that helps U.S. universities regulate their 
student athletic programs.  Pavisian, supra note 42, at 194.  Under the NCAA scheme, when a 
student athlete tests positive for a banned substance, the NCAA suspends that athlete until he or she 
tests negative on a subsequent drug test.  Id.  The United States Anti-Doping Agency administers 
drug tests for WADA on any foreign athlete present within the United States and on any athlete who 
participates in a competition sanctioned by the United States Olympic Committee.  Id. at 195–96.  
Both athletic organizations give athletes therapeutic use exemptions when they consume prohibited 
drugs for authorized medical purposes.  Id. (explaining that the athlete has the burden of requesting 
such an exemption from his or her respective anti-doping agency). 
 310.  Griffin et al., supra note 307, at 467–68.  Private companies began to increasingly drug test 
employees and applicants in the early 1980s, but the Anti-Drug Abuse Act of 1986 really spurred 
drug-testing growth in both the private and public sectors.  Id. at 468; see also Anti-Drug Abuse Act 
of 1986, Pub. L. No. 99-570, 100 Stat. 3207.  In the public arena, the Omnibus Transportation 
Employee Testing Act of 1991 (implemented in 1994 and amended in 2010) mandated drug and 
alcohol testing for all “employees in safety-sensitive positions in the railroad, airline, mass transit, 
motor carrier, and pipeline industries.”  Griffin et al., supra note 307, at 468; see also Omnibus 
Transportation Employee Testing Act of 1991, Pub. L. No. 102-143, 105 Stat. 917.  Currently, the 
federal government applies random drug testing to all its employees in safety-sensitive positions.  
Griffin et al., supra note 307, at 468.  In the private arena, drug-testing policies also remain on the 
rise; for example, from 1987 to 1996, drug-testing schemes implemented by major corporations 
actually increased fourfold.  Id. 
 311.  James Velasquez, Drug Testing in Schools: A Brief Review and Analysis of Recent Events, 
41 AM. J. HEALTH EDUC. 180, 180 (2010).  In 2003, 13% of United States middle and secondary 
schools applied random drug-testing programs on their students; in 2006, this figure rose to 25.5%.  
Id. (noting that drug testing policies vary widely among school districts across the country); see also 
Paul J. Fudala et al., An Examination of Current and Proposed Drug-Testing Policies at US Colleges 
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schemes in an academic environment, concerns center on the balance 
between students’ privacy rights under the Fourth Amendment312 and 
university administrators’ interests in preventing drug abuse and medicinal 
cheating.313  Fourth Amendment protections are triggered when a state or a 
state agent conducts the drug-testing search.314  Generally, courts consider 
scholastic state actors to include publicly-funded colleges or universities.315  
Therefore, drug testing at private universities may not require the same 
Fourth Amendment scrutiny.316 
For public universities317 to apply a constitutionally permissible drug-
testing scheme, the drug testing must be (1) voluntary, (2) based on 
reasonable suspicion, or (3) administered in a reasonable manner that 
furthers an important governmental interest.318  Obtaining voluntary consent 
 
and Universities, 42 J. AM. C. HEALTH 267, 267 (1994) (analyzing results from a national survey 
encompassing 332 colleges that drug test their students). 
 312.  The Fourth Amendment to the U.S. Constitution protects an individual’s right to be secure in 
his person or effects against unreasonable searches and seizures.  U.S. CONST. amend. IV. 
 313.  Velasquez, supra note 311, at 180.  Fourth Amendment analysis requires this balancing test 
to determine if searches either are unreasonable or permissible under the special needs doctrine—a 
doctrine “applied ‘only in those exceptional circumstances in which special needs, beyond the 
normal need for law enforcement, make the [Fourth Amendment’s] warrant and probable-cause 
requirement impracticable.’”  Schieffelin, supra note 13, at 962–63. 
 314.  Pavisian, supra note 42, at 185.  Random searches by state actors traditionally required 
probable cause, a search warrant, or both to satisfy Fourth Amendment reasonableness standards.  
See Velasquez, supra note 311, at 181. 
 315.  Pavisian, supra note 42, at 192; see also NCAA v. Tarkanian, 488 U.S. 179, 192 (1988) 
(explaining that private parties perform state actions when “the State provide[s] a mantel of authority 
that enhance[s] the power of the harm-causing individual actor[s]”). 
 316.  See generally Private Law Schools, AM. BAR ASS’N, http://www.americanbar.org/groups/ 
legal_education/resources/aba_approved_law_schools/private_law_schools.html (last visited Mar. 3, 
2012) (listing 117 private law schools); Private Medical Schools—Tuition and Fees First Year 
Medical Students 2011–2012, ASS’N OF AM. MED. COLLS., http://services.aamc.org/tsfreports/ 
report.cfm?select_control=PRI&year_of_study=2012 (last visited Mar. 3, 2012) (listing fifty-four 
private medical schools). 
 317.  See generally Public Law Schools, AM. BAR ASS’N, http://www.americanbar.org/ 
groups/legal_education/resources/aba_approved_law_schools/public_law_schools.html (last visited 
Mar. 3, 2012) (listing eighty-one public law schools); Public Medical Schools—Tuition and Fees 
First Year Medical Students 2011–2012, ASS’N OF AM. MED. COLLS., http://services.aamc.org/ 
tsfreports/report.cfm?select_control=PUB&year_of_study=2012 (last visited Mar. 3, 2012) (listing 
eighty public medical schools). 
 318.  See Pavisian, supra note 42, at 201; Velasquez, supra note 311, at 184.  Public middle and 
secondary schools can perform drug testing through the doctrine of in loco parentis, which allows 
“school officials [to] stand in place of parents/guardians in maintaining discipline, supervision, and 
safety.”  Velasquez, supra note 311, at 181.  Graduate universities cannot use the in loco parentis 
doctrine because their students typically are adults, which means they must apply the traditional 
Fourth Amendment balancing test to justify random drug-testing searches.  Pavisian, supra note 42, 
at 189; see also supra note 313 and accompanying text. 
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may be the simplest way to implement a legal drug-testing policy.319  
Medical and law school admissions can include drug-testing consent forms 
within their acceptance applications320 or even make these forms 
prerequisites for participation in extracurricular activities—such as clinical 
programs, journals, and moot court competitions.321 
Suspicion-based drug testing enables school administrators to test 
students who act in a manner that gives rise to the reasonable suspicion of 
drug abuse.322  For example, in Pierce v. Smith,323 the Fifth Circuit upheld 
the drug testing of a medical resident after she slapped a patient because the 
Texas Tech University teaching hospital had written policies that provided 
for drug testing when a medical student’s behavior was consistent with drug 
use.324  In the same way, medical and law school administrators can 
 
 319.  Pavisian, supra note 42, at 201.  For example, numerous universities require student athletes 
to sign drug-testing consent forms before they can participate in intercollegiate athletics.  See, e.g., 
CHARLESTON S. UNIV., STUDENT-ATHLETE HANDBOOK 20–24 (2011), available at 
http://csusports.athleticsite.net/SAHandbook.pdf; FLA. GULF COAST UNIV., STUDENT-ATHLETE 
HANDBOOK 64–74 (2011), available at http://www.fgcuathletics.com/media/2011-12/Student%20 
Athlete%20Handbook%201112.pdf; UNIV. OF TEX. STUDENT-ATHLETE MANUAL 49–53 (2011), 
available at http://grfx.cstv.com/photos/schools/tex/genrel/auto_pdf/2011-12/misc_non_event/11-
acad-serv-student-manual.pdf. 
 320.  See Pavisian, supra note 42, at 201 (noting that consent precludes students from asserting 
Fourth Amendment claims).  For example, Florida International University requires drug testing for 
all applicants as a prerequisite to entering the first year of its medical school.  Background Check 
and Drug Testing, FLA. INT’L UNIV., http://medicine.fiu.edu/admissions.php?ss=back (last visited 
Mar. 3, 2012).  However, such a broad policy creates strong Fourth Amendment challenges that may 
incentivize courts to strike this admissions procedure.  See WILLIAM A. KAPLIN & BARBARA A. LEE, 
THE LAW OF HIGHER EDUCATION: A COMPREHENSIVE GUIDE TO LEGAL IMPLICATIONS OF 
ADMINISTRATIVE DECISION MAKING 267–68 (4th ed. 2006); see, e.g., Ga. Ass’n of Educators v. 
Harris, 749 F. Supp. 1110, 1114 (N.D. Ga. 1990) (holding that the absence of a governmental 
interest made a drug-testing scheme for all job applicants unconstitutional under the Fourth 
Amendment balancing test).  Instead, universities can seek voluntary consent from all incoming 
applicants—but not as a prerequisite for enrollment.  If an applicant opts out of the drug-testing 
scheme, administrators can note this decision on a student’s transcript or file in a similar manner as 
transcript asterisking.  See infra notes 346–48 and accompanying text. 
 321.  For example, Oregon Health and Science University requires all of its medical students who 
participate in clinics and involve themselves with patient care to first go through a drug-screening 
process.  Medical Student Information Regarding Drug Testing, OR. HEALTH & SCI. UNIV., 
available at http://www.ohsu.edu/xd/education/schools/school-of-medicine/students/upload/Drug-
Testing-Information-4.pdf.  Most universities also employ the “prerequisite scheme” with student-
athletes.  See supra note 319.  For middle and secondary schools, courts have held that adolescent 
students who participate in athletics or school-sponsored extracurricular activities have reduced 
privacy rights and can be subjected to prerequisite consent forms.  Velasquez, supra note 311, at 
181–82; see also Bd. of Educ. of Indep. Sch. Dist. No. 92 v. Earls, 536 U.S. 822 (2002) (upholding 
random drug testing for all students who participate in extracurricular activities); Vernonia Sch. Dist. 
47J v. Acton, 515 U.S. 646 (1995) (upholding random drug testing for all student-athletes). 
 322.  Velasquez, supra note 311, at 181 (“Reasonable suspicion may result from an eyewitness 
account, a tip or information from a reliable source, suspicious behavior, drug or alcohol odor, or 
behavior consistent with intoxication.”). 
 323.  117 F.3d 866 (5th Cir. 1997). 
 324.  Id. at 882–83; see also KAPLIN & LEE, supra note 320, at 268 (noting that the nature of 
medical students’ work means medical universities have special reasons to prevent drug abuse).  For 
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implement clear rules that require drug testing of their respective students 
who exhibit the common signs of cognitive-enhancement drug abuse.325 
If public universities do not obtain students’ consent or rely on 
reasonable suspicion, they must establish that their drug testing policies 
further sufficient governmental interests326 and are reasonably 
administered.327  When drug-testing schemes apply to adults,328 courts 
repeatedly have held that such warrantless searches are valid under the 
Fourth Amendment if the governmental interests outweigh the individual’s 
constitutional rights.329  In medical and law schools, randomized drug testing 
targeted at medicinal cognitive-enhancement use furthers two governmental 
interests: academic integrity330 and student safety.331  Courts have found both 
concerns are valid state interests in Fourth Amendment analyses.332  
Therefore, public universities can implement drug-testing schemes that will 
pass constitutional muster if their applicable policies are also reasonably 
administered.333 
Reasonable administration considers the type of drug testing, the 
procedures for the drug testing, and the policy of confidentiality.334  
 
more information on drug-testing policies in the health-care sector, see Dana Devon, Drug Testing of 
Health Care Workers: Toward a Coherent Hospital Policy, 23 AM. J.L. & MED. 399, 400–08 (1997). 
 325.  See supra notes 131, 134, 137 and accompanying text (listing the common side effects for 
different cognitive enhancers). 
 326.  See supra note 318 and accompanying text. 
 327.  For instance, in Colorado v. Derdeyn, the Colorado Supreme Court held that mandatory 
drug testing for student-athletes, absent consent, was unconstitutional when the university failed to 
(1) specify the method of administration and (2) provide advance notice.  863 P.2d 929, 949–50 
(Colo. 1993). 
 328.  Again, most medical and law school students are adults.  See supra note 318. 
 329.  See, e.g., Nat’l Treasury Emps. Union v. Von Raab, 489 U.S. 656, 679 (1989) (drug testing 
U.S. Customs Service employees who dealt with drugs or possessed firearms); Skinner v. Ry. Labor 
Execs’ Ass’n, 489 U.S. 602, 628, 634 (1989) (drug testing railroad employees involved in 
accidents); Int’l Union v. Winters, 385 F.3d 1003, 1013 (6th Cir. 2004) (drug testing employees with 
law enforcement powers); Dimeo v. Griffin, 943 F.2d 679, 685 (7th Cir. 1991) (drug testing 
employees of the Illinois Racing Board); Int’l Bhd. of Teamsters, Chauffeurs, W. Conference of 
Teamsters v. Dep’t of Transp., 932 F.2d 1292, 1304–05 (9th Cir. 1991) (drug testing drivers of 
commercial vehicles). 
 330.  See supra notes 285–87 and accompanying text. 
 331.  See supra notes 131–81 and accompanying text. 
 332.  See Pavisian, supra note 42, at 201–04 (providing an in-depth examination into courts’ 
opinions and common-sense arguments that support drug-testing policies based on safety and 
academic integrity); see also Schieffelin, supra note 13, at 974 (noting that the government has a 
“special need” to ensure a fair and safe educational environment). 
 333.  See supra notes 326–27 and accompanying text. 
 334.  Pavisian, supra note 42, at 205–06 (explaining that courts measure reasonableness by 
weighing the proffered governmental interests with the testing intrusions). 
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Administrators can test different samples—such as urine, hair, sweat, and 
saliva—with varying degrees of intrusion.335  To avoid overly broad privacy 
infringement, some universities may only check for cognitive enhancers, and 
not for other illegal substances, to further the purpose of the medicinal 
screening.336  Procedures for drug testing focus on whether the testing should 
be randomly applied throughout the school year or predominantly 
administered before or after exams.337  They also consider how 
administrators should handle students with valid prescriptions—by either 
giving them pre-exemptions338 or requiring them to prove valid use after 
testing positive for cognitive-enhancer consumption.339  Lastly, drug testing 
necessitates policies of confidentiality to protect students’ privacy rights.340  
Inherent in privacy protection is the idea that positive drug-testing results 
will not result in criminal penalties because schools will deal with testing 
outcomes internally.341 
While drug testing is a viable method to combat the overarching 
problem of medicinal cognitive enhancement,342 school administrators may 
 
 335.  Id. at 205.  Pavisian recommends saliva testing as the most accurate, convenient, and least 
intrusive method.  Id.  Hair and sweat samples, while less intrusive than urinalysis, create too many 
false positives.  Id.  However, all types of drug testing are susceptible to error.  Velasquez, supra 
note 311, at 184.  Therefore, universities may wish to implement subsequent follow-up tests to 
combat the fears of flawed or inaccurate results.  See id. 
 336.  Schieffelin, supra note 13, at 976.  Because student safety is one of the governmental 
interests furthered by randomized drug testing, administrators may feel the need to also test for 
illegal substances.  See supra notes 331–32.  However, this will implicate privacy concerns to a 
larger extent, requiring the governmental interest to be even greater.  See supra note 334. 
 337.  Pavisian, supra note 42, at 206.  Because medical and law school students consume 
cognitive enhancers to improve their mental capabilities for final exams or papers, drug testing 
during final exam periods makes more sense.  See supra note 6 and accompanying text. 
 338.  See Pavisian, supra note 42, at 206–07; Schieffelin, supra note 13, at 976.  Administrators 
should only give preexemptions to students who can prove their prescriptions are for FDA-approved 
purposes, and not for off-label use.  See supra note 69.  For example, students who take Adderall for 
AD/HD can receive medical exemptions in a similar manner as athletes under the NCAA or WADA 
policies.  Pavisian, supra note 42, at 206–07; see also supra note 309. 
 339.  See Velasquez, supra note 311, at 184. 
 340.  Pavisian, supra note 42, at 206.  Pavisian suggests that universities can ensure 
confidentiality by replacing “student names with identification numbers to ensure that lab 
technicians are blindly testing the samples” and by limiting “the group of people involved in 
administering the tests, analyzing it, and reading the results.”  Id. 
 341.  Schieffelin, supra note 13, at 976; see also Velasquez, supra note 311, at 184 (stressing that 
schools should not use drug testing to academically or legally punish student drug users).  As one 
commentator noted, courts probably are “more open to allowing a drug-testing scheme that does not 
include jail time.”  Pavisian, supra note 42, at 207.  Because this drug testing is meant to catch 
scholastic cheaters, university administrators have the discretion to determine appropriate academic 
sanctions.  Schieffelin, supra note 13, at 976. 
 342.  Society has used drug testing to deter drug abuse since at least the 1960s, and, of course, 
medicinal cognitive enhancement is a form of drug abuse.  See supra notes 307–08 and 
accompanying text. 
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encounter other difficulties in its implementation—including expense,343 
logistics, and potential liability.344  Specifically in the medical and law 
school settings, drug screening serves to effectively negate the traditional 
honor code framework that forms the “bedrock” of their educational 
systems.345  Therefore, when weighing the pros and cons of drug-testing 
policies, universities should also consider two other deterrence methods—
transcript asterisking and early preventative action.346 
2. Transcript Asterisking 
Transcript asterisking347 enables administrators to mark students’ 
transcripts with indiscrete asterisks to indicate grades may be a result of 
cognitive-enhancer use—rather than solely talent or studious effort.348  An 
asterisking policy will not reduce a grade;349 instead, it will warn potential 
 
 343.  Expense is one of the biggest factors weighing against drug-testing policies, especially since 
the cost “will ultimately rest with the university and the student body.”  Pavisian, supra note 42, at 
205.  However, while urinalysis is expensive, other testing procedures are less expensive and 
continue to drop in cost.  See id.; Velasquez, supra note 311, at 184. 
 344.  Fenton & Wunderlich, supra note 44, at 21.  For a comparison of the advantages and 
disadvantages of drug-testing schemes, see Griffin et al., supra note 307, at 470–71. 
 345.  Fenton & Wunderlich, supra note 44, at 21; see also supra notes 22–23 and accompanying 
text. 
 346.  See supra note 298 and accompanying text. 
 347.  An asterisk “is a star-shaped symbol used in writing to serve as a reference point.”  Jody 
Weisel, Asterisk is Not a Dirty Word, 37 MOTOCROSS ACTION MAG. 154, 154 (Feb. 2009).  It 
indicates “there is more to the story” than a record, statistic, or file reveals on its face.  See id. 
 348.  See Fenton & Wunderlich, supra note 44, at 21.  This type of asterisk policy is commonly 
found in sports.  See, e.g., Karen Crouse, Swimming Bans High-Tech Suits, Ending an Era, N.Y. 
TIMES (July 24, 2009), http://www.nytimes.com/2009/07/25/sports/25swim.html (considering 
asterisks for athletes who wore swimsuits akin to “doping on a hanger”); Jere Longman, Track 
Hears a Call to Wipe Out Records, N.Y. TIMES (July 18, 2004), http://www.nytimes.com/ 
2004/07/18/sports/track-and-field-track-hears-a-call-to-wipe-out-records.html?pagewanted=all&src=pm 
(mentioning asterisks in international track and field annuals for drug use and faulty equipment); 
Tom Verducci, Is Baseball in the Asterisk Era?, SPORTS ILLUSTRATED (Mar. 15, 2004), 
http://sportsillustrated.cnn.com/vault/article/magazine/MAG1031393/index.htm (discussing asterisks 
for steroid use).  However, an asterisk essentially reflects disgust for cheating or alleged cheating in 
any competitive setting, not just sports.  Melinda Rosenberg, Nietzsche, Competition and Athletic 
Ability, 2 SPORT, ETHICS & PHIL. 274, 283 (2008); see also supra notes 234–35 and accompanying 
text (recognizing that medical and law schools are competitive environments). 
 349.  Rules that reduce grades when disciplining students for nonacademic conduct may be illegal 
depending on the jurisdiction.  Gary Chartier, Truth-Telling, Incommensurability, and the Ethics of 
Grading, 2003 BYU EDUC. & L.J. 37, 38.  For instance, in Smith v. School City of Hobart, a federal 
district court held that a school violated a student’s substantive due process rights when it reduced 
her grade by twenty percent as punishment for alcohol-related misconduct.  Smith v. Sch. City of 
Hobart, 811 F. Supp. 391, 399 (N.D. Ind. 1993).  However, courts also have taken the opposite 
stance, such as the Texas Tenth District Court of Appeals that rejected the claim that “an academic 
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employers350 that a grade may not “accurately reflect students’ abilities in 
the subject matter taught.”351  Essentially, asterisking has two effects: 
deterrence and exposure.352  “[I]t will deter those who understand that the 
behavior is unethical; and it will expose those who don’t.”353 
Transcript asterisking is an inexpensive and effective academic 
sanction354 that universities can employ for different forms of scholastic 
cheating.355  In terms of medicinal academic dishonesty, administrators can 
mark student files and transcripts for brain-boosting use if students (1) are 
caught taking cognitive enhancers356 or (2) test positive for cognitive 
 
penalty for non-academic disciplinary purposes is constitutionally unreasonable and impermissible.”  
New Braunfels Indep. Sch. Dist. v. Armke, 658 S.W.2d 330, 332 (Tex. App. 1983) (noting that the 
grade reduction came from school suspension relating to alcohol use).  The difficulty with medicinal 
cognitive enhancement is that it is both nonacademic drug abuse and academic dishonesty.  See 
supra notes 303–06 and accompanying text. 
 350.  It will also alert other graduate schools, certification boards, and bar examiners.  See Fenton 
& Wunderlich, supra note 44, at 21 (explaining that asterisking warns that a “student’s grade may be 
more reflective of a chemical induction”). 
 351.  Chartier, supra note 349, at 41.  Grades should represent natural abilities and retained 
knowledge: 
A grade is accurate to the extent that it permits someone to estimate the extent of a 
student’s knowledge and skills in a given area.  It is inaccurate to the extent that it leads 
someone to believe that she knows more or less than she does or that she can do more or 
less than she can. 
Id.; see also supra notes 211–13 and accompanying text.  Grades should not represent artificially 
acquired and transient capabilities.  See supra notes 237, 241–42 and accompanying text. 
 352.  Fenton & Wunderlich, supra note 44, at 21. 
 353.  Id. 
 354.  To compare asterisk policies with the expense of drug testing, see supra notes 343–44 and 
accompanying text. 
 355.  Many universities already use permanent transcript notations to punish academic dishonesty.  
See, e.g., Academic Integrity and the Judiciary Process: Frequently Asked Questions—Students, 
STONY BROOK UNIV., http://www.stonybrook.edu/uaa/academicjudiciary/faqistudent.shtml (last 
visited Mar. 4, 2012); The Code for General Behavior and Citizenship Expectations, TUFTS UNIV., 
available at http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cts=13308 
88437919&ved=0CDQQFjAA&url=http%3A%2F%2Fuss.tufts.edu%2Fstudentaffairs%2Fcodeofco
nduct%2Fgeneral_citizenship_expectations.doc&ei=jb1TT6uxC4LciAKMvrm0Bg&usg=AFQjCNH
84pWXcb5xiWjzVCUSsyonUhmgfg&sig2=hL2_Fe8BW8HRYT2SaT0qwg; Undergraduate 
Academic Ethics Board, JOHNS HOPKINS UNIV., http://www.jhu.edu/design/oliver/ 
academic_manual/ethics.html (last visited Mar. 4, 2012). 
 356.  Professors or other students who discover cognitive-enhancement drug use can report it in 
the same manner as any other form of academic cheating.  See supra note 350 and accompanying 
text.  For example, professors or students can approach either university administrators or academic 
honor boards.  See supra notes 22–23, 355 and accompanying text.  Accused students then have the 
opportunity to refute the charges or prove valid prescription use.  See supra notes 338–39 and 
accompanying text.  For examples of university honor codes, see The Medical Student Honor Code 
for the University of Washinton School of Medicine, UNIV. OF WASH., available at 
http://depts.washington.edu/honorsom/Honor_Code.pdf; Academic Honor Code: University of 
California, Irvine—School of Law, UNIV. OF CAL., IRVINE, available at http://www.law.uci.edu/ 
current/ UCI_Law_Honor_Code.pdf. 
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enhancers.357  For universities to validly facilitate asterisk procedures, they 
also must implement early preventive actions that specifically acknowledge 
that cognitive-enhancement drug use is an academic violation.358 
3. Early Preventative Action 
Because medical and law schools already require students to adhere to 
honor codes, they can execute preventative actions within this ethical 
framework.359  For example, they can include specific guidelines within 
these codes that address medicinal cheating and its resulting sanctions.360  
Additionally, orientations for first-year students can incorporate the signing 
of honor statements that explain the ethics of cognitive-enhancement drug 
use.361  Finally, mandatory professional responsibility and ethics courses362 
 
 357.  See supra note 341 and accompanying text.  If students opt out of voluntary drug-testing 
programs, universities can also use asterisks to note their non-participation.  See supra note 320 and 
accompanying text. 
 358.  See infra note 360 and accompanying text.  “[T]here is something to be said of declaring the 
conduct unethical in and of itself.  To many, they may not consider taking [cognitive enhancers] a 
form of cheating.  [S]chools should take a firm stance and announce that the conduct is against the 
rules.”  Fenton & Wunderlich, supra note 44, at 21. 
 359.  See supra notes 15, 22–23 and accompanying text. 
 360.  See supra notes 303–06 and accompanying text; see also supra note 356 (listing examples of 
university honor codes).  If honor codes state that cognitive-enhancement drug use is a form of 
academic dishonesty, then administrators will need to teach professors and honor board student 
members how to detect signs of this scholastic cheating.  See supra note 325 and accompanying text.  
Most honor codes also require student witnesses to report violations or face their own possible 
sanctions.  See Justin Imperato, Trust Flourishes When Students Enforce Their Own Honor Code, 
CHRISTIAN SCI. MONITOR, Nov. 7, 2000, at 15 (explaining the Statement of Non-Toleration); see 
also supra note 23. 
 361.  Fenton & Wunderlich, supra note 44, at 21–22 (“[O]nce people begin thinking about 
honesty, they stop cheating completely; although, when you remove the benchmark of ethical 
thought, they stray into dishonesty.”).  Dan Ariely, the author of Predictably Irrational, explored 
whether honor codes and professional oaths actually affected behavior: “He notes that occasional 
swearing of oaths and statements of adherence of rules are not enough.  Oaths and rules must be 
recalled at, or just before, the moment of temptation.  Students must be indoctrinated with honesty 
early on.”  Id. at 23; see also Tricia Bertram Gallant & Patrick Drinan, Organizational Theory and 
Student Cheating: Explanation, Responses, and Strategies, 77 J. HIGHER EDUC. 839, 850 (2006) 
(remarking that most researchers agree honor codes are not sufficient in and of themselves).  During 
high peak periods of potential cheating, such as finals weeks, schools can heed Ariely’s advice by 
reminding students about the honor statements they previously signed.  See David D. Wagaman & 
Ibolya Balog, Reminders Work Wonders with Ethics, PA. CPA J., Winter 2011, at 1, 2.  Furthermore, 
exam procedures can require students to sign and submit statements that represent they have not 
engaged in any form of academic cheating, including medicinal cognitive enhancement.  Fenton & 
Wunderlich, supra note 44, at 20 (discussing similar exam requirements for Loyola University 
Chicago School of Law); see also Gary Pavela, Encouraging Students to Stop Cheating, 
CURRICULUM REV., Jan. 1996, at 4, 4 (explaining exam procedures for the University of Maryland). 
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can discuss the safety, legal, and ethical implications of brain boosting as 
part of their curriculum.363  Even if instructors take just a day to address 
cognitive-enhancement drug abuse, their discussions will give validity to the 
scholastic problem and may engage the “moral imagination” of students in a 
way that will encourage them to embrace the values of their prospective 
professions.364 
B. The Drug War: Recruitment of Professional Organizations 
Besides university rules and honor codes, medical and law school 
students must also study and work under the restrictions and regulations 
imposed by their respective professional associations—including the AMA 
and ABA.365  Both of these associations have rules against illicit substance 
abuse and professional misconduct,366 but neither specifically tackles illegal 
or legal cognitive-enhancer consumption for the sole purposes of academic 
cheating.367 
In the medical profession, students are especially vulnerable to 
substance abuse because of their easy access to prescription medications.368  
For example, one survey reported that senior medical students and 
residents369 had a five to fifteen percent lifetime risk of developing a 
chemical dependence.370  The AMA plays a key role in assisting medical 
 
 362.  See supra notes 22–23 and accompanying text (explaining that medical and law school 
students must take an ethics course within their respective curriculum); see also McCulley, supra 
note 19, at 862 (suggesting the need for additional ethics education beyond one mandatory course). 
 363.  See Fenton & Wunderlich, supra note 44, at 23 (noting that many educators find ethics 
instruction sorely lacking).  Universities rarely discuss the ethics of drug use.  See Richard D. Aach 
et al., Alcohol and Other Substance Abuse and Impairment Among Physicians in Residency 
Training, 116 ANNALS INTERNAL MED. 245, 245–47 (1992).  For example, most medical schools do 
not provide educational programs on student drug abuse, do not have a formal system to address the 
problem, and do not train faculty to recognize the problem.  Id.; see also Barbara B. Blechner et al., 
The Jay Healey Technique: Teaching Law and Ethics to Medical and Dental Students, 20 AM. J.L. & 
MED. 439, 440–42 (1994) (describing and recommending a needed law and ethics program). 
 364.  See Fenton & Wunderlich, supra note 44, at 23; supra note 16 and accompanying text.  As 
one commentator aptly stated, “By implementing these suggestions, [medical and] law schools will 
play a more active role in [medical and] legal professionalism.”  McCulley, supra note 19, at 869. 
 365.  See supra notes 17–18 and accompanying text. 
 366.  See CODE OF MEDICAL ETHICS OP. 8.15 (1986) (addressing substance abuse among 
doctors); MODEL CODE OF PROF’L CONDUCT R. 8.4(b) (2010) (discussing professional misconduct 
among lawyers). 
 367.  See supra note 366 and accompanying text. 
 368.  Aach et al., supra note 363, at 245; see also Deborah Brooke et al., Addiction as an 
Occupational Hazard: 144 Doctors with Drug and Alcohol Problems, 86 BRIT. J. ADDICTION 1011, 
1011–12 (1991) (noting the same concern for physicians). 
 369.  Medical residents are newly graduated medical students who are training in medical 
residency programs.  David C. Yao & Scott M. Wright, The Challenge of Problem Residents, 16 J. 
GEN. INTERNAL MED. 486, 486 (2001). 
 370.  Edward C. Halperin et al., Pre-Placement Screening of Resident Physicians by Substance 
Abuse Testing: Efficacy, Cost, and Physician Opinions, 15 DRUGS: EDUC., PREVENTION & POL’Y 
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students, residents, and physicians with their alcohol and drug-related 
problems.371  The association even recommends drug testing for student 
doctors and residents in certain health positions to further the “highest 
traditions of the profession” because they have “voluntarily accepted 
behavioral and ethical standards” that govern their vocation.372  In keeping 
with this position, the AMA should adopt codes within the Principles of 
Medical Ethics373 that clearly discourage both illegal and legal cognitive-
enhancer consumption when utilized as a form of scholastic cheating.374  
Because studies have found links between medical student burnout and the 
propensity to cheat,375 the AMA can further its ethical regulations by 
continuing to encourage “medical schools to establish relationships between 
faculty members and students to promote a positive learning 
environment.”376  Finally, the AMA can approve and support Continuing 
Medical Education (CME)377 classes that discuss the ethics of cognitive-
 
77, 78 (2008) (noting that physicians have the same prevalent risk); see also Aach et al., supra note 
363, at 246 (listing other surveys for medical students and residents-in-training with varying results). 
 371.  See Aach et al., supra note 363, at 247. 
 372.  Devon, supra note 324, at 411.  The AMA also directly discourages student doctors from 
self-prescribing or prescribing medications for their peers.  See supra notes 122, 368 and 
accompanying text. 
 373.  See supra note 17 and accompanying text. 
 374.  See infra notes 387–89 and accompanying text.  The AMA already has a rule that addresses 
substance abuse: “It is unethical for a physician to practice medicine while under the influence of a 
controlled substance, alcohol, or other chemical agents which impair the ability to practice 
medicine.”  CODE OF MEDICAL ETHICS OP. 8.15 (1986).  However, this Opinion does not recognize 
cognitive-enhancer consumption as cheating.  See supra note 367.  The AMA can either (1) add a 
comment to this Opinion that specifically states cognitive-enhancement use is a form of cheating, or 
(2) adopt a new Opinion, such as “it is unethical for a medical student to practice or learn medicine 
while under the influence of an illegal or legal cognitive enhancer when utilized for cheating 
purposes.”  See supra note 367. 
 375.  See, e.g., Liselotte N. Dyrbye et al., Medical Student Distress: Causes, Consequences, and 
Proposed Solutions, 80 MAYO CLINIC PROC. 1613, 1616 (2005) [hereinafter Medical Student 
Distress]; Liselotte N. Dyrbye et al., Relationship Between Burnout and Professional Conduct and 
Attitudes Among US Medical Students, 304 J. AM. MED. ASS’N 1173, 1176–77 (2010). 
 376.  Medical Student Distress, supra note 375, at 1617–19 (listing other actions that the AMA 
can suggest—such as implementing student-led support programs, identifying and assisting 
struggling students, and teaching stress-coping skills). 
 377.  CME are educational courses that physicians must take to earn their required annual credits 
for continued certification.  See supra note 25 and accompanying text.  See generally Continuing 
Medical Education, AM. MED. ASS’N, http://www.ama-assn.org/ama/pub/education-careers/ 
continuing-medical-education/cme-credit-offerings.page? (last visited Mar. 4, 2012) (describing the 
importance of a physician’s continuing educational and professional development).  For more 
information on CME activities and the credit system, see The Physician’s Recognition Award and 
Credit System: Information for Accredited Providers and Physicians, AM. MED. ASS’N, 1–5 (2010), 
available at http://www.ama-assn.org/ama1/pub/upload/mm/455/pra-booklet.pdf. 
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enhancement drug use and teach physicians how to detect such medicinal 
abuse in their student doctors.378 
In a similar vein as the AMA, the ABA needs to explicitly state in the 
Model Rules of Professional Conduct379 that cognitive-enhancement drug 
abuse is a form of dishonesty or deceit that constitutes professional 
misconduct.380  Recognizing that medicinal brain boosting is an academic 
violation will allow bar examiners to use the existing ABA framework for 
evaluating the good moral character of legal applicants found guilty of such 
cheating.381  This legal professional association, which requires active 
lawyers to take Continuing Legal Education (CLE)382 classes in a manner 
comparable to the AMA,383 can also promote and endorse courses that 
 
 378.  See Yao & Wright, supra note 369, at 486–90 (explaining how residency program directors 
and attending physicians can identify and handle problem residents); see also supra note 360 (noting 
that medical and law schools also should teach professors and students how to recognize medicinal 
cognitive enhancement).  In a 2006 large-sample survey of health-care providers, respondents stated 
that ethics-based CME classes were more likely to assist them with more effective client care.  Mark 
E. Johnson et al., The Need for Continuing Education in Ethics as Reported by Rural and Urban 
Mental Health Care Providers, 37 PROF. PSYCHOL.: RES. & PRAC. 183, 184, 187 (2006).  
Specifically, they asked for more classes dealing with the ethical management of clients with 
substance abuse problems and the ethical issues of colleague misconduct.  Id. at 187.  The authors of 
the study challenged continuing education providers “to offer ethics learning experiences that not 
only provide critical information on key ethical issues, but also engage the learner by providing 
information on timely and relevant topics that can be applied on a daily basis.”  Id. at 188.  
Education on cognitive-enhancement drug use fits these criteria because it is a growing, relevant 
problem among medical students and physicians-in-training who provide health services and intern 
under the doctors taking the CME classes.  See supra notes 84, 372 and accompanying text. 
 379.  See supra note 18 and accompanying text. 
 380.  See McCulley, supra note 19, at 845.  Generally, the Model Rules already warn that lawyers 
will have to answer professionally for offenses of dishonesty and breach of trust.  Id. at 845–46; see 
also RONALD D. ROTUNDA, PROFESSIONAL RESPONSIBILITY 20 (3d ed. 1992) (“Conduct, whether or 
not a crime, that involves dishonesty, fraud, deceit, or misrepresentation, is disciplinable.”).  
Specifically, Rule 8.4(b) states, “It is professional misconduct for a lawyer to commit a criminal act 
that reflects adversely on the lawyer’s honesty, trustworthiness or fitness as a lawyer in other 
respects.”  MODEL CODE OF PROF’L CONDUCT R. 8.4(b) (2010).  While this Rule may encompass the 
illegal consumption of cognitive enhancers, the ABA can definitively address cognitive-
enhancement cheating by either (1) adding a comment to this Rule that specifically states that both 
illegal and legal cognitive-enhancement cheating is professional misconduct, or (2) adopting a new 
Rule, such as “it is professional misconduct for a law student to practice or learn law while under the 
influence of an illegal or legal cognitive enhancer when utilized for cheating purposes.”  See supra 
note 374 (suggesting similar phrasing for an AMA proposed rule). 
 381.  McCulley, supra note 19, at 846.  Bar examiners already consider an applicant’s academic 
violations in determining whether to certify the applicant for legal practice.  Id. at 846, 849 (noting 
that bar examiners also take an applicant’s suspected cheating and failure to disclose into account 
when assessing good moral character). 
 382.  ABA Model Rule for Continuing Legal Education and Comments, AM. BAR ASS’N, 1–2 
(2004), available at http://www.americanbar.org/content/dam/aba/migrated/2011_build/cle/mcle/ 
aba_model_rule_cle.authcheckdam.pdf (explaining that lawyers must acquire twelve to fifteen credit 
hours annually through CLE classes). 
 383.  See supra note 377 and accompanying text. 
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address medicinal brain boosting and its ethical implications.384  Lastly, the 
ABA should encourage law school administrators, professors, and lawyers to 
uphold its regulations against cognitive-enhancement drug abuse through 
their own respective programs, rules, and reporting methods.385  Only with 
the AMA and ABA’s official recognition and approval can medical and law 
schools begin to effectively combat Generation Rx’s growing trend of 
cognitive cheating.386 
V. CONCLUSION 
Cognitive enhancers improve the mental performance of the average 
consumer and arguably are appropriate brain-boosting tools for the majority 
of society.387  While numerous proponents lobby for general utilization of 
these prescription medications,388 medicinal cognitive enhancement abuse is 
not ethically appropriate in the higher-educational setting of medical and law 
schools.389  Instead, such use is equivalent to academic cheating.390  Both 
university administrators and professional organizations need to address this 
growing trend of dishonesty before new, more potent memory drugs hit the 
scholastic market.391  Further, the adoption of clear prohibitions against 
cognitive-enhancement drug abuse will enable these respective parties to 
monitor and prevent Generation Rx’s latest cheating technique.392 
 
 384.  See supra note 378 and accompanying text.  While medical students work with practicing 
physicians in clinical programs, law students intern with lawyers through clinics and externships.  
James Backman, Externships and New Lawyer Mentoring: The Practicing Lawyer’s Role in 
Educating New Lawyers, 24 BYU J. PUB. L. 65, 65–66 (2009).  Therefore, lawyers who recognize 
the signs of cognitive-enhancer abuse will facilitate prevention in the same way as informed 
physicians.  See supra note 378 and accompanying text.  For example, under the Model Rules, 
lawyers who supply character references for bar applicants are discouraged from recommending 
applicants who demonstrate behavior not in accord with good moral character.  ROTUNDA, supra 
note 380, at 29.  If a lawyer discovers that a student is cognitively cheating, he should not 
recommend that student for legal certification.  Id.  He also may “volunteer [this] unfavorable 
information to the bar authorities about an applicant” to support “ethical aspiration[s].”  Id. at 30; see 
also MODEL CODE OF PROF’L CONDUCT R. 8.1 (2010). 
 385.  See supra notes 306, 381, 384 and accompanying text. 
 386.  See supra notes 374, 380 and accompanying text. 
 387.  See supra notes 4–7, 124 and accompanying text. 
 388.  See supra notes 10, 124, 281 and accompanying text. 
 389.  See supra notes 282–86 and accompanying text. 
 390.  See supra note 283 and accompanying text. 
 391.  See Goodman, supra note 81, at 148–49; supra notes 287–90 and accompanying text. 
 392.  See supra notes 360, 386 and accompanying text. 
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